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 General Introduction  
1 Gastric helicobacters in humans and pigs  
 
It was first reported in 1984 that gastritis and gastric ulcer disease in humans can be 
caused by a curved bacterium (Marshall and Warren, 1984), which was named Helicobacter 
pylori in 1989 (Goodwin et al., 1989). Nowadays, it is clear that this bacterium plays an 
important role in the development of gastritis, peptic ulcer disease, gastric adenocarcinoma 
and mucosa-associated lymphoid tissue (MALT) lymphoma (Parsonnet et al., 1991; Stolte et 
al., 1993; Kusters et al., 1996). This bacterium is very successful in the way that it colonizes 
the human stomach, since in developing countries, more than 80% of the population is 
infected with H. pylori, even at young age. In more developed countries, the prevalence rate 
of H. pylori generally remains under 40% and is considerably lower in children and 
adolescents than in adults and elderly people (Kusters et al., 2006; Pounder and Ng, 1995).  
On histology, H. pylori bacteria are identified on the basis of their typical localization 
in gastric mucus or closely associated with mucus-secreting gastric epithelial cells and their 
characteristic, slightly curve-shaped morphology (Testerman et al., 2001). H. pylori, however, 
is not the only bacterial pathogen capable of colonizing the human gastric mucosa. Indeed, 
non-H. pylori helicobacters with a typical spiral-shaped morphology have been found in 0.2 to 
6% of gastric biopsies (Heilmann and Borchard, 1991; Stolte et al., 1994; Svec et al., 2000; 
Solnick et al., 2003). These spiral-shaped non-H. pylori helicobacters were first described in 
1987 (Dent et al., 1987) and were originally referred to as “Gastrospirillum hominis” 
(McNulty et al., 1989). Analysis of the 16S rRNA gene of these uncultivated organisms 
resulted in their classification in the genus Helicobacter. They were provisionally named “H. 
heilmannii” after the German pathologist Konrad Heilmann, who first studied the pathology 
associated with these microorganisms (Heilmann and Borchard, 1991). Humans infected with 
these large spiral-shaped organisms have been reported to suffer from gastritis (Stolte et al., 
1997) sometimes accompanied by gastric ulcer, gastric MALT lymphoma and even gastric 
adenocarcinoma (Stolte et al., 1997; Debongnie et al., 1998; Morgner et al., 1995; Morgner et 
al., 2000). Further research on “H. heilmannii” has been seriously hampered by the very 
fastidious nature of these microorganisms. Even today, to our knowledge, only two “H. 
heilmannii” strains have been cultured from human tissue (Andersen et al., 1996; Kivistö et 
al., 2010). Recent investigations, however, have shown that these gastric non-H. pylori 
helicobacters comprise different species which have been detected in the stomach of different 
animal species (De Groote et al., 2005; Van den Bulck et al., 2005). 
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1.1 Gastric non-H. pylori Helicobacter nomenclature 
 
Since the description of H. pylori, the number of species in the genus Helicobacter has 
rapidly expanded. Today, a large number of non-H. pylori Helicobacter species have been 
described in a wide variety of animals and humans and the genus Helicobacter contains at 
least 32 species with validly published names (http://www.bacterio.cict.fr/h/ 
helicobacter.html). The frequent changes in nomenclature of non-H. pylori helicobacters 
colonizing the stomach of humans have caused much confusion, not only among clinicians, 
but also among bacteriologists. Today, there is a serious problem in trying to reach 
international agreement on the nomenclature of this complex and expanding group of micro-
organisms, all of which have in common their tightly coiled morphology and their difficulty 
to culture in vitro. 
Subsequent to the renaming of “Gastrospirillum hominis” as “H. heilmannii”, further 
genetic analysis of the 16S rRNA gene revealed two types that differed by more than 3% in 
their nucleotide sequence, which prompted the subclassification of the non-H. pylori 
helicobacters into “H. heilmannii” type 1 and “H. heilmannii” type 2.  
It is now accepted that “H. heilmannii” type 1 is identical to the recently cultured and 
described Helicobacter suis, formerly “Candidatus Helicobacter suis” (De Groote et al., 
1999; O’Rourke et al., 2004b; Baele et al., 2008b), a spiral-shaped bacterium that colonizes 
the stomach of more than 60 % of slaughter pigs (Mendes et al., 1991; Grasso et al., 1996; 
Park et al., 2004; Hellemans et al., 2007b). This micro-organism was first designated 
“Gastrospirillum suis” (Mendes et al., 1990, Queiroz et al., 1990). Almost ten years later, 
sequencing of the 16S rRNA gene, fluorescent in-situ hybridization (FISH) and electron 
microscopy showed that this organism belongs to the genus Helicobacter and is sufficiently 
different from all existing species to constitute a new taxon. Because at that time this species 
could not be thoroughly characterized due to the lack of pure in vitro isolates, the organism 
was described as “Candidatus Helicobacter suis” (De Groote et al., 1999). Only a few years 
ago, a successful in vitro cultivation method has been developed, resulting in the valid 
description of H. suis as a species (Baele et al., 2008b). 
The situation with regard to “H. heilmannii” type 2 is even more complex. This type 
does not represent a single Helicobacter species but rather a group of species, including H. 
felis, H. bizzozeronii and H. salomonis, which all three have been isolated from the stomachs 
of cats and dogs. To add to the confusion, one uncultivable species detected in the stomachs 
of humans, wild felids, dogs and cats was named “Candidatus Helicobacter heilmannii” 
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(O’Rourke et al., 2004b). Very recently, however, we succeeded in isolating this bacterium 
from the gastric mucosa of cats and proposed the name Helicobacter heilmannii (Smet et al., 
2011). Two other closely related species, one of which was isolated from a dog and the other 
from a cat, have been described as H. cynogastricus and H. baculiformis, respectively (Van 
den Bulck et al., 2006; Baele et al., 2008a). For the latter two species, however, no 
information is available about their presence in humans. 
Besides the fact that all non-H. pylori Helicobacter species are spiral-shaped and 
possess variable numbers of bipolar flagella, differences in morphology between different 
non-H. pylori Helicobacter species have been described. H. felis is characterized by the 
presence of periplasmic fibrils, which can be lost during in vitro cultures (Eaton et al., 1996). 
Similarly, H. cynogastricus and H. baculiformis possess periplasmic fibrils (Van den Bulck et 
al., 2006; Baele et al., 2008) while H. bizzozeronii, H. salomonis, H. heilmannii and H. suis 
do not have periplasmic fibrils (Hänninen et al., 1996; Jalava et al., 1997; Baele et al., 2008; 
Smet et al., 2011). H. felis and H. bizzozeronii are large and tightly coiled organisms (Lee et 
al.,1988; Hänninen et al., 1996), whereas H. salomonis is shorter and less tightly coiled 
(Jalava et al., 1997). H. cynogastricus generally is the largest non-H. pylori Helicobacter 
species and upon repeated subculture the bacteria become less tightly coiled. H. baculiformis 
is a large, slender to slightly spiral rod with periplasmic fibrils (Baele et al., 2008a). The 
recently isolated H. heilmannii is morphologically very similar to H. suis and both species 
possess tight coils (De Groote et al., 1999; Baele et al., 2008b; Smet et al., 2011). Despite 
these differences and because, based on our observations and those of others (Eaton et al., 
1996), morphology can slightly alter when cultured in vitro or after repeated subculture, 
microscopic investigation of biopsy samples is not an accurate method for species 
identification. 
Sequencing of the 16S and 23S ribosomal RNA encoding genes allows differentiation 
of H. suis from the other gastric non-H. pylori Helicobacter species mentioned above, but it 
can not distinguish between H. felis, H. bizzozeronii, H. salomonis, H. cynogastricus, H. 
baculiformis and “Candidatus H. heilmannii” (Dewhirst et al., 2005; Van den Bulck et al., 
2006; Baele et al., 2008). For differentiation between these species sequencing of the hsp60 
gene (Mikkonen et al., 2004), the urease A and B genes (Neiger et al., 1998; O’Rourke et al., 
2004b) and gyrB gene (Hannula and Hänninen, 2007) is useful, as well as whole cell protein 
profiling (Vandamme et al., 2000) if pure in vitro cultures are available.  
Phylogenetic trees for the gastric helicobacters are shown in Figure 1 (16S rRNA gene 
sequence) and Figure 2 (partial ureA and ureB gene sequences). 
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Figure 1: Phylogenetic tree, based on the near-complete 16S rRNA gene sequences from gastric Helicobacter 
species and other closely related bacteria. Sequences were aligned by using the CLUSTAL W program 
(Thompson et al., 1994) and a phylogenetic tree was constructed using the neighbour-joining method (Saitou & 
Nei, 1987) via the PHYLIP package (Felsenstein, 1989), using DNADIST for distance analysis (Kimura, 1980). 
Bootstrap values (for branches present in more than 50 out of 100 resamplings of the data) are indicated at the 
nodes. Original names found at the Entrez Nucleotide database (NCBI) are shown between brackets. Sequences 
marked with an * are derived from bacteria present in the stomach of humans. Bar, 0.1 substitution per 
nucleotide position.  
 
 
 
H. suis (Gastrospirillum hominis clone G1A1) L10079*
H. suis HU1 (‘H. heilmannii’ HU1) AF506784*
H. suis HU3 (‘H. heilmannii HU3) AF506771*
H. suis HU4 (‘H. heilmannii’ HU4)AF506773*
H. suis P1 (‘H. heilmannii’ P1) AF506787
H. suis HS1 (‘Candidatus H. suis’ HS1) EF204589
H. suis HU5 (‘H. heilmannii’ HU5) AF506769*
H. suis V2BXA AF127028
H. suis HS2 (‘Candidatus H. suis HS2) EF204590
H. suis HS3 (‘Candidatus H. suis HS3) EF204591
H. suis CM1 (‘H. heilmannii’ CM1) AF506780
H. suis RM2 (‘H. heilmannii’ RM2) AF506792
H. suis MM1 (‘H. heilmannii’ MM1) AF506782
H. bizzozeronii RH53 (‘H. heilmannii’) Y18028*
‘Candidatus H. heilmannii’ BC1 (‘H. heilmannii’ BC1) AF506772
H. bizzozeronii ATCC 700031 AF302107
H. felis ATCC 49179;CS1 M57398
H. salomonis Inkinen U89351
H. cynogastricus JKM4 DQ004689
H. baculiformis M50 EF070342
‘Candidatus H. heilmannii’ HU2 (‘H. heilmannii’ HU2) AF506786*
‘Candidatus H. heilmannii’ (Gastrospirillum hominis clone G2A9) L10080*
H. acinonychis Eaton 90-1908-3 (H. acinonyx Eaton 90-1908-3) M88149
H. pylori ATCC 43504 AF302106*
H. pylori ATCC 49396 (H. nemestrinae ATCC 49396) AF363064
H. pylori SS1 AY366421*
‘Candidatus H. bovis’ R2XA AF127027
H. mustelae ATCC 43772 M35048
H. bilis Hb1; MIT 93-1909 U18766
W. succinogenes ATCC 29543 M88159
H. muridarum ATCC 49282; ST1 M80205
H. aurati MIT 97-5075c AF2978680.1
50
53
97
84
100
100
100
100
70
59
99
100
90
55
61
51
97
68
61
57
60
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Figure 2: Phylogenetic tree, based on the partial ureA and ureB gene sequences from gastric Helicobacter 
species and other closely related bacteria. Sequences were aligned by using the CLUSTAL W program 
(Thompson et al., 1994) and a phylogenetic tree was constructed using the neighbor-joining method (Saitou and 
Nei, 1987) via the PHYLIP package (Felsenstein, 1989), using DNADIST for distance analysis (Kimura, 1980). 
Bootstrap values (for branches present in more than 50 out of 100 resamplings of the data) are indicated at the 
nodes. Original names found at the Entrez Nucleotide database (NCBI) are shown between brackets. Sequences 
marked with an * are derived from bacteria present in the stomach of humans. Bar, 0.1 substitution per 
nucleotide position.  
 
In literature, gastric infections with spiral-shaped bacteria in humans are often referred 
to as “H. heilmanni” or “H. heilmannii”-like organism infections. However, at present, the 
name “H. heilmannii“ should be reserved to the species as described by Smet et al. (2011) and 
should no longer be used as a covering name, according to taxonomical rules. To avoid 
confusion, we propose to use the term “gastric non-H. pylori helicobacters” to designate these 
spiral-shaped bacteria when only results of histopathology or crude taxonomic data are 
available and to reserve true species designations for those situations in which the species is 
defined. 
 
 
 
0.1
H. pylori 26695 AF507994*
H. pylori OB AY368264*
H. pylori DA AY368262/1*
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H. hepaticus ATCC 51449 AF066862
H. baculiformis M50 EF070343
H. salomonis 06 AY368266
H. salomonis Inkinen AF508005
H. felis DS5 AY368261
H. felis WD1 (‘Candidatus H. heilmannii’ WD1) AF508011
H. felis ATCC 49179;CS1 AF508004
H. felis C4E (‘Candidatus H. heilmannii’ C4E) AF508000
H. cynogastricus JKM4 EF070340
H. bizzozeronii Storkis; CCUG 35545 AF508003
H. bizzozeronii 14 AF508002
‘Candidatus H. heilmannii’ C3E AF507999
‘Candidatus H. heilmannii’ BC1 AF507996
‘Candidatus H. heilmannii’ T1 AF508017
‘Candidatus H. heilmannii’ HU2 AF508012*
‘Candidatus H. heilmannii’ (‘H. heilmannii’) L25079*
H. suis CM2 (‘Candidatus H. heilmannii’ CM2) AF508007
H. suis P4 (‘Candidatus H. heilmannii’ P4) AF508013
H. suis HU1 (‘Candidatus H. heilmannii’ HU1) AF508010*
H. suis HU4 (‘Candidatus H. heilmannii’ HU4) AF508001*
H. suis HU3 (‘Candidatus H. heilmannii’ HU3) AF507995*
H. suis HS1 (‘Candidatus H. suis’ HS1) EF204592
H. suis HS2 (‘Candidatus H. suis’ HS2) EF204593
H. suis HS3 (‘Candidatus H. suis’ HS3) EF204594
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 12 
 
 General Introduction 
1.2 Gastric non-H. pylori helicobacters in humans 
1.2.1 Origin of infection 
 
In 1999, Andersen and coworkers succeeded for the first time in the in vitro isolation 
of a non-H. pylori Helicobacter strain from human gastric mucosa. Later, phenotypic 
analysis, sequencing of the 16S rRNA gene, DNA-DNA hybridization analysis and whole-cell 
protein profiling revealed that this isolate belongs to the species H. bizzozeronii (Jalava et al., 
2001). Recently, another in vitro isolate was obtained from a human gastric non-H. pylori 
Helicobacter infection. Despite the low prevalence of H. bizzozeronii in human biopsies, 
polyphasic identification analysis revealed that this second isolate also belonged to this 
species (Kivistö et al., 2010). O’Rourke et al. (2004b) demonstrated that 3 human and 4 
porcine non-H. pylori Helicobacter strains isolated in vivo in mice showed a very high degree 
of homology, based on 16S rRNA and partial ureA and ureB gene sequences. This led to the 
conclusion that they represent the same species, later described as H. suis (O’Rourke et al., 
2004b; Baele et al., 2008). Another human in vivo isolate in this study was shown to cluster 
with helicobacters from domestic and wild feline species and was designated ‘Candidatus 
Helicobacter heilmannii’ (O’Rourke et al., 2004b). 
The prevalence of non-H. pylori helicobacters in humans suffering from gastric 
disease varies between 0.1 and 6% (Stolte et al., 1994; Boyanova et al., 2003; Yang et al., 
1998; Yali et al., 1998; Ierardi et al., 2001). Although the exact mechanisms of transfer 
remain largely unknown, human infections with non-H. pylori Helicobacter organisms most 
likely originate from animals. Several case reports suggest the transmission of these large 
spiral-shaped bacteria from dogs to humans (Thomson et al., 1994; Jalava et al., 2001; De 
Bock et al., 2007) or from cats to humans (Lavelle et al., 1994; Stolte et al., 1994; Dieterich et 
al., 1998; van Loon et al., 2003; Hiroshi et al., 2008). Additionally, it has been shown that 
living in close proximity to dogs, cats and especially pigs is a significant risk factor for 
contracting these infections (Meining et al., 1998). The intensity of contact with animals is 
thought to be important as well, since a higher incidence of these infections has been noted in 
pig farmers and people having intensive contact with pet animals (Stolte et al., 1994; 
Yoshimura et al., 2002; van Loon et al., 2003). It is remarkable that H. suis is the most 
prevalent gastric non-H. pylori Helicobacter species in humans (Trebesius et al., 2001; Van 
den Bulck et al., 2005). This might indicate that the infectivity in humans of cat- or dog-
related strains is less than that of H. suis, or else that consumption of contaminated pig meat 
might also be an, albeit sporadic, source of infection. 
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1.2.2 Clinical significance of gastric non-H. pylori Helicobacter infections in humans 
 
Reports in literature about human non-H. pylori helicobacter infections often lack a 
detailed description of the exact causative Helicobacter species and should therefore be 
interpreted with caution. Clinical symptoms associated with non-H. pylori helicobacters in 
man can be characterized by atypical complaints such as acute or chronic epigastric pain and 
nausea. Other aspecific symptoms include dyspepsia, heartburn, vomiting, hematemesis, 
abdominal pain, irregular defecation frequency and consistency, and dysphagia, often 
accompanied by a decreased appetite (Morgner et al., 1995; Goddard et al., 1997; Dieterich et 
al., 1998; Yang et al., 1998; Mention et al., 1999; Yoshimura et al., 2002; Seo et al., 2003; 
Sykora et al., 2003; Van Loon et al., 2003). However, some people infected with non-H. 
pylori helicobacters do not present obvious clinical signs (Mazzucchelli et al., 1993). 
Very often, inspection of the gastric mucosa through endoscopy is performed in 
humans suffering from gastric disease. In persons infected with long spiral bacteria, a variety 
of lesions is observed, ranging from a normal to slightly hyperemic mucosa, mucosal edema, 
nodular inflammation, and the presence of multiple erosions and ulcerations in the antrum or 
in the duodenum (Goddard et al., 1997; Debongnie et al, 1998; Dieterich et al., 1998; Mention 
et al., 1999; Yoshimura et al., 2002; Seo et al., 2003; Sykora et al., 2003; Van Loon et al., 
2003). In contrast to a H. pylori infection, non-H. pylori Helicobacter colonization is 
predominantly focal and is found predominantly in the antrum (Stolte et al., 1997). 
Microscopic examination of gastric biopsies of non-H. pylori Helicobacter-infected patients 
often reveals a chronic gastritis, characterized by infiltration with lymphocytes and plasma 
cells, sometimes organized into lymphoid aggregates (Morgner et al., 1995; Stolte et al., 
1997; Ierardi et al., 2001; Sykora et al., 2003; Van Loon et al., 2003). Compared to a H. 
pylori-associated gastritis, gastritis associated with non-H. pylori helicobacters is mostly less 
active and less severe (Stolte et al., 1997), although a predominant acute neutrophilic 
inflammation can also be observed (Yoshimura et al., 2002). Other lesions, such as atrophic 
gastritis and intestinal metaplasia, are rare and observed less frequently in humans infected 
with non-H. pylori helicobacters compared to H. pylori-infected patients (Debongnie et al., 
1995; Goddard et al., 1997; Stolte et al., 1997). 
Interestingly, the risk of developing MALT lymphoma is higher with non-H. pylori 
helicobacters than with H. pylori (Stolte et al., 1997 and 2002; Morgner et al., 2000). Both 
gastritis and MALT lymphoma have been reported to resolve after clearance of the non-H. 
pylori Helicobacter infections, further underlining the causal relationship (Morgner et al., 
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2000). Again, however, no description of the exact Helicobacter species was included. Only 
occasionally, the presence of non-H. pylori Helicobacter bacteria has been associated with 
gastric adenocarcinoma, mostly accompanied by necrosis and erosive or ulcerative lesions 
(Yang et al., 1995; Morgner et al., 1995). This is accompanied by a mild non-active gastritis 
in the corpus tissue surrounding the tumor and a mild, moderately active gastritis in the 
antrum. 
 
1.3 Helicobacter suis in pigs 
  
 In 1990, the first description of large, spiral-shaped bacteria in the mucus layer of 
lumen and antral pits of pig stomachs was made (Mendes et al., 1990; Queiroz et al., 1990). 
Initially, “Gastrospirillum suis” was proposed as a name, but subsequent characterization 
showed that this organism in fact belonged to the genus Helicobacter (De Groote et al., 1999). 
A new name, ‘Candidatus Helicobacter suis’ was then proposed and despite numerous 
attempts worldwide, the first successful in vitro isolate was only obtained in 2007, by using a 
new biphasic culture method, which finally led to the description of H. suis as a new species 
(Baele et al., 2008b). Sequence analysis of 16S rRNA, 23S rRNA, partial hsp60 and partial 
ureAB gene sequences confirmed that H. suis is identical to the previously called “H. 
heilmannii” type 1, colonizing the stomach of humans and other primates (O’Rourke et al., 
2004b).  
  
1.3.1 Prevalence of Helicobacter suis in pigs 
 
The pig stomach is often colonized by Helicobacter suis. Its reported prevalence 
depends on the study. Mostly, however, this bacterium is detected in more than 60% of the 
pigs at slaughter age (Barbosa et al., 1995; Grasso et al., 1996; Cantet et al., 1999; Park et al., 
2004; Hellemans et al., 2007b). Recently, similar prevalences have been described in the US, 
with varying prevalence rates depending on the geographic region (Kopta et al., 2010). 
Despite a very high prevalence in adult pigs, much lower degrees of infection have been 
shown in younger animals. Hellemans et al. (2007b) detected a prevalence of only 2% in 
suckling piglets, which however increased rapidly after weaning. This might be due to the 
protective effect of sow milk, which has been shown to inhibit H. pylori colonization in mice 
through the presence of H. pylori-binding epitopes on milk proteins (Gustafsson et al., 2006).  
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1.3.2 Possible role of Helicobacter suis in porcine gastric pathology 
 
Gastric H. suis infection in pigs has been shown to cause gastritis in experimentally 
and naturally infected pigs, mainly in the antrum (Mendes et al., 1991; Grasso et al., 1996; 
Queiroz et al., 1996; Park et al., 2000; Hellemans et al., 2007a; Kumar et al., unpublished 
results). This gastritis shows a spatial association with the main site of colonization, as shown 
in experimentally infected pigs (Hellemans et al., 2007a; Kumar et al., unpublished results). 
Sapierzynski et al. (2007) demonstrated that an H. suis infection in pigs results in an increased 
number of gastrin producing cells and a decreased number of somatostatin producing cells. 
Since gastrin stimulates and somatostatin inhibits the secretion of hydrochloric acid by 
parietal cells, this may result in excessive acid production.  
The non-glandular part of the pig stomach is a small rectangular area around the 
esophageal opening, covered by a stratified squamous epithelium and also called the pars 
esophagea of the stomach. Besides the strong association with gastritis, H. suis infection has 
also been associated with ulcers of this non-glandular part of the stomach, although H. suis 
bacteria probably do not colonize this specific stomach region (Barbosa et al., 1995; Queiroz 
et al., 1996; Choi et al., 2001; Roosendaal et al., 2000; Hellemans et al., 2007b). Other 
research groups did not find this association (Grasso et al., 1996; Cantet et al., 1999; 
Melnichouk et al., 1999; Park et al., 2000; Szeredi et al., 2005), so the exact role of H. suis in 
the development of these lesions remains to be elucidated. The discrepancies found in 
literature may be due to differences in laboratory techniques for demonstration of 
Helicobacter, different sampling practices or differences in virulence between different H. 
suis strains. In any case, hyperkeratosis and ulceration of the non-glandular part of the 
stomach have been reported in many countries (Friendship et al., 2006). Up to 80% of the 
market pigs in Australia (Robertson et al., 2002) and 60% of the sows (Hessing et al., 1992) in 
the Netherlands have been described to present gastric lesions.  
The development of lesions in the non-glandular pars esophagea is most likely a 
process involving different factors, including stress, transport, the presence in the stomach of 
short chain fatty acids and pelleting and fine grinding of the feed (Potkins et al., 1989;  
Hessing et al., 1992; Elbers et al., 1994; Argenzio et al., 1995). The latter factor could have an 
influence on the fluidity of gastric contents (Elbers et al., 1994), leading to an increased 
contact of the stratified squamous epithelium of the non-glandular region with the luminal 
content of the distal part with acid, bile (refluxed from the duodenum) and pepsin. Chronic 
insult of the non-glandular region will eventually lead to ulceration.   
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Ulceration of the porcine gastric non-glandular mucosa may result in decreased feed 
intake, a decrease in daily weight gain and even sudden death due to fatal hemorrhage (Ayles 
et al., 1996; Friendship et al., 2006), thus leading to significant economic losses. There is also 
little doubt that this disease can cause pain and discomfort. Interestingly, a decrease in daily 
weight gain has also been observed in pigs experimentally infected with H. suis, however 
without a clear association with the development of lesions of the non-glandular part of the 
stomach (Kumar et al., 2010). 
Besides H. suis, other Helicobacter species have been described in the stomach of 
pigs, including a H. pylori-like bacterium, responsible for the development of ulcers of the 
pars esophagea in gnotobiotic piglets (Krakowka et al., 2006), H. bilis and H. trogontum 
(Hänninen et al., 2003 and 2005). The main site of colonization of the latter two is most 
probably the lower intestinal tract and it remains to be determined whether these bacteria are 
able to colonize the porcine stomach and cause gastric pathology.  
 
 
2 The host response to Helicobacter pylori infection 
 
Throughout the years, H. pylori has adapted to its host in a remarkable way. Infection 
with this bacterium persists for life, despite the development of an often distinct host response 
(Wilson and Crabtree, 2007). Because the evoked inflammation plays a central role in H. 
pylori-induced gastric pathology, a brief overview (summarized in Figure 3) is distilled from 
the abundance of available literature. 
 
2.1 Innate immune recognition of H. pylori 
 
H. pylori is mainly considered an extracellular pathogen, implying that the interactions 
with epithelial cells are important for the induction of the host response. Toll-like receptors 
(TLR) are important pathogen-recognition molecules (PRM) expressed by epithelial cells and 
cells of the innate immunity system, including dendritic cells and macrophages (Kaparakis et 
al., 2010), and TLRs are involved in the recognition of pathogen-associated molecular 
patterns (PAMP). TLR2, -4, -5 and -9 are expressed by gastric epithelial cells in the antrum 
and corpus of both patients suffering from H. pylori gastritis and those with a non-inflamed 
gastric mucosa (Schmausser et al., 2004). H. pylori LPS has been shown to activate NF-κB 
through TLR2 (Smith et al., 2003), while most authors agree that H. pylori can not be 
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recognized by TLR4 (Backhëd et al., 2003; Smith et al., 2003). Bacterial flagellin is typically 
recognized by TLR5, but conflicting reports have been made about a possible recognition of 
H. pylori flagellin by this specific receptor (Smith et al., 2003; Andersen-Nissen et al., 2005). 
Besides LPS, also the H. pylori neutrophil-activating protein (HP-NAP) has been described as 
a TLR2 agonist (Amedei et al., 2006). Eventually, the recruitment of myeloid differentiation 
primary response gene 88 (MyD88) to the formed TLR complex leads to activation of 
transcription factors NF-κB or activator protein-1 (AP-1) and production of pro-inflammatory 
cytokines (Allison et al., 2009; Kaparakis et al., 2010).  
In addition to surface-expressed TLR’s, cytosolic PRM’s also exist, including the 
nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) family. Nod1 has 
been shown to be responsible for the recognition  of H. pylori peptidoglycan, delivered by the 
type IV secretion system (Viala et al., 2004). This results in the induction of NK-κB 
activation and subsequent production of pro-inflammatory cytokines, including CXCL-8 (IL-
8) and a murine IL-8 homologue, CXCL-2 (Viala et al., 2004), although other mechanisms 
are also involved here, as shown by the fact that direct contact between epithelial cells and 
metabolically inactive bacteria is sufficient to induce IL-8 expression (Rieder et al., 1996). 
Interestingly, transformation of H. pylori  to coccoid forms, which retain their infectious 
ability (Wang et al., 1997), promotes their escape from Nod1 detection, which probably 
involves modifications of cell wall peptidoglycan (Chaput et al., 2006). A variety of other 
receptor proteins have been shown to play a role in innate H. pylori immunity, including 
triggering receptors expressed on myeloid cells (TREM) (Kaparakis et al., 2010). 
 
2.2 Inflammatory cells involved in the H. pylori-induced innate and acquired immune 
response  
 
After production of pro-inflammatory cytokines by epithelial cells exposed to H. 
pylori, innate immune cells are recruited, including neutrophils, macrophages and dendritic 
cells (Kaparakis et al., 2010). An important H. pylori factor involved in enhancement of early 
immune responses is the H. pylori neutrophil activating protein (HP-NAP). Interestingly, a 
homologue of the coding gene is found in the H. suis genome (Vermoote et al., 2011). HP-
NAP promotes the adherence of neutrophils to endothelium, transendothelial migration of 
neutrophils, chemotaxis of leukocytes and the release of ROS by neutrophils and monocytes 
(Evans et al., 1995; Satin et al., 2000 ; Montecucco and de Bernard, 2003; Brisslert et al. 
2005; Polenghi et al., 2007). Macrophages and dendritic cells are important for the 
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recruitment of CD4+ T helper (Th) cells to the gastric mucosa, which orchestrate the adaptive 
immune response. After stimulation of peripheral blood mononuclear cells with whole H. 
pylori bacteria or bacterial products, expression of cytokines as IFN-γ and IL-12 is 
upregulated, eliciting a predominant Th1 response (Haeberle et al., 1997; Meyer et al., 2000; 
Kaparakis et al., 2010). In H. pylori-infected patients, most infiltrating CD4+ T cells indeed 
show a Th1 phenotype (Sommer et al., 1998; Bamford et al., 1998), although cells showing a 
Th1 and a Th2 phenotype have both been observed in the H. pylori-infected gastric mucosa 
(Robinson and Atherton, 2010). This was confirmed in numerous experimental mouse 
infection studies. For instance, Smythies et al. (2000) have shown that, in C57BL/6 mice, H. 
pylori-elicited inflammation is regulated by an increase of IFN-γ expression and a 
downregulation of IL-4 expression, which is a distinct Th2 cytokine. In this same study, gene-
deficient IL-4-/-  animals were shown to have more severe gastritis compared to wild-type 
mice. A H. pylori virulence factor involved in this polarization again is HP-NAP, which has 
been shown to strongly induce a shift from a Th2 to a Th1 response (Amedei et al., 2006).  
More recently, IL-17, a Th17 cytokine, has been shown to be involved in neutrophil 
infiltration during H. pylori infection and different IL-17 expression patterns have been 
described in different mouse strains (Scott Algood et al., 2007; Shiomi et al., 2008). Mice 
infected with H. pylori have been shown to develop a mixed Th17/Th1 response, with the 
Th17/IL-17 pathway preceding and modulating the Th1 response (Shi et al., 2010). In IL-17-/- 
mice, a decreased H. pylori colonization and inflammation is observed. In another study, H. 
pylori-infected mice lacking the IL-17A receptor were shown to contain fewer neutrophils in 
their gastric mucosa, compared to wild-type mice. Interestingly, this was accompanied by an 
increased presence of gastric B cells and lymphoid follicles, highlighting an important role of 
IL-17 signaling in chronic H. pylori-induced inflammation (Scott Algood et al., 2009). 
Regulatory T cells (Tregs) are mainly CD4+ T cells expressing high levels of CD25 
(IL-2Rα) and actively controlling or suppressing the function of other cells (Robinson and 
Atherton, 2010). The most important cytokine secreted by these Tregs is considered IL-10. 
Infection of IL-10-/- mice, lacking IL-10 expression, with H. pylori or H. felis elicits a more 
severe chronic gastritis compared to that seen in wild-type mice (Ismail et al., 2003), which 
can lead to spontaneous eradication of helicobacters in these animals (Blanchard et al., 2004; 
Matsumoto et al., 2005). These results are supported by others. For instance, studying the role 
of mucosal dendritic cells, which are more abundant during H. pylori infection, show that 
these cells induce a Treg-biased response suppressing the induction of a Th17 response. This 
could in part be responsible for the chronicity of the infection (Kao et al., 2010). Seen from a 
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clinical perspective, Robinson et al. (2008) have suggested that low numbers of Tregs result 
in an increased Th1 response, leading to more severe gastritis and the development of gastric 
ulcers. In addition to regulatory T cells, other mechanisms are involved in a decreased 
immune response towards a H. pylori infection. The bacterium has been shown to cause 
apoptosis of macrophages, possibly resulting in a decreased immune response (Gobert et al., 
2002; Menaker et al., 2004) and certain H. pylori virulence factors, including VacA and H. 
pylori GGT, have been shown to impair the host immune response by inhibiting the activation 
and proliferation of T cells (Gebert et al., 2003; Schmees et al., 2007). 
In infected hosts, H. pylori stimulates the production of antibodies, as shown by the 
presence of anti-H. pylori IgG and IgM in serum and IgG and IgA in gastric contents, 
respectively (Ferrero et al., 1998). As discussed in section 6, specific antibodies are not 
required for protection against H. pylori infection, which is confirmed by several studies on 
the immune response elicited by H. pylori infection. In B cell-deficient mice, early H. pylori 
colonization has been shown to follow the normal pattern, described in wild-type mice 
(Akhiani et al., 2004). This, however, finally resulted in the development of a severe gastritis 
and clearance of the bacteria, which lead the authors to conclude that specific anti-H. pylori 
antibodies can even facilitate bacterial colonization and counteract the host resistance against 
H. pylori infection. 
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Figure 3: Summarized overview of the host response to Helicobacter pylori infection. After innate immune 
recognition of Helicobacter pylori pathogen-associated molecular patterns (PAMP) by pathogen-recognition 
molecules (PRM), a signalling cascade is initiated, leading to activation and translocation of various 
transcription factors. This in turn leads to production of pro-inflammatory cytokines, promoting the recruitment 
of innate immune cells, including neutrophils, macrophages and dendritic cells. Subsequent expression of 
cytokines by these cells leads to the recruitment of various CD4+ T helper cells. A more detailed description can 
be found in the text of section 2. 
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3 Virulence factors of gastric helicobacters involved in gastric epithelial cell death 
 
Gastric epithelial, mainly apoptotic, cell death is considered an important feature 
contributing to H. pylori-related gastric disease (Shirin and Moss, 1998; Blaser and Atherton, 
2004). Most of the research concerning Helicobacter virulence factors contributing to gastric 
epithelial cell death has been done with H. pylori and is summarized in this section and Figure 
4. Far less information is available about the virulence mechanisms of non-H. pylori 
helicobacters. Although some virulence factors of non-H. pylori helicobacters may indeed be 
similar to those described for H. pylori, there are also important differences.  
 
Urease 
For colonization of the host stomach, all gastric Helicobacter species require a family 
of genes involved in the production of urease (Andrutis et al., 1995; Eaton and Krakowka, 
1994). This enzyme consists of two subunits, UreA and UreB. Urease is mainly localised in 
the cytoplasm but also becomes associated with the surface of the viable bacteria after 
autolysis of surrounding bacteria (Phadnis et al., 1996; Krishnamurthy et al., 1998; Marcus 
and Scott, 2001). In vitro, this autolysis occurs at the onset of the stationary culture phase 
(Fujita et al., 2005). Urease hydrolizes urea to ammonia and carbon dioxide and is an 
important mechanism of survival required to colonize the stomach. The production of 
ammonia, most likely occurring at or near the inner bacterial membrane, neutralizes the 
hydrochloric acid of the stomach, creating a neutral microenvironment around the bacterium 
(Hong et al., 2003).  
The urease-mediated production of ammonia has been shown to reduce the viability of 
gastric epithelial cells (Smoot et al., 1990). Others have suggested that ammonia accelerates 
cytokine-induced apoptosis in gastric epithelial cells, while the urease or ammonia molecules 
alone are unable to induce apoptosis (Igarashi et al., 2001). Either process, however, results in 
damage of the mucosal barrier, thereby releasing nutrients for the bacterium and sustaining 
the inflammation process (Smoot et al., 1990).  
 
VacA 
Already more than 20 years ago, Leunk et al. (1988) found that broth culture 
supernatants of the majority of H. pylori isolates induced cytoplasmic vacuolation of 
epithelial cells in vitro. The factor involved was shown to be heat-labile and protease-
sensitive, strongly suggesting a protein was responsible for the observed effects. A few years 
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later, a soluble protein was purified from H. pylori broth culture supernatant (Cover and 
Blaser, 1992). The coding gene, vacA, is present in nearly all H. pylori strains, although not 
all strains induce vacuolation of epithelial cells in vitro (Leunk et al., 1988; Cover et al., 1990; 
Cover et al., 1994). The vacA gene possesses several polymorphic sites, namely the signal (s) 
region, the midregion (m) and the intermediate region. Type s1/m1 strains have been shown 
to produce higher levels of cytotoxin activity in vitro compared to s1/m2 strains, whereas s2 
genotypes are inactive in vacuolating cytotoxicity assays (Atherton et al., 1995). From a 
clinical perspective, H. pylori strains with vacA type s1/m1 have been shown to be associated 
with duodenal and gastric ulceration and gastric adenocarcinoma, whereas the intermediate 
region is even a more important marker for H. pylori strains associated with gastric 
adenocarcinoma (Rhead et al., 2007).  Interestingly, recombinant strains with altered toxicity 
have been described to emerge during human infection (Aviles-Jimenez et al., 2004).  
The vacA gene encodes a pro-toxin of approximately 140 kDa, although VacA 
proteins of this size have never been reported. During secretion, the amino-terminal signal 
sequence and a carboxy-terminal domain are cleaved to yield a mature toxin of around 88 
kDa, which is secreted through an autotransporter mechanism (Cover and Blanke, 2005). This 
mature, secreted protein can undergo further limited cleavage into what are believed to be 2 
subunits, called p33 and p55, although other names have been used quite frequently (Blaser 
and Atherton, 2004; Backert et al., 2010). Once secreted, VacA has been described to interact 
with various receptors on the eukaryotic plasma membrane, including Receptor Protein 
Tyrosine Phosphatases (RPTP) α and β (Yahiro et al., 1999; Yahiro et al., 2003; Fujikawa et 
al., 2003; Rieder et al., 2005a). Binding to the latter influences signalling rather than 
vacuolation (Fujikawa et al., 2003) and an increase of this specific interaction has been 
described after acidic treatment of VacA (Yahiro et al., 2003). Several authors have described 
an important interaction between VacA and membrane lipid rafts (Ricci et al., 2000; Schraw 
et al., 2000; Kuo et al., 2003), which are dynamic assemblies of cholesterol, sphingolipids and  
proteins, including constitutive glycosylphosphatidylinositol-anchored proteins (GPI-AP). 
The sensitivity of epithelial cells to VacA has been described to depend on the presence of 
one or more GPI-AP (Ricci et al., 2000), although Schraw et al. (2000) found that these were 
no prerequisite for internalization of VacA. More recently, it was shown that sphingomyelin is 
important for VacA binding to cells and its association with membrane lipid rafts (Gupta et 
al., 2008).   
After binding to the plasma membrane, VacA oligomers form low-pH-triggered anion-
selective channels in the plasma membrane (Czajkowsky et al., 1999; Szabo et al., 1999). The 
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toxin is internalized through an actin-dependent endocytic pathway (Ricci et al., 2000), which 
is, again, only possible after acidic activation of VacA (McClain et al., 2000). Once inside the 
host cell, VacA causes accumulation of large vacuoles, which are hybrid compartments 
presenting both late endosomal and lysosomal features (Molinari et al., 1997). Important 
driving forces in this process include v-ATPase, which is colocalized on the vacuolar 
membranes with the late endosomal marker Rab7, a GTPase (Papini et al., 1996; Papini et al., 
1997.  Most likely, the presence of VacA channels stimulates v-ATPase proton pump activity, 
causing acidification of the endosomal compartments with a subsequent increase of the 
osmotic pressure (Genisset et al., 2007). 
Besides vacuolation, which is mainly observed in vitro, VacA has also been shown to 
be an important cause of epithelial cell apoptosis, which is often detected in H. pylori-infected 
humans (Kuck et al., 2001; Blaser and Atherton, 2004). Cover et al. (2003) have shown that 
mainly a type s1/m1 VacA toxin causes apoptosis in a dose-dependent manner. No apoptosis 
could be detected when cells were incubated with a chimaeric s2/m1 toxin or a VacA mutant 
protein. Early studies showed that purified VacA causes a decrease of the mitochondrial 
membrane potential and a subsequent dramatic decrease of intracellular levels of ATP, 
however both independent from vacuolation (Kimura et al., 1999). These mitochondrial 
changes cause an impairment of the glutathione metabolism, requiring ATP, most likely 
increasing the chance of developing oxidative stress-induced cell damage (Kimura et al., 
2001). Additionally, a release of cytochrome c in the cytosol has been observed in VacA-
treated cells (Galmiche et al., 2000). Interestingly, Yamasaki et al. (2006) showed that VacA 
reduced the membrane potential of isolated mitochondria, without the release of cytochrome 
c. In intact cells, however, VacA-induced cytochrome c release could indeed be observed and 
involved the activation of pro-apoptotic regulators, including Bax. Additionally, a specific 
inhibitor of v-ATPase, bafilomycin A1, inhibited VacA-induced vacuolation, but not VacA-
induced apoptosis, confirming the theory of Kimura et al. (1999) that different mechanisms 
underlie both effects. Very recently, it was shown that the small VacA subunit acts as a small 
pore-forming toxin in the inner mitochondrial membrane (Domańska et al., 2010), but future 
investigations should clarify possible pathological consequences of this observation. 
As to the presence of VacA in non-Helicobacter pylori helicobacters, Xiang et al. 
(1995) did not detect the gene nor the protein in H. felis. Very recently, the whole-genome 
sequence of two H. suis strains has been determined, revealing the absence of a vacA homolog 
in H. suis strain 5, but also the presence of a vacA paralog in H. suis strain 1. Sequence 
analysis, however, suggests that no functional toxin is produced (Vermoote et al., 2011). 
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Further research is needed to confirm or enfeeble this hypothesis. To the author’s knowledge, 
no information is available on the presence or absence of VacA in other gastric non-H. pylori 
Helicobacter species. 
 
Cag PAI 
The most widely investigated virulence factor of H. pylori is the Cytotoxin-associated 
genes Pathogenicity Island or cag PAI, encoding a  type IV secretion system, which has, until 
now not been reported to be present in any other Helicobacter species. It represents a DNA 
insertion element of approximately 40 kb, carrying about 30 genes (Akopyants et al., 1998; 
Backert et al., 2010). In H. pylori strains carrying a functional cagPAI,  a syringe-like 
structure is formed, capable of penetrating gastric epithelial cells and delivering the CagA 
protein into the host cells (Odenbreit et al., 2000; Backert et al., 2008). Some other proteins 
encoded by the cagPAI are VirB proteins, including channel or core components, NTPases 
supplying energy for secretion, and the components forming the pilus, of which VirB2 (CagC) 
is the major component (Andrzejewska et al., 2006; Backert et al., 2008). Once delivered 
inside the eukaryotic cell, CagA becomes phosphorylated on tyrosine residues by Src, a 
tyrosine kinase (Stein et al., 2002). Another cagPAI-encoded protein, CagL interacts with 
integrins at the cell surface, in this way triggering CagA delivery in the target cell and 
activation of Src (Kwok et al, 2007). The CagA phosphorylation sites are so-called EPIYA 
motifs (Glu-Pro-Ile-Tyr-Ala), which are present in variable numbers at the carboxy-terminal 
half of CagA (Backert et al., 2001; Stein et al., 2002). Phosphorylated CagA is recruited to the 
plasma membrane where it forms a complex with Src homology 2 (SH2) domains of the 
protein tyrosine phosphatase SHP-2 (Higashi et al., 2002a; Rieder et al., 2005a). Interestingly, 
differences in CagA phosphorylation and subsequent interaction with SHP-2 have an 
influence on the biological activity of CagA (Higashi et al., 2002b). These diversities are 
caused by variations in both the number and sequence of phosphorylation sites. The CagA-
specific sequence from East Asian H. pylori strains virtually always induces a stronger 
binding to SHP-2, resulting in an increased ability of causing the hummingbird phenotype 
(see below) in vitro. In CagA proteins from Western H. pylori strains, SHP-2 binding is 
determined by the number of EPIYA motifs (Higashi et al., 2002b; Rieder et al., 2005a). The 
importance of this finding is confirmed by the observation that H. pylori strains that deliver 
CagA with more phosphorylation motifs are most often associated with gastric cancer 
(Azuma et al., 2002; Argent et al., 2004). 
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A variety of effects have been attributed to the presence of a functional cag PAI in H. 
pylori. Some of these effects depend on the phosphorylation of CagA. The elongation and 
scattering of H. pylori-infected host cells, also known as the ‘hummingbird’ phenotype, is 
probably the best known (Segal et al., 1999). The interaction between phosphorylated CagA 
and SHP-2 induces cytoskeletal rearrangements, in part through activation of the Rap1->B-
Raf->Erk signalling pathway (Higashi et al., 2004). Eventually, deregulation of SHP-2, 
caused by CagA-SHP-2 complex formation results in apoptosis of gastric epithelial cells in 
vitro (Tsutsumi et al., 2003). Besides interaction with SHP-2, phosphorylated CagA is known 
to also interact with other host cell proteins, including the tyrosine kinase Csk. This 
interaction downregulates CagA-SHP-2 signaling, underlining the complexity of cellular 
signalling after CagA translocation (Tsutsumi et al., 2003).  
Other effects are dependent on the translocation of CagA, but not phosphorylation. 
Examples are the activation of the pro-inflammatory transcription factor NF-κB through the 
Ras->Raf->Mek->Erk pathway (Brandt et al., 2005) and the CagA-mediated upregulation of 
the expression of the anti-apoptotic myeloid cell leukemia sequence 1 (MCL1) protein 
(Mimuro et al., 2007) in vivo, which contrasts with the CagA-induced increase of apoptosis 
described by Tsutsumi et al. (2003) in vitro. Finally, effects can also depend on the type IV 
secretion system encoded by the genes in the cag PAI, however without the need for injection 
of CagA in the host cell. Viala et al. (2004) described that peptidoglycan delivery through the 
same pilus is responsible for Nod1 activation. This results in activation of NF-κB and the 
upregulated translation of the pro-inflammatory cytokine interleukin-8. 
Le’Negrate et al. (2001) showed that intestinal epithelial cell apoptosis in vitro was 
mainly dependent on the presence of a cag PAI, rather than VacA. Peek et al. (1999), 
however, showed that the enhanced apoptosis induced in AGS cells by CagA-positive strains, 
was in part dependent of the simultaneous action of VacA. The results of yet another study 
showed that H. pylori exerts pro-apoptotic effects, which are apparently more dependent on a 
functional cag PAI than on an intact vacuolating cytotoxin. Simultaneously, however, H. 
pylori-mediated anti-apoptotic effects were described to be mediated by activation of NF-κB 
(Maeda et al., 2002). Also for H. pylori-infected humans, conflicting reports have been made 
on the effect of CagA on apoptosis. Overexpression of both pro-apoptotic and anti-apoptotic 
proteins has been detected in gastric biopsies of H. pylori-infected humans, with the higher 
apoptosis rates associated with CagA-positive strains (Cabral et al., 2006). Peek et al. (1997), 
however, found that the number of apoptotic cells is lower in the gastric epithelium of humans 
infected with a CagA-positive strain compared to individuals infected with a CagA-negative 
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strain. Additionally, these CagA-positive strains were associated with an increase of epithelial 
cell proliferation. In contrast, Moss et al. (2001) found an increased gastric epithelial cell 
proliferation in H. pylori-infected humans, unrelated to the CagA status but associated with 
the presence of gastritis. In this study, increased epithelial cell apoptosis was only observed in 
humans infected with a CagA-positive H. pylori strain.  
The available literature on the cag PAI and the vacuolating cytotoxin reveal very 
complex mechanisms used by H. pylori to control both cell death and proliferation. These two 
genes are thought to downregulate each other’s effects on epithelial cells, raising the 
possibility of avoiding excessive cellular damage (Argent et al., 2008). Recently, this was 
confirmed by showing that CagA inhibits VacA-induced apoptosis by two complementary 
mechanisms, one dependent on the prevention of pinocytosis of VacA by tyrosine-
phosphorylated CagA and one dependent on blocking of VacA-induced apoptosis at the 
mitochondrial level, which requires no phosphorylation of CagA (Oldani et al., 2009).  
 
GGT 
By focusing on the genetic and molecular characterization of genes that are known to 
be expressed by all H. pylori clinical isolates and only a restricted number of bacteria 
belonging to other genera, Chevalier et al. (1999) identified a catalytically active enzyme, γ-
glutamyl transpeptidase (GGT), as essential for colonization of mice. In contrast, the results 
of another study suggest that this enzyme is not essential for colonization of both mice and 
piglets, although the presence of this enzyme provides a clear advantage for H. pylori 
colonization (McGovern et al., 2001). A H. pylori membrane preparation fraction has been 
shown to induce apoptosis of a gastric adenocarcinoma cell line (AGS) (Shibayama et al., 
2003). This fraction contains the H. pylori GGT, inducing apoptosis in a dose-dependent 
manner. Additionally, the apoptosis-inducing capacity is partly inhibited when cells are 
treated with a H. pylori GGT mutant, lacking enzymatic GGT activity. The authors 
hypothesize that the bacteria could gain essential nutrients from the apoptotic cells, which was 
confirmed by showing that this enzyme very efficiently hydrolyzes both glutamine and 
glutathione, causing a depletion of both substrates (Shibayama et al., 2007). Kim et al. (2007) 
confirmed that H. pylori GGT causes apoptosis of AGS cells. The analysis of various factors 
revealed cytochrome c release by mitochondria, activation of caspase-3 and -9, upregulation 
of Bax and downregulation of Bcl-2 and Bcl-Xl, suggesting apoptosis mediated through 
mitochondrial damage. More recent work of these same authors with recombinant H. pylori 
GGT showed that the enzyme inhibits growth of AGS cells by inducing cell cycle arrest in the 
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G1-S transition phase, associated with the downregulation of several members of the cyclin 
and cyclin-dependent kinase families (Kim et al., 2010). In addition to its role in the induction 
of cell death, H. pylori GGT has also been shown to inhibit T-cell proliferation (Schmees et 
al., 2007). This effect depends on the catalytic activity of the enzyme, disrupting Ras-
dependent signalling and finally inducing G1 cell cycle arrest. Apoptosis of T cells was not 
observed. Very recently, H. pylori GGT was shown to be an important factor in the 
development of peptic ulcer disease. In this study, NF-κB activation was shown to upregulate 
the expression of pro-inflammatory IL-8 (Gong et al., 2010). 
Interestingly, GGT activity is detected in all gastric non-H. pylori Helicobacter 
species (Haesebrouck et al., 2009). As part of this thesis, the role of H. suis GGT in the 
induction of gastric epithelial cell death was thorougly investigated. 
 
LPS 
Experimental application of H. pylori lipopolysaccharide (LPS) to the gastric surface 
epithelium of rats causes a marked increase of epithelial cell apoptosis (Piotrowski et al., 
1997). This was confirmed in primary guinea pig gastric mucosal cells by Kawahara et al. 
(2001). However, the fact that H. pylori LPS induces apoptosis only at much higher 
concentrations compared to E. coli LPS, suggests that it has a lower toxicity compared to the 
latter (Durkin et al., 2006). Interestingly, this study showed that H. pylori LPS and ibuprofen, 
a NSAID, interact to enhance gastric cell loss. 
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Figure 4: Summarized overview of important Helicobacter pylori virulence factors involved in the promotion or 
inhibition of gastric epithelial cell death. The urease enzyme leads to the production of ammonia (NH3), which 
reduces the viability of gastric epithelial cells. The secreted vacuolating cytotoxin, VacA, interacts with various 
plasma membrane receptors and is internalized. VacA oligomerization is involved in the formation of large 
cytoplasmic vacuoles. Besides vacuolation, VacA is an important cause of epithelial cell apoptosis. The cag 
PAI, a type IV secretion system, injects CagA and peptidoglycan (PG) into epithelial cells. After injection into 
the host cell, CagA can become phosphorylated (P-o) on tyrosine residues. Phosphorylated and 
unphosphorylated CagA, as well as injected bacterial peptidoglycan, cause a variety of changes inside the host 
cell, including cytoskeletal rearrangements and activation of NF-κB. Finally, the H. pylori GGT enzyme is 
involved in the induction of mitochondria-mediated apoptosis. More detailed descriptions can be found in the 
text of section 3. 
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4 Oxidative stress and cell death in gastric Helicobacter infections 
4.1 Oxidative stress, apoptosis and necrosis 
 
It is well-known that reactive oxygen species (ROS) can cause molecular changes to 
lipids, proteins and DNA, finally leading to apoptosis or necrosis (Fiers et al., 1999; Duprez et 
al., 2009) (Figure 5). Typically, activation of caspases is observed during apoptosis, and these 
caspases (including effector caspases such as caspase-3) are activated mainly through the 
intrinsic or extrinsic apoptotic pathway. Briefly, the intrinsic pathway is activated through 
different stimuli, including DNA damage, and acts through the mitochondria. The apoptotic 
stimulus promotes Bax/Bak oligomerization which leads to the formation of a channel in the 
outer mitochondrial membrane, through which cytochrome c is released into the cytosol. The 
subsequent association between cyt c and Apaf-1 leads to activation of the caspase cascade 
(Riedl and Salvesen, 2007; Duprez et al., 2009; Circu and Aw, 2010). The extrinsic pathway 
involves binding of death ligands such as, but not limited to, FasL and TNF-α, to their 
receptors on the cell surface, including Fas and TNFR-1 (TNF receptor 1). This can lead to 
recruitment of specific death domains, including FADD (Fas-associated death domain) and 
TRADD (TNFR associated death domain), the subsequent formation of a DISC (death-
inducing signalling complex) and activation of the caspase cascade through the initiator 
caspase-8 (Peter and Krammer, 2003; Duprez et al., 2009; Circu and Aw, 2010). ROS, for 
instance, can induce apoptosis through different pathways, including ROS-induced 
ASK1/JNK signalling, either leading to upregulated expression of proapoptotic factors such 
as TNFα and FasL or to mitochondrial signalling resulting in mitochondrial cytochrome c 
release (Circu and Aw, 2010).  
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Figure 5: ROS can induce damage to lipids, proteins and DNA. Upon DNA damage, poly(ADP-ribose) 
polymerase 1 is hyperactivated, leading to ATP depletion. ROS-induced lipid peroxidation can lead to 
membrane damage of various organelles and loss of plasma membrane integrity (Adapted from Vanlangenakker 
et al., 2008). 
 
As opposed to apoptosis, primary necrosis or oncosis is characterized by cytoplasmic 
and organelle swelling and loss of plasma membrane integrity (Duprez et al., 2009; Kroemer 
et al., 2009). Irrespective of the stimulus, ROS are often involved in the induction of necrosis. 
They can cause oxidative DNA damage, triggering the overactivation of PARP-1 (Figure 3), a 
poly(ADP-ribose) polymerase involved in DNA repair, which can lead to depletion of 
cytosolic ATP (Los et al., 2002; Vandenabeele et al., 2010). ROS can also cause lipid 
peroxidation, both of organelle membranes and the plasma mebrane, which can result in loss 
of plasma membrane integrity (Vanlangenakker et al., 2008). Lipid peroxidation of 
mitochondrial membranes impairs oxidative phosphorylation, maintenance of the 
mitochondrial membrane potential and the mitochondrial Ca++ buffering capacity (Orrenius et 
al., 2007). Lyosomal membranes are also a possible target, resulting in the leakage of protease 
or efflux of Ca++. Interestingly, large amounts of redox-active iron are present in lysosomes, 
enabling the possible auto-amplification of ROS through the Fenton reaction, generating the 
highly reactive hydroxyl radical:  H2O2 + Fe2+  OH- + HO· + Fe3+ 
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Proof of the possible threat of redox-active iron is also provided by the finding that TNF-α-
induced ROS formation is enhanced by JNK1-dependent ferritin degradation (Antosiewicz et 
al. 2007). The degradation of this iron-binding protein causes an increase of the labile iron 
pool (Vandenabeele et al., 2010). 
 
4.2 H. pylori-induced oxidative stress 
 
Only very little is known about a possible relation between non-H. pylori Helicobacter 
infection and oxidative stress, although it has been shown that a chronic H. felis infection 
causes oxidative damage through the recruitment of neutrophils (Kawasaki et al., 2005). 
Impairment of IKKβ/NF-κB signaling also results in an increased level of oxidative stress and 
subsequent apoptosis or necrosis in gastric epithelial cells of mice chronically infected with 
H. felis (Shibata et al., 2010).  
In contrast to the limited data available for non-H. pylori helicobacters, gastric 
infection with H. pylori has regularly been shown to cause an increase of the oxidative stress 
burden. Increased levels of lipid peroxidation have been observed in H. pylori-positive 
patients (Farinati et al., 1996). Also, higher levels of oxidized and nitrated proteins have been 
described in these patients, indicating cells are exposed to higher levels of oxidative and 
nitrative stress. These alterations at the protein level were clearly associated with the presence 
of chronic gastritis and duodenal ulcers (Li et al., 2001). At the DNA level, the formation of 
8-hydroxydeoxyguanosine (8-OHdG) is considered the main change induced by reactive 
oxygen species. Significantly higher concentrations of 8-OHdG have been detected in the 
mucosa of humans suffering from chronic atrophic gastritis and intestinal metaplasia. But the 
most important factor involved in the induction of DNA oxidative damage in the gastric 
mucosa is mere infection with H. pylori (Farinati et al., 1998; Papa et al., 2002). Interestingly, 
the increased local levels of ROS are also reflected in the peripheral blood of H. pylori-
infected humans (Mashimo et al., 2006).  
Various factors contribute to these detrimental changes. First, H. pylori bacteria 
generate substantial amounts of superoxide radicals themselves, an effect which is negligible 
in, for instance, E. coli (Nagata et al., 1998; Ding et al., 2007). Additionally, several reports 
have been made about the H. pylori-induced production of reactive oxygen species (ROS) in 
epithelial cells. Compared to non-infected humans, gastric mucosa from H. pylori-infected 
humans shows an altered expression of proteins that have been reported to be affected by 
oxidative stress, including members of the aldehyde dehydrogenase family (Baek et al. 2004). 
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In vitro, H. pylori causes an increase of spermine oxidase expression and activity, resulting in 
the generation of H2O2 (hydrogen peroxide) and subsequent oxidative DNA damage (Xu et 
al., 2004). Finally, development of gastritis is often seen in H. pylori-infected humans 
(Kusters et al., 2006).  Among other inflammatory cells, neutrophils are recruited to the site of 
inflammation, generating reactive oxygen and nitrogen species (Yoshikawa and Naito, 2000). 
H. pylori has been shown to be capable of triggering the oxidative burst of both monocytes 
and neutrophils in vitro (Nielsen and Andersen, 1992). This was confirmed in human gastric 
biopsies, showing higher levels of ROS released by neutrophils when patients were infected 
with H. pylori (Jung et al., 2001). Eradication of H. pylori has been shown to cause a decrease 
in the presence of inducible nitric oxide synthase (iNOS), resulting in lower levels of nitric 
oxide (NO) production (Felley et al., 2002). NO can combine with superoxide to form 
peroxynitrite, capable of inducing host cell damage. 
Although conflicting results have been published, several virulence factors have been 
shown to be important for the increased generation of ROS during H. pylori infection. The H. 
pylori neutrophil activating protein (HP-NAP) is important for the development of gastritis. 
Interestingly, a homologue of the coding gene is found in the H. suis genome (Vermoote et 
al., 2011). HP-NAP promotes the adherence of neutrophils to endothelium, transendothelial 
migration of neutrophils, chemotaxis of leukocytes and the release of ROS by neutrophils and 
monocytes (Evans et al., 1995; Satin et al., 2000 ; Montecucco and de Bernard, 2003; 
Brisslert et al. 2005; Polenghi et al., 2007). Unemo et al. (2005), however, found that not HP-
NAP but instead the sialic acid-binding adhesin (SabA) is important for the induction of the 
oxidative burst in neutrophils. In gastric epithelial cells in vitro, H. pylori strains with a 
functional cag PAI have been shown to induce higher levels of intracellular ROS compared to 
isogenic cag PAI-deficient mutant strains (Ding et al., 2007). Also in H. pylori-infected 
humans, CagA-positive strains have been associated with the highest production of ROS and 
subsequent oxidative DNA damage (Papa et al., 2002), although Farinati et al. (2008) did not 
find a relation between the CagA status and the increase of oxidative DNA damage in patients 
suffering from gastric cancer. Two other H. pylori virulence factors, GGT and VacA, have 
been described to cause a higher production of ROS by gastric epithelial cells (Bagchi et al., 
2002; Gong et al., 2010). For both proteins, an impaired metabolism of glutathione, an 
important free thiol involved in protection against oxidative stress, has been suggested to 
underlie these changes (Kimura et al., 2001; Gong et al. 2010).  
As a consequence of the increased oxidative stress burden in humans infected with H. 
pylori, the bacteria are also confronted with these hostile agents. H. pylori combats this 
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oxidative stress using a number of enzymes, such as superoxide dismutase, catalase and a 
family of peroxiredoxins, including alkylhydroperoxide reductase and a thiol-reductase 
(Wang et al., 2006). Interestingly, the oxidative stress-inducing HP-NAP has been shown to 
protect H. pylori bacteria from oxidative stress, through ferric uptake regulator (fur)-involved 
regulation of napA expression and intracellular colocalization of HP-NAP with DNA, 
protecting it from damaging by free radicals (Cooksley et al., 2003). 
 
4.3 The protective role of glutathione against oxidative stress  
 
The tripeptide reduced glutathione (L-γ-glutamyl-L-cysteinylglycine) is by far the 
most abundant free thiol in eukaryotic cells (Meister and Anderson, 1983). It has an important 
role in metabolisation and detoxification of exogenous compounds (e.g. drugs) involving the 
activity of various Glutathione S-transferases (GST’s), conjugation reactions with endogenous 
metabolites and radiation protection (Meister and Anderson, 1983; Sau et al., 2010). Above 
all, it is an important antioxidant which degrades reactive oxygen species (ROS), including 
O2–derived free radicals, as well as O2–derived nonradical species such as hydrogen peroxide 
(H2O2) (Circu and Aw, 2010). The antioxidant activity involves the conversion of reduced 
glutathione (GSH) to its oxidized form, glutathione disulfide (GSSG) (Meister and Anderson, 
1983; Pompella et al., 2003). This can take place through numerous reactions, including both 
nonenzymatic transhydrogenation, often mediated by metal ions, and enzymatic pathways, 
involving the activity of selenium-containing GSH peroxidases and transhydrogenases 
(Meister and Anderson, 1983; Valencia et al., 2001; Pompella et al. 2003). In turn, GSSG can 
be reduced to GSH via the NADPH-dependent GSSG reductase (Meister and Anderson, 1983; 
Pompella et al., 2003). 
The vast majority of glutathione can be found intracellularly, compartmentalized as 
distinct redox pools in cytosol, mitochondria, endoplasmatic reticulum and nucleus, with 
concentrations in the mM range (Meister and Anderson, 1983; Body et al., 1979; Circu and 
Aw, 2010). The set of reactions involved in GSH synthesis is often referred to as the γ-
glutamyl cycle (Meister and Anderson, 1983). Briefly, intracellular synthesis involves the 
activity of different ATP-dependent enzymes such as γ-glutamylcysteine synthetase and GSH 
synthetase (Orlowski and Meister, 1970; Meister and Anderson, 1983). However, 
extracellular GSH is also found in tissues and plasma in the micromolar range (20-30 µM; 
Anderson and Meister, 1980; Yang et al., 1997; Inoue, 2001). Indeed, during GSH 
metabolism a significant amount is translocated outside the cells, often mediated by GSH 
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transporters (Griffith and Meister, 1979a; Meister et al., 1979; Griffith and Meister, 1979b; 
Dethmers and Meister, 1981; Lu et al., 1996; Shibayama et al., 2007). Outside the cell, it can 
serve as a substrate for membrane-bound γ-glutamyl transpeptidase (GGT), which catalyzes 
transfer of the γ-glutamyl moiety to various acceptors, including amino acids, dipeptides and 
GSH (Meister and Anderson, 1983; Del Bello et al., 1999; Pompella et al., 2003). After 
further cleavage by dipeptidases the constituent amino acids (or dipeptides) are taken up by 
the cells, where they can be utilized in de novo glutathione synthesis (Griffith and Meister, 
1979b; Meister and Anderson, 1983; Zhang et al., 2005). Interestingly, plasma membrane-
bound GGT of mammalian cells has been shown to initiate pro-oxidant reactions through the 
catabolism of GSH (Dominici et al., 1999; Maellaro et al., 2000). Transpeptidation of the γ-
glutamyl group generates the more reactive thiol cysteinyl-glycine, leading to the production 
of H2O2 through the reduction of Fe3+ and subsequent production of thiyl radicals and the 
superoxide anion (O2•—) (Dominici et al., 1999). 
Cells depleted of reduced glutathione are more sensitive to oxidative stress (Ueda et 
al., 1998). However, various studies show that the ratio between GSH and GSSG is a better 
indicator for determining the redox state of a cell (Schafer et al., 2001). Despite elevated 
levels of GSH per se, low cellular ratios of GSH/GSSG have been linked with decreased cell 
survival (Pias et al., 2003). In vitro GSSG treatment of cells results in increased production of 
ROS leading to a dose-dependent induction of cell death through the p38 MAP kinase 
pathway (Filomeni et al., 2003). This can be counteracted by treatment of cells with GSH 
ethyl ester, which is known to increase the intracellular GSH content, underlining the 
importance of the GSH/GSSG balance. Similarly, depletion of GSH through impaired de novo 
synthesis results in an overproduction of ROS, leading to apoptosis through the activation of 
protein kinase c (PKC)-delta (Marengo et al., 2008). This can, however, be prevented by 
supplementation with other antioxidants, showing that the observed effect depends on the 
formation of ROS. In contrast, GSH depletion through transporter-mediated efflux has been 
shown to induce apoptosis independent of ROS formation (Franco et al., 2007). During 
oxidative stress, an optimal mitochondrial GSH/GSSG ratio has been shown to be crucial for 
further cell survival (Circu and Aw, 2010). Indeed, a decrease of mitochondrial GSH has been 
shown to result in enhanced production of mitochondrial ROS, loss of mitochondrial 
membrane potential and release of cytochrome c, which is known to initiate apoptosis (Lluis 
et al., 2007). 
In the stomach, intracellular glutathione concentrations are high (up to 10 mM), 
compared to most other tissues (Body et al., 1979; Meister and Anderson, 1983; Mårtensson 
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et al., 1990). Farinati et al. (1996) have described an increase of both the reduced and 
oxidized glutathione content of gastric mucosa of H. pylori-infected humans suffering from 
chronic nonatrophic gastritis. Similar results have been described for total (sum of reduced 
and oxidized) glutathione contents in the stomach of H. pylori-infected Mongolian gerbils 
(Suzuki et al., 1999). However, these findings are in contrast with the results from other 
studies, describing lower levels of reduced glutathione in H. pylori-infected human patients 
compared to H. pylori-negative individuals (Jung et al., 2001; Shirin et al., 2001).  
 
5 In vivo modelling of non-H. pylori Helicobacter-related gastric disease in rodents 
 
 Most of the current knowledge on the complex interplay between gastric helicobacters 
and their hosts derives from experimental infection studies in small rodents, mainly because 
of the small size, low price and easy manipulation of these animals. This overview will 
mainly focus on popular in vivo models of non-H. pylori Helicobacter associated gastric 
disease. 
 
Mouse 
The vast majority of experimental in vivo research on the pathogenesis of H. pylori has 
been conducted in mice. In the early days, in vivo H. pylori research in mice was often 
hampered by a poor and inconsistent colonization ability of the H. pylori strains used. After 
long-term adaptation in mice, Lee et al. (1997) introduced the Sydney strain (SS1), which 
showed an excellent chronic colonization ability and became one of the standard strains, 
although it lacks a functional cagPAI (Crabtree et al., 2002). Both in C57BL/6 and BALB/c 
mice, this strain elicited an active chronic gastritis, evolving to severe atrophy. In the years to 
follow, various severe gastric pathologies associated with a H. pylori infection in humans 
were reproduced in experimentally infected mice. These included MALT lymphoma, which 
also developed with CagA- and VacA-negative strains (Wang et al., 2003), and 
adenocarcinoma following an increased mucosal expression of IL-1β, although these lesions 
were only generated in hypergastrinemic INS-GAS mice (Fox et al., 2003). 
In the meantime, however, H. felis became more popular to model H. pylori-induced 
gastric pathologies in vivo, mainly because of its high and reproducible colonization ability in 
mice. H. felis infection was shown to cause gastritis in different mouse strains, including 
BALB/c and C57BL/6 mice, which are considered to be mainly Th2 and Th1 responders, 
respectively. A moderate to severe chronic inflammation could be observed in the 
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corpus/fundus region of C57BL/6 mice, along with increased numbers of neutrophils and the 
development of other lesions, including mucosal erosions, mucous cell hyperplasia and 
atrophy (Mohammadi et al., 1996; Sakagami et al., 1996). In contrast, no corpus atrophy and a 
milder inflammation in fundus or antrum were seen in BALB/c mice. In a comparative H. 
felis/H. pylori infection study in C57BL/6 mice, H. felis was shown to induce more severe 
inflammation, both in fundus and antrum, compared to H. pylori strain SS1 and only H. felis 
infection was associated with an increased epithelial cell proliferation in the fundus (Court et 
al., 2002). Interestingly, the onset of chronic inflammation and loss of parietal and chief cells 
was shown to be earlier in female mice, compared to males, further underlining the 
importance of host factors in the development of gastric pathologies (Court et al., 2003).  
Besides severe inflammation, more severe pathologies have been observed in H. felis-
infected mice. Long-term infection of BALB/c mice with this bacterium has been shown to 
induce lesions identical to those seen in patients suffering from gastric MALT lymphoma, 
including poor definition of B-cell germinal centers in lymphoid aggregates and lympho-
epithelial lesions (Enno et al., 1995). In contrast, long-term H. felis infection of wild-type 
C57BL/6 mice has been shown to lead to the development of chronic gastritis, atrophy, 
metaplasia, dysplasia and finally adenocarcinoma, which is similar to the sequence of 
pathologies leading to the formation of gastric cancer in humans (Cai et al., 2005). 
Interestingly, bacterial eradication in mice with severe lesions significantly prevented gastric 
cancer-related deaths in these animals. Takaishi et al. (2009) have revealed an important role 
for gastrin in H. felis-induced gastric corpus carcinogenesis in C57BL/6 mice, whereas this 
same hormone seems to inhibit the development of similar lesions in the antrum. Finally, in 
outbred Swiss mice, which are expected to show a more balanced Th response, both lymphoid 
tissue and glandular lesions have been shown to develop in response to a H. felis infection 
(Ferrero et al., 2000).  
Besides their extensive use in research on H. felis-induced gastric pathology, mouse 
models have also been used with other non-H. pylori Helicobacter species. Until now, no 
successful mouse colonization by H. salomonis has been described, whereas H. bizzozeronii 
induces less striking pathological changes in mice, when compared to H. felis (De Bock et al., 
2005). In literature, several studies describe experimental infection of mice with “H. 
heilmannii” or “tightly coiled spiral bacteria”. Often, however, this name is misleading, as 
several of these studies probably have in fact used H. suis bacteria, obtained from mucus or 
homogenized gastric tissue of infected mice, pigs or non-human primates, because no in vitro 
isolate was available. Infection of mice with these inocula induced inflammation, already 7 
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days after inoculation (Moura et al., 1993). During long-term infection studies of up to 2 
years, infiltration of gastric mucosa with lymphocytes and plasma cells with subsequent 
development of lymphoid follicles has been observed (Park et al., 2003; Park et al., 2008). 
Cinque et al. (2006) have described this inflammation to be mainly driven by a Th1 response, 
in C57BL/6 and even in BALB/c mice, although others have described a mixed Th1/Th2 
response in C57BL/6 mice (Park et al., 2008). In BALB/c mice infected experimentally with 
different “H. heilmannii” bacteria, “isolated” in vivo in mice and originating both from 
humans and animals, gastric MALT lymphoma has been shown to develop starting from 18 
months post infection (O’Rourke et al., 2004a). In this study, the most severe pathological 
changes were seen in mice infected with in vivo “isolates” from humans and different non-
human primates and in fact belonging to 2 different species, H. suis and “Candidatus H. 
heilmannii”. Similar lesions were observed in C57BL/6 mice infected for at least 6 months 
with an in vivo “isolate” that was erroneously designated “Candidatus H. heilmannii” 
(Nakamura et al., 2007), but that in fact belonged to the species H. suis (Baele et al., 2009) 
and the development of MALT lymphoma-like lesions was accompanied by an increased 
detection of several vascular endothelial growth factors (Nishikawa et al., 2007). In contrast 
to what has been described for H. pylori, the development of gastritis, caused by this same 
“isolate” has been shown not to depend upon the presence of Peyer’s patches in the small 
intestine (Nagai et al., 2007; Nobutani et al., 2010). In conclusion, until before the start of the 
present PhD research, no experimental studies in rodent models have been carried out with 
pure cultures of H. suis, due to the lack of an in vitro isolation protocol. 
 
Mongolian gerbil 
 The first experimental evidence that H. pylori alone can result in the development of 
gastric adenocarcinoma was provided by a long-term experimental infection study for up to 
62 weeks in Mongolian gerbils (Watanabe et al., 1998). Moreover, chronic H. pylori infection 
in this animal model brings about other severe lesions, including intestinal metaplasia and 
development of gastric ulcers (Watanabe et al., 1998; Ikeno et al., 1999). The rapid 
development of these lesions in this animal model urged other research groups to start using 
the Mongolian gerbil model for research on H. pylori-induced gastric pathology.  
When gerbils are infected experimentally with H. pylori for 4 weeks, inflammation 
can mainly be observed in the antrum. This gastritis, however, has been shown to extend to 
the corpus in the majority of animals infected for over 30 weeks (Crabtree et al., 2004) and 
this corpus inflammation shows a strong correlation with the presence of an intact cagPAI 
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(Rieder et al., 2005b). Interestingly, the cytokine response in female animals shows a strong 
Th1 profile whereas in male animals, a much more moderate Th1-polarized response was 
observed (Crabtree et al., 2004). In animals of both genders, no increased expression of Th1-
downregulating cytokines TGF-β and IL-10 was found. As for the balance between cell death 
and proliferation, experimental H. pylori infection has been shown to induce apoptosis in the 
antrum of gerbils 2-4 weeks after challenge (Peek et al., 2000). This increased apoptotic ratio 
dropped back to baseline levels at later timepoints and was succeeded by increased epithelial 
cell proliferation, peaking at 16-20 weeks post inoculation.  
 Only few studies describe experimental infection of gerbils with non-H. pylori 
Helicobacter species. Court et al. (2002) have shown that H. felis infection for 4 weeks 
mainly induces antral gastritis and an increased epithelial cell proliferation in this same 
region. These bacteria have, however, also been shown to induce severe loss of parietal cells, 
starting from the limiting ridge at the forestomach/stomach transition zone and extending into 
the fundus (De Bock et al., 2006a and 2006b) (Figure 6). This was associated with increased 
apoptosis and proliferation at the transition zone between normal and affected tissue, 
occasional pyloric gland metaplasia and complete loss of the parietal cell population in some 
animals after 70 days of infection. Interestingly, H. felis could be found in close association 
with parietal cells, in contrast to H. bizzozeronii, which induced similar but less severe lesions 
compared to H. felis (De Bock et al., 2006b).  
 
 
 
 
 
 
 
 
 
Figure 6: H+-K+-ATPase staining of (A) an uninfected control gerbil, indicating differential staining between 
purple chief cells and brown stained parietal cells (Bar insert = 50 µm). (B) Gerbil infected with H. felis for 3 
weeks, showing severe parietal cell loss and “antralisation” (arrow). (De Bock et al., 2006a). 
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6 Immunization against gastric helicobacters  
 
Gastric infection in humans with H. pylori or a non-H. pylori Helicobacter species is 
so widespread that eradication therapies with antimicrobial agents are limited to patients 
suffering from gastric disease. Similarly, the prevalence of H. suis in pigs is very high 
(Hellemans et al., 2007b), which makes eradication of this zoonotic agent with antimicrobials 
virtually impossible. Moreover, as for other bacteria, clinicians face an increasing problem of 
antimicrobial resistance in the H. pylori population (Malfertheiner et al., 2007). For these 
reasons, vaccination is considered a valuable approach for controlling gastric Helicobacter 
infections and disease (Blanchard and Nedrud, 2010). Similar to experimental Helicobacter 
infection studies, the mouse has by far been the most widely used animal model. The present 
overview will thus focus on vaccination studies in the mouse model, complemented with 
some information on vaccination studies in other animals and humans. 
 
6.1 Candidate antigens for Helicobacter vaccination 
 
To determine the efficacy of different Helicobacter vaccination strategies, the mouse 
model has been by far the most widely used (Nedrud, 2001). Especially in the nineties and 
mainly because a stable chronic H. pylori infection mouse model was not available before the 
mid-nineties (Nedrud, 2001), challenge of mice was often done with H. felis, both after 
immunization with H. pylori and H. felis antigens.  
In the past, but also more recently, whole bacterial cell preparations have often been 
used for vaccination (Goto et al., 1999; Eisenberg et al., 2003; Garhart et al., 2003; Nyström 
et al., 2006; Sutton et al., 2007). In several of these studies and both after prophylactic and 
therapeutic immunization, a strong reduction of Helicobacter colonization was observed, 
sometimes even leading to complete protection. However, in these cases, culture and 
histology were used for assessment of protection, which might not be the most sensitive 
techniques. In addition to whole bacterial cell lysates, purified or recombinant proteins have 
also been used. Although the IgG antibody response to H. pylori urease is poor in naturally 
infected humans (Leal-Herrera et al., 1999), this enzyme or its subunits have often been used 
in mouse vaccination studies, both in prophylactic (Michetti et al., 1994; Pappo et al., 1995; 
Ermak et al., 1998; Morihara et al., 2007) and therapeutic (Corthésy-Theulaz et al., 1995; 
Dieterich et al., 1999; Guy et al., 1999) vaccination studies. For both strategies, a complete 
protection was suggested in some animals in certain studies, although culture, histology, 
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urease activity or a combination of these techniques were used for assessing the level of 
protection. Michetti et al. (1994) found that quantification of urease activity in the stomach 
was the most sensitive of these three techniques.  
The important H. pylori virulence factors CagA and VacA have also been used as 
antigens for immunization (Ghiara et al., 1997), although VacA has been shown to inhibit T-
cell activation and proliferation (Gebert et al., 2003; Rieder et al., 2005a) and CagA is not 
secreted by all H. pylori strains, which could make these proteins less suitable for vaccination 
(Blanchard and Nedrud, 2010). HP-NAP, which is a key modulator of H. pylori-induced 
gastritis has also been used for prophylactic vaccination purposes and has been shown to 
induce similar partial protection rates, compared to vaccination with CagA and H. pylori 
lysate (Satin et al., 2000).  Other antigens used in H. pylori mouse vaccination studies include 
catalase (Radcliff, 1997), the blood group antigen-binding adhesin BabA (Hultberg et al., 
2005) and the lipoprotein HpaA. The latter has been shown to confer protection against 
subsequent H. pylori challenge in some mouse strains (inbred BALB/c and outbred QS mice), 
but not in others (inbred C57BL/6 mice), underlining the importance of the host genetic 
background (Sutton et al., 2007). In this same study, however, therapeutic immunization was 
efficient in all three mice strains and H. pylori lysate was shown to be more effective than 
HpaA. The authors concluded that HpaA could be a candidate for vaccination against H. 
pylori, however most likely as a component of a multiantigenic vaccine. The fact that 
multicomponent vaccines could provide better protection compared to one single antigen was 
also shown by Ferrero and coworkers, already in 1995. They found that dual antigen 
vaccination with a combination of Heat-shock protein A (HspA) from H. pylori in 
combination with the H. pylori ureB subunit conferred protection against H. felis challenge in 
all animals, whereas some animals in groups vaccinated with only one of both antigens 
became infected after H. felis challenge. Again, protection was assessed by histology and 
urease activity, which might not be the most sensitive techniques.  
 
6.2 Possible immunization routes 
 
Besides the use of the appropriate antigen (combinations), the choice of the 
immunization route with the appropriate adjuvant has also been shown to play an important 
role in Helicobacter vaccination studies. In general, vaccination strategies were designed to 
generate an optimal immune response at the mucosal surface, in line with strategies designed 
for other mucosal bacterial infections (Blanchard and Nedrud, 2010). This includes oral, 
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gastric, intranasal and rectal administration, combined either with mucosal adjuvants or 
delivery vehicles. Some studies indicate that intranasal administration yields better results, 
compared to the intragastric route (Garhart et al., 2002; Sutton et al., 2007). As adjuvants for 
mucosal immunization, cholera toxin (CT) and the heat-labile toxin of enterotoxigenic 
Escherichia coli (LT) have been the most widely used in mice, although they are known to 
cause diarrhoea in humans, even at low doses (Corthésy-Theulaz et al., 1995; Guy et al., 
1998; Guy et al., 1999; Banerjee et al., 2002; Garhart et al., 2002; Nyström et al., 2006; 
Sutton et al., 2007; Svennerholm and Lundgren, 2007). As a consequence, several mouse 
vaccination studies have been perfomed with success using CT- or LT-based adjuvants with 
reduced toxicity. Examples are vaccination using the recombinant non-toxic cholera toxin B 
subunit (Kubota et al., 2005), detoxified mutant LT toxins (Ghiara et al., 1997; Satin et al., 
2000) and an adjuvant containing the ADP-ribosylating ability of the cholera toxin A subunit 
combined with a dimer of an immunoglobulin-binding fragment of Staphylococcus aureus 
protein A (Akhiani et al., 2006). Several other adjuvants have also been used with success in 
mucosal H. pylori mouse immunization studies. These include linear polysaccharides such as 
chitosan (Xie et al., 2007) and immunostimulatory CpG oligonucleotides, both alone or in 
combination with antigens (Raghavan et al., 2003; Jiang et al., 2003). Interestingly, when 
using a combination of H. felis lysate, CT and CpG, a sterilizing immunity was assessed by 
means of quantitative PCR, revealing a possible synergy between both adjuvants (Jiang et al., 
2003). The use of H. pylori ghosts, which are bacterial cell envelopes devoid of cytoplasmic 
contents, has shown a certain degree of efficacy (Panthel et al., 2003; Hoffelner et al., 2008; 
Talebkhan et al., 2010), as did the use of vectors expressing Helicobacter urease subunits, 
including Lactobacillus spp. and attenuated Salmonella strains (Corthésy-Theulaz et al., 1998; 
Corthésy et al., 2005).  
Since H. pylori infection also recruits inflammatory cells from the circulation 
(Blanchard and Nedrud, 2010), protective immunity may also be achieved through parenteral 
vaccination. Indeed, a certain degree of protection has been described using prophylactic and 
therapeutic vaccination via several possible parenteral administration routes, mostly 
accompanied by the use of established adjuvants, such as complete and incomplete Freund’s 
adjuvant (Eisenberg et al., 2003; Morihara et al., 2007) and aluminium hydroxide (alum) 
(Ermak et al., 1998; Gottwein et al, 2001; Nyström et al., 2006). Rarely, complete protection 
was assessed, and again, histology and detection of urease activity were the applied 
techniques. Interestingly, systemic unadjuvanted vaccination with bacterial lysate or formalin-
fixed Helicobacter pylori has also been shown to confer partial protection against challenge 
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with a heterologous H. pylori strain, as determined by bacterial culture (Harbour et al., 2008). 
Conflicting results have been reported when comparing the efficacy of mucosal vs. systemic 
immunization routes, but most studies suggest that mucosal immunization is the better of two 
options (Ermak et al., 1998; Guy et al., 1999; Nyström et al., 2006).  
  
6.3 Mechanisms of vaccine-mediated protection against H. pylori infection 
 
In prophylactic H. pylori mouse vaccination studies, an enhanced gastritis is often 
observed after challenge of immunized mice (Blanchard and Nedrud, 2010). This post-
immunization gastritis is often associated with the degree of protection against colonization, 
as shown by a clear correlation between the severity of post-immunization gastritis and a 
reduction of the bacterial load (Goto et al., 1999; Garhart et al., 2002; Morihara et al., 2007). 
Eventually, however, the disparity in gastritis between infected animals and 
immunized/challenged animals disappears, showing that this is a transient event, both in the 
H. pylori and H. felis mouse immunization model (Sutton et al., 2001; Garhart et al., 2002). 
Identification of cell populations has shown that protection mainly depends on the presence of 
a MHC class II-restricted CD4+ T cell population (Ermak et al., 1998; Ruggiero et al., 2003), 
which was confirmed by protection induced in mature B and T cell-deficient rag11/1 mice, by 
transfer of purified  CD4+ T cells from vaccinated C57BL/6 mice (Gottwein et al., 2001). As 
for the polarization of the CD4+ T-helper cells, some conflicting reports can be found in 
literature. Although initially, an elicited Th2 response (with prophylactic systemic alum-
adjuvanted and therapeutic mucosal CT-adjuvanted immunization) or a balanced Th2/Th1 
response were shown to confer protection (Ermak et al., 1998; Saldinger et al., 1998; 
Gottwein et al., 2001), it is now accepted that Th1 responses are probably most important for 
Helicobacter immunity (Taylor et al., 2008; Blanchard and Nedrud, 2010). Garhart et al. 
(2003) found that IL-4 is not essential for vaccine-induced protection and Nyström and 
Svennerholm (2007) described a protection after therapeutic oral vaccination which was 
strongly related to specific mucosal CD4+ T cells with a Th1 profile. As for the role of IFN-γ 
in this protective response, the debate is still ongoing. The same goes for other cytokines, 
including IL-12p40 and the IL-23/IL-17 pathway (Blanchard and Nedrud, 2010). The latter 
has been described as being important for neutrophil-dependent protection (DeLyria et al., 
2009), which was again questioned by the same research group (Blanchard and Nedrud, 
2010). Very recently, it has been shown that H. pylori infection causes an imbalance between 
interleukin-17+ helper T cell (Th17) and regulatory T cells (Tregs) in favour of the Tregs and 
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resulting in a suboptimal Th17 response and failure to eliminate the bacterium (Kao et al., 
2010). Possibly, T cell activation at lymph nodes due to immunization could circumvent this 
Treg-mediated suppression of immunity (Blanchard et al., 2004). 
Generally, antibodies are considered not to be essential for vaccine-mediated 
immunity to H. pylori. Several research groups have been able to obtain a similar level of 
protection in antibody-deficient mice, when compared to wild-type animals (Ermak et al., 
1998; Gottwein et al., 2001; Garhart et al., 2003), although others have described a strong 
relation between protection and mainly the presence of antigen-specific IgA antibodies, both 
local and circulating (Czinn et al., 1993; Nyström and Svennerholm, 2007; Morihara et al., 
2007). 
 
6.4 Immunization against gastric helicobacters: other animal models and non-H. 
pylori helicobacters 
 
Only few studies have described vaccination in the Mongolian gerbil model. Jeremy et 
al. (2006) achieved a successful protection, assessed by culture, histology and urease, against 
H. pylori challenge in gerbils vaccinated orogastrically with H. pylori whole bacterial cell 
sonicate along with CT. Interestingly, protection in this animal model was not accompanied 
by post-immunization gastritis, 6 weeks after challenge of immunized animals. Intragastric 
and, to a lesser extent, intramuscular immunization with a combination of UreB, HspA, HpaA 
and low-toxic LTR72DITH or Al(OH)3, respectively, also have been shown to induce a good 
protection against H. pylori challenge (Wu et al., 2008). As a consequence, the gerbil model 
may be very useful for H. pylori vaccination studies, especially since highly virulent type I 
strains, with a functional CagA type IV secretion system and a functional VacA are 
incompatible with a stable colonization in the mouse model (Hoffelner et al., 2008). In 
Mongolian gerbils, however, a stable chronic infection with type I H. pylori strains is possible 
(Rieder et al., 2005b) and VacA has even been suggested to be important for chronic 
persistence in gerbils (Hoffelner et al., 2008). A clear disadvantage of this rodent model, 
however, is the relative lack of tools, including antibodies and options of genetic manipulation 
(Hoffelner et al., 2008). 
Some Helicobacter vaccination studies have been done in animals other than rodents. 
Two studies by the same research group describe both prophylactic and therapeutic 
vaccination against H. pylori infection in gnotobiotic piglets (Eaton and Krakowka, 1992; 
Eaton et al., 1998). Prophylactic vaccination did not prevent infection by subsequent 
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challenge but reduced bacterial colonization, whereas therapeutic vaccination was 
unsuccessful. In cats and dogs, a prophylactic oral immunization with recombinant urease and 
LT and a therapeutic intramuscular vaccination with a multicomponent vaccine and 
aluminium hydroxide, respectively, have been shown to elicit a reduced H. pylori colonization 
(Batchelder et al., 1996; Rossi et al., 2004). In non-human primates, only some studies 
describe a partial protection by immunizing with urease against subsequent H. pylori 
challenge or natural H. pylori infection (Dubois et al., 1998; Lee et al., 1999b; Solnick et al., 
2000). This partial protection was achieved with oral vaccination or oral priming and 
subsequent parenteral vaccination, whereas parenteral vaccination alone was unsuccessful. 
Therapeutic vaccination protocols have been described to confer limited protection when 
using parenteral administration or a combination of parenteral and oronasal vaccination (Guy 
et al., 1998; Lee et al., 1999a). 
For gastric non-H. pylori helicobacters, vaccination studies are mostly limited to H. 
felis, as discussed in the previous sections. Additionally, Dieterich et al. (1999) have 
described a prophylactic and therapeutic vaccination regimen against a so-called “H. 
heilmannii” challenge. Similar results were obtained for prophylactic intranasal vaccination 
using recombinant “H. heilmannii” ureB or H. pylori urease, both adjuvanted with CT. The 
results of therapeutic immunization with H. pylori urease suggested that successful treatment 
is more difficult to achieve for “H. heilmannii” infection when compared to H. felis. 
However, caution is needed, since gastric tissue of “H. heilmannii”-infected mice was used 
for challenge and  the exact species status of the “H. heilmannii” strain remains unknown. 
Finally, a single mouse study describes both intranasal (+ CT) and subcutaneous (+ saponin 
formulation) immunization with heterologous H. pylori and H. felis whole bacterial cell 
antigens against challenge with “Candidatus H. suis”, which was unculturable at the time of 
publication (Hellemans et al., 2006). Although urease activity in the stomach of 
vaccinated/challenged mice was often reduced to basal levels, all immunization protocols 
conferred only partial protection, since all animals remained positive in a H. suis-specific 
PCR. 
 
6.5 Immunization against gastric helicobacters in humans 
 
In early human H. pylori vaccination trials, mucosal administration of recombinant H. 
pylori urease and LT was used, often leading to diarrhoea in volunteers (Michetti et al., 1999; 
Banerjee et al., 2002; Sougioultzis et al., 2002). Often, an immune response was elicited, 
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although LT was shown to be more immunogenic than urease. Only in the study by Michetti 
et al. (1999), the effect on H. pylori colonization was assessed, after therapeutic vaccination, 
however no eradication could be achieved. Similarly, successful eradication could not be 
achieved after therapeutic immunization using a formalin-inactivated whole-cell preparation 
(Kotloff et al., 2001).  
To avoid the undesirable side-effects of toxic adjuvants such as LT, several research 
groups have performed vaccination with H. pylori urease, expressed by an attenuated 
Salmonella enterica vector. Also in the most recent study, this did not induce satisfactory 
protection against H. pylori challenge, although higher percentages of H. pylori-responsive T 
cells were detected in patients with reduced H. pylori colonization (Aebischer et al., 2008). 
Finally, intramuscular administration of a multicomponent vaccine, composed of CagA, 
VacA, HP-NAP and aluminium hydroxide, elicited no adverse reactions and generated a 
humoral and antigen-driven T-cell proliferation and cytokine production (Malfertheiner et al., 
2008). It remains, however, to be elucidated whether this vaccination protocol can really 
protect against colonization with H. pylori and the subsequent development of severe gastric 
pathologies.  
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 Scientific Aims 
Worldwide, infection with Helicobacter (H.) pylori is considered to be the major cause 
of gastritis, peptic ulcer disease, gastric adenocarcinoma and mucosa-associated lymphoid 
tissue (MALT) lymphoma in humans. Besides H. pylori, large, spiral-shaped non-H. pylori 
helicobacters have also been associated with these gastric disorders and comprise different 
species naturally occurring in the stomach of various animal species. H. suis colonizes the 
stomach of the vast majority of pig populations and is the most prevalent non-H. pylori 
Helicobacter species detected in humans suffering from gastric disease. 
 
For all non-H. pylori Helicobacter species in general and H. suis in particular, very 
little is known about their exact role in human gastric pathology. In part, the very fastidious 
nature of these bacteria has hampered the progress of non-H. pylori Helicobacter-related 
research. Our research group was the first to successfully isolate H. suis in vitro in 2008, 
opening new doors to investigate the exact role of this bacterium in gastric pathology and to 
develop possible strategies to control this infection. 
 
To obtain better insights into the pathogenesis of human gastric diseases associated 
with a H. suis infection, experimental infections with pure cultures of the bacterium are 
essential. In the past, various animal models of human gastric disease, including the 
Mongolian gerbil model, have been used to investigate H. pylori-induced gastric pathology. 
Therefore, the first aim of this thesis was to investigate the possibility of using the Mongolian 
gerbil model in H. suis research. 
 
In the second study, experimental H. suis infections in mouse and Mongolian gerbil 
models were performed in order to examine in detail the interactions between the bacterium 
and the gastric mucosa of the host. 
 
Prevention and eradication of gastric Helicobacter infection are two very important 
steps to drastically reduce the number of people suffering from gastric disease. Therefore, in 
the third study, in vitro grown H. suis was used to vaccinate mice, in a first attempt to 
evaluate the protective effect of the in vitro cultured organisms. 
 
Loss of gastric epithelial cells has been shown to be a major factor contributing to H. 
pylori-induced gastric pathology. For H. suis, however, nothing is known about its possible 
role in human gastric epithelial cell death. Therefore, it was the fourth aim of this thesis to 
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investigate H. suis-induced cell death and to characterize H. suis virulence factors involved in 
this process.  
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Abstract 
 
Background: The Mongolian gerbil model is often used to investigate the interactions 
between different gastric Helicobacter species and the gastric tissue. A preliminary screening 
of a gerbil population intended for use in Helicobacter suis infection studies revealed a 
natural yeast infection in the stomach of these animals. After identification, we have 
investigated the effect of the gastric yeast infection on the outcome of an experimental H. suis 
infection in Mongolian gerbils. 
Materials and methods: Yeast cells were isolated from the stomachs of Mongolian gerbils. 
Identification was done by Internally Transcribed rRNA Spacer 2 Region (ITS2) PCR 
fragment length analysis. To investigate a possible pathologic role of this yeast,  Mongolian 
gerbils were infected experimentally with this yeast. Co-infection with the newly isolated 
Helicobacter suis was performed to investigate possible interactions between both micro-
organisms. 
Results: Kazachstania heterogenica was found colonizing the stomach of Mongolian gerbils, 
mainly in the antrum. Few pathologic changes were seen in the stomachs of infected animals. 
Experimental co-infection of gerbils with this yeast and the newly isolated Helicobacter suis 
showed a significant increase in inflammation in animals infected with both micro-organisms 
compared to animals infected only with Helicobacter suis. 
Conclusions: Kazachstania heterogenica colonizes the stomach of Mongolian gerbils in 
exactly the same regions as gastric Helicobacter species. The uncontrolled presence of this 
yeast in the gerbil stomach can lead to an overestimation of the inflammation caused by 
Helicobacter in this animal model. 
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Introduction 
 
Helicobacter (H.) suis is a newly isolated Helicobacter species (Baele et al., 2008) 
colonizing the gastric mucosa of the vast majority of the pig population (Park et al., 2004; 
Hellemans et al., 2007). This large spiral-shaped bacterium has been suggested to play a role 
in the development of hyperkeratosis and ulcers of the pars oesophagea in the pig stomach 
(Haesebrouck et al., 2009). In addition, this Helicobacter species is identical to ‘H. 
heilmannii” type 1 (Haesebrouck et al., 2009; O’Rourke et al., 2004). Bacteria belonging to 
the group comprising “H. heilmanni” type 1 and 2 have been associated with gastritis, gastric 
ulcers and even gastric MALT lymphoma in a minority of the human population (Debongnie 
et al., 1995; Debongnie et al., 1998; Morgner et al., 2000; Stolte et al., 2002). To date, very 
little is known about the pathogenesis of an H. suis infection. 
Rodent models are commonly used to study the pathogenesis of gastric Helicobacter 
infections. In H. pylori research, the mouse and the Mongolian gerbil (Meriones unguiculatus) 
model are the two rodent species most commonly used to investigate the interactions between 
this bacterium and the gastric tissue (O’Rourke and Lee, 2003; Rogers and Fox, 2004). Also, 
vaccination studies against H. pylori infection are performed in the Mongolian gerbil model 
(Jeremy et al., 2006; Wu et al., 2008). Besides extensive use in H. pylori research, the 
Mongolian gerbil has also been used to investigate the pathogenic effects of other gastric 
helicobacters, such as H. felis and H. bizzozeronii (De Bock et al., 2006a and 2006b). During 
a preliminary screening of a gerbil population prior to their use for the study of H. suis 
infection, yeast-like organisms were found colonizing the antral region of their stomachs. The 
purpose of the present study was to identify the yeasts and to study the effect of a gastric yeast 
infection on the outcome of an experimental H. suis infection in Mongolian gerbils. 
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Materials and Methods 
 
Natural yeast infection in the stomach of Mongolian gerbils: animals, sampling and 
processing of samples 
Seventeen specific-pathogen-free (SPF) female gerbils of six weeks old were 
purchased from an authorized laboratory animal supplier (supplier A). The animals were 
barrier-maintained in a room with controlled environment and housed in filtertop cages. They 
were fed an autoclaved diet containing 18% protein (Teklad Global Rodent Diet, Harlan NL, 
Horst, The Netherlands) and received autoclaved tap water ad libitum. Two animals were 
sacrificed by cervical dislocation after isoflurane (5% vol/vol) anaesthesia at eight weeks of 
age and seven animals at thirteen weeks of age. The eight remaining animals were sacrificed 
at eightteen weeks of age. The stomachs were opened along the greater curvature and rinsed 
with sterile HBSS (Gibco, Carlsbad, USA). For histological analysis, a longitudinal strip of 
tissue along the greater gastric curvature from the oesophagus to the duodenum, was taken 
from all animals. After fixation in 4 % phosphate buffered formalin, tissues were processed 
by standard methods and embedded in paraffin. Serial 5 µm sections were cut and stained 
with haematoxylin and eosin (H&E), periodic acid-Schiff (PAS) and Gomori silver to 
visualize the yeasts. 
To isolate the yeast cells, a swab was taken from the antrum pyloricum of ten animals 
(two animals of eight weeks old and eight animals of eightteen weeks old) and plated onto 
Sabouraud (SAB) dextrose agar (Oxoid, Basingstoke, UK) containing penicillin and 
streptomycin (Sigma-Aldrich, St. Louis, USA).  Plates were incubated aerobically at 37°C for 
at least 48 hours. A faecal sample was collected from the cage housing the two animals 
euthanized at eight weeks of age, homogenized in sterile HBSS and plated out as described 
above.  
 
Identification of the yeast strains 
Two yeast colonies obtained from the antral swabs of five animals (n= 10) as well as 
two colonies obtained from the faecal sample were used for subcultivation and subsequent 
identification to species level. DNA-extraction of single colonies was done by a boiling-
freezing method. Next, identification was done by Internally Transcribed rRNA Spacer 2 
Region (ITS2) PCR fragment length analysis (De Baere et al., 2002). Further discrimination 
between the members of the Kazachstania (K.) telluris complex was carried out by sequence 
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analysis of the ITS2-region followed by comparison of the obtained sequence to all known 
sequences in Genbank using the BLAST software at NCBI. An isolate from each animal was 
passed onto new SAB agar plates and frozen at -80°C in a medium consisting of 7.5 g 
glucose, 25 ml Brain Heart Infusion broth and 75 ml sterile inactivated horse serum (isolates 
001-005).  
   
Bacterial and yeast strains for experimental infection 
H. suis strain HS5, isolated as described previously from the gastric mucosa of a sow 
(Baele et al., 2008), was grown on Brucella agar (Oxoid, Basingstoke, UK) supplemented 
with 20% fetal calf serum, 5 mg/l amphotericin B (Fungizone; Bristol-Myers Squibb, 
Epernon, France), Campylobacter selective supplement (Skirrow, Oxoid; containing 10 mg/l 
vancomycin, 5 mg/l trimethoprim lactate and 2500 U/l  polymyxin B) and Vitox supplement 
(Oxoid). In addition, the pH of the agar was adjusted to 5 by adding HCl to a final 
concentration of approximately 0.05%. One ml of Brucella broth (Oxoid) with a pH of 5 was 
added on top of the agar to obtain biphasic culture conditions, essential for cultivation of this 
bacterium. After three days of incubation at 37°C in microaerobic conditions, the broth, 
containing the bacteria, was harvested. The final concentration was adjusted to an optical 
density of 1 at 660 nm, corresponding to approximately 2 x 108 viable bacteria/ml, as 
determined by counting bacteria in an improved Neubauer counting chamber. 
 K. heterogenica (isolate 002) was first grown on SAB plates, as described above. After 
48 hours, one colony was suspended in 50 ml of SAB broth (containing 10g special peptone 
(Oxoid), 20 g glucose and 1000 ml distilled water at a pH of 5,5) and grown with shaking 
overnight (16 hours) at 37°C to obtain a liquid culture containing 2.5 x 107 CFU/ml. 
 
Experimental infection of Mongolian gerbils with Kazachstania heterogenica 
The experimental protocol was approved by the Ethical Committee of the Faculty of 
Veterinary Medicine, Ghent University, Belgium. Thirty-four female SPF outbred gerbils 
(Crl:MON) of five weeks old were obtained from another authorized laboratory animal 
supplier (supplier B) and housed as described above. Preliminary screening of four extra 
animals showed gerbils of this supplier to be free of gastric K. heterogenica infection by 
direct culture from both stomach and faeces (as described above). Twenty-three animals were 
inoculated two times at 48 hours intervals (Day 0 and Day 2) with 107 CFU of K. 
heterogenica, grown overnight in SAB broth. Eleven animals served as uninfected controls 
and were inoculated with SAB broth. Inoculation was performed intragastrically using a ball-
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tipped gavage needle, under isoflurane (IsoFlo; Abbott, Illinois, USA) anaesthesia. Five 
infected animals were euthanized at Day (D) 4, as well as two uninfected controls. At D8, 
D15 and D22 of the experiment, six infected and three uninfected animals were euthanized. 
This was done by cervical dislocation following isoflurane anaesthesia. The stomach of each 
animal was resected, opened along the greater curvature and rinsed with sterile HBSS 
(Gibco). Yeast isolation and histological analysis were performed as described above. H&E-
stained sections were used for blind scoring of the intensity of gastric inflammation 
(infiltration of mononuclear cells and neutrophils), according to the Updated Sydney System 
(Dixon et al., 1996). PAS-stained sections were used for blind scoring of the colonization with 
K. heterogenica, with a scale from 0 (no yeasts visible) to 3 (extensive colonization).      
 
Experimental co-infection of Mongolian gerbils with Kazachstania heterogenica and 
Helicobacter suis 
The experimental protocol was approved by the Ethical Committee of the Faculty of 
Veterinary Medicine, Ghent University, Belgium. Fourty female SPF outbred gerbils 
(Crl:MON) of five weeks old were obtained from laboratory animal supplier B (see previous 
section) and housed as described above. Preliminary screening of four extra animals with an 
H. suis-specific PCR showed gerbils of this authorized laboratory animal supplier to be free of 
H. suis. As described above, these animals were also shown to be free of K. heterogenica.  
The animals were divided into 5 groups (Table 2). The animals from the control group (group 
1) were inoculated with SAB broth at D0 and D2, with Brucella broth at D14 and D16, and 
again with SAB broth at D21 and D23. Gerbils in group 2 were inoculated with 107 CFU of K. 
heterogenica at D0 and D2. At D14 and D16 they were administered Brucella broth, followed 
by SAB broth administration at D21 and D23. Animals in the third group were given SAB 
broth at D0 and D2, inoculated with 108 CFU of H. suis at D14 and D16, and given SAB 
broth again at D21 and D23. Animals from group 4 were given SAB broth at D0 and D2. 
Inoculation of H. suis (108 CFU) was performed at D14 and D16, followed by administration 
of K. heterogenica (107 CFU) at D21 and D23. Animals in group 5 received inoculation with 
K. heterogenica (107 CFU) at D0 and D2 and with H. suis (108 CFU) at D14 and D16. At D21 
and D23 the gerbils were given SAB broth. At D35, all animals were sacrificed. All 
inoculations were performed intragastrically as described above. Euthanasia was performed as 
described in the previous section. At euthanasia, the stomach of each animal was resected, 
opened along the greater curvature and rinsed with sterile HBSS (Gibco). The procedure for 
yeast isolation was performed as described above. Samples for PCR analysis and urease 
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testing were taken in both antrum and fundus using disposable sterile biopsy punches (∅ 
3mm). DNA extraction was done with the DNeasy Tissue Kit (Qiagen, Hilden, Germany) 
according to the manufacturer’s protocol. All samples were screened for the presence of H. 
suis DNA using an H. suis specific PCR (De Groote et al., 2000). For urease testing, samples 
were immersed in 500 µl of rapid urease test (CUTest; Temmler Pharma, Marburg, Germany) 
and incubated at 37°C for 3 h. After centrifugation (5 min., 1000 x g), the level of urease 
activity was measured by spectrophotometric analysis at 550 nm. Basal values were 
determined by measuring the optical density of the rapid urease test incubated for 3h without 
addition of a tissue sample (negative control). All urease values were subtracted with the 
mean value of the negative control samples. Histological evaluation was performed as 
described above. An additional 5 µm section was used for immunohistochemical staining of 
Helicobacter bacteria, by using a polyclonal genus-specific rabbit anti-H. pylori antibody 
(1/320; DakoCytomation, Glostrup, Denmark) (De Groote et al., 2000).  The H. suis 
colonization density was scored blindly according to the Updated Sydney System (Dixon et 
al., 1996). 
 
Statistical analysis 
 All statistical analyses were performed using SPSS, version 17 (SPSS Inc., Chicago, 
Illinois, USA). For comparison of urease values between different groups, a Student’s t-test 
was performed. For comparison of inflammation and both colonization scores, a Wilcoxon 
rank-sum test was used. Tests were performed at the 5% global significance level. 
 
 
 Results 
 
Kazachstania heterogenica occurs naturally in the stomach of Mongolian gerbils 
In twelve out of seventeen animals, on histological examination a mild to severe 
colonization with yeast cells was seen in the antrum, ranging from a few yeast cells to 
massive numbers forming a thick layer on the mucosa. The organisms were intensely positive 
by periodic acid-Schiff and Gomori Silver staining. Most of the yeast cells were seen in the 
surface mucus layer, although a substantial number of yeast cells also were seen in close 
association with the apical surface of the epithelial cells. In some animals, yeast cells were 
seen deep in the crypts.  
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In eight out of seventeen animals, a limited number of yeast cells were also observed 
in the fore stomach-stomach transition zone (i.e. limiting ridge). This colonization, however, 
was always substantially milder than that seen in the antrum. Colonization in the fundus was 
limited to a small region in only one animal. 
Most animals had a well-developed gastric mucosa with a normal foveolate surface 
and no inflammatory cell infiltration. In three out of seventeen animals, however, a mild 
inflammation was observed, mainly consisting of small lymphocytic infiltrates in the mucosa 
and submucosa of the antrum. This region was always colonized by yeast cells. 
Yeast cells were isolated from seven out of ten antral swabs and from the stool sample. 
In all seven of these animals, yeasts were also detected on histological sections. No organisms 
were isolated from the remaining three animals which were also histologically negative. 
Macroscopically, separate colonies shared the same phenotype and were visible after twenty 
four hours, ranging from 1mm to 3mm in diameter. Two colonies per plate obtained from the 
antral swabs of five animals and the faecal sample were selected for subcultivation and further 
analysis.  
ITS2-PCR fragment length analysis of all selected colonies resulted in a fragment 
length of 329 bp. This fragment length was already present in the Basehopper database as 
Kazachstania telluris complex. Previously we obtained different fragment lengths for strains 
of this complex, which was divided into five separate species four years ago (Kurtzman et al., 
2005). The obtained fragment length corresponded to K. heterogenica, one of those new 
species. Final confirmation was done by ITS2 sequence analysis, resulting in a 100% 
sequence similarity to strains CBS 2675T and CBS 2778, which were used for the description 
of the species K. heterogenica (Kurtzman et al., 2005). No other yeast species were detected 
in this study. 
 
Experimental infection of Mongolian gerbils with Kazachstania heterogenica leads to a 
predominant antral colonization without an appreciable inflammatory response   
 As opposed to control animals, in which no yeasts could be isolated from the antral 
region of the stomach, all Kazachstania-infected animals were positive for K. heterogenica 
culture in the antral stomach region at all four timepoints after experimental infection. 
 At four days post infection (D4), colonization by K. heterogenica was already 
established, since all animals had a colonization score of at least 1 in the antrum (Table 1). In 
contrast, only 2 out of 5 animals showed PAS-positive organisms colonizing the fundus at the 
forestomach-stomach transition zone. At 8 days post infection, 4 out of 6 animals showed a 
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maximum colonization score of 3 in the antrum, while only one animal showed no visible 
colonization at the forestomach-stomach transition zone. Colonization scores did not increase 
further in course of time. 
 When comparing active and chronic inflammation between K. heterogenica infected 
and uninfected groups at all timepoints, no differences were observed (p>0.05) (data not 
shown). Only five infected animals, spread out over all timepoints, showed a very mild 
neutrophilic infiltrate (score 1), mainly in the antrum.  Moreover, when using time as 
stratification factor, no differences in active (p = 0.147) and chronic (p = 1) antral 
inflammation were observed between uninfected and infected animals. 
 
Table 1. Colonization results of gerbils infected experimentally with K. heterogenica 
Timepoint of 
euthanasia 
 Number of animals with respective 
colonization score in fundus at forestomach-
stomach transition zone 
Number of animals with respective 
colonization score in antrum 
n 0* 1 2 3 0 1 2 3 
D4 5 3 2 0 0 0 2 2 1 
D8 6 1 5 0 0 0 0 2 4 
D15 6 2 4 0 0 0 0 4 2 
D22 6 0 6 0 0 0 0 3 3 
 
* colonization scores: 0, 1, 2, 3 
n: total number of K. heterogenica-infected animals euthanized at each time point 
 
Kazachstania heterogenica exacerbates a Helicobacter suis infection in Mongolian gerbils 
 K. heterogenica was isolated from the antral stomach region of all animals inoculated 
with this yeast, whereas all animals not inoculated with K. heterogenica were negative for this 
yeast. Animals infected only with K. heterogenica (group 2), showed higher Kazachstania 
colonization scores on PAS-stained sections in the antrum compared to the animals infected 
both with K. heterogenica and H. suis (groups 4 and 5) (Table 2) [P(2-4) = 0.032; P(2-5) = 
0.003]. Pooling the data from groups 4 and 5 confirmed these findings [P(2-4/5) = 0.004]. 
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Table 2. Experimental infection study with H. suis and K. heterogenica: colonization scores and urease values  
Group 
Number 
of 
animals/ 
group 
Inoculation  
D0/D2 
Inoculation 
D14/D16 
Inoculation  
D21/D23 
H. suis 
colonization 
score antrum: 
mean (min-
max) 
K. 
heterogenica 
colonization 
score antrum: 
mean (min-
max) 
Urease 
value 
antrum : 
mean ± SD 
1 5 SAB broth Brucella broth SAB broth 0 (0-0) 0 (0-0) 0 ±  0 
2 5 K. heterogenica Brucella broth SAB broth 0 (0-0) 3 (2-3) 0 ± 0 
3 10 SAB broth H. suis SAB broth 2 (1-2) 0 (0-0) 1.601 ± 0.110 
4 10 SAB broth H. suis K. heterogenica 2 (2-3) 2 (1-3) 1.533 ± 0.178 
5 10 K. heterogenica H. suis SAB broth 2 (1-3) 2 (1-2) 1.524 ± 0.063 
 
D: day of the experiment; Min-max: minimum-maximum individual score per group; SD: standard deviation; 
SAB:  Sabouraud 
 
 All animals infected with H. suis (groups 3, 4 and 5) were positive in the H. suis 
specific PCR, in contrast to the animals in both the negative and K. heterogenica control 
group (data not shown). The results of the urease testing showed positive values, mainly in the 
antrum, for all H. suis-infected animals (Table 2). Although slightly lower values for urease 
activity were detected in the antrum of groups 4 and 5 compared to animals which received H. 
suis inoculation only (group 3), these differences were not significant [P(3-4) = 0.323; P(3-5) 
= 0.075; P(3-4/5) = 0.125]. This was confirmed by the results of the Helicobacter 
colonization scores, showing no difference in antral colonization density between animals 
infected with H. suis alone and animals infected with both H. suis and K. heterogenica (Table 
2). Often, both organisms colonized the exact same places in the antrum (Figure 1A) and were 
seen in close proximity of each other (Figure 1B). 
Results of the inflammation scores in the antrum are shown in figure 2. All animals in 
the negative control group (group 1) showed a normal gastric mucosa with no inflammatory 
cell infiltration (Figure 3). Four out of five animals infected with K. heterogenica alone 
showed no inflammation, while one animal showed a very mild lymphocytic infltrate. All H. 
suis-inoculated animals had an inflamed gastric mucosa, mainly visible as lymphocytic 
infiltrates in the antrum. Animals infected experimentally with both H. suis and K. 
heterogenica (groups 4 and 5, respectively) (Figures 4A and 4B) showed higher inflammation 
scores than animals infected with H. suis only (group 3) (Figures 5A and 5B) [P(3-4) = 0.104; 
P(3-5) = 0.042]. This difference was confirmed by pooling the data from groups 4 and 5 [P(3-
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4/5) = 0.039]. This was done because no differences in antral inflammation were seen 
between groups 4 and 5 [P(4-5) = 0.706].   
 
 
Figure 1 (A) Immunohistochemical Helicobacter staining showing antral colonization with H. suis (brown; 
score 2 on a scale from 0-3) and K. heterogenica (arrows; score 2 on a scale from 0-3). Original magnification: 
200x; bar: 100 µm. (B) Immunohistochemical Helicobacter staining of a stomach gland showing antral 
colonization both with H. suis (brown) and K. heterogenica. Original magnification: 1000x; bar: 20 µm. 
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Figure 2 Antral inflammation scores (0-3) per group (between brackets). Shown are the individual scores of 
each animal. Bars represent the median antral inflammation score of each group. * Kaz: experimental infection 
with Kazachstania heterogenica. Hel: experimental infection with Helicobacter suis. 
 
 
Figure 3 Immunohistochemical Helicobacter staining of a negative control animal showing no antral 
colonization with H. suis nor K. heterogenica. No inflammation can be seen. Original magnification 200x; bar: 
100 µm. 
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Figure 4 (A) and (B) Immunohistochemical Helicobacter staining of the antrum of an animal infected with both 
H. suis and K. heterogenica showing antral colonization with H. suis (brown) and K. heterogenica (small 
arrows) and a more severe inflammation (large arrow) compared to animals infected with H. suis alone. Original 
magnification 200x; bar: 100 µm. 
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Figure 5 (A) and (B) Immunohistochemical Helicobacter staining of the antrum of an animal infected with H. 
suis alone showing H. suis bacteria (brown) and a mild to moderate inflammatory cell infiltrate (arrow). Original 
magnification 200x; bar: 100 µm. 
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Discussion 
Over the past fifteen years, the mouse model has been widely used to investigate 
Helicobacter pathology. Until now, only a few reports have been published about gastric 
yeast infections in these animals (Savage and Dubos, 1967; Artwohl et al., 1988; Kurtzman et 
al., 2005). During the past decade, the Mongolian gerbil model has increasingly been used to 
study the pathogenesis of Helicobacter infections. The data presented here describe the 
spontaneous colonization of the gerbil stomach with yeasts. Sequence analysis of a 198 bp 
fragment from Internally Transcribed Spacer 2 allowed identification as Kazachstania 
heterogenica, a yeast belonging to the Kazachstania (Arxiozyma) telluris complex.  
All of the yeast-infected animals in the first study (naturally infected) and all animals 
experimentally infected with K. heterogenica were colonized mainly in the antrum, showing 
striking similarities between the colonization patterns of K. heterogenica and gastric 
helicobacters in the Mongolian gerbil. Namely, this pattern of colonization is similar to what 
Court et al. (2002) reported in Mongolian gerbils experimentally infected for 4 weeks with H. 
pylori. Similar results were obtained for Mongolian gerbils infected with H. felis and H. 
bizzozeronii (De Bock et al., 2006a and 2006b) and the results of the present study reveal that 
also H. suis shows the same colonization pattern. In the studies of De Bock and coworkers, as 
well as in the present study, antral biopsies were more often PCR- positive than fundus tissues 
and immunohistochemical staining for Helicobacter bacteria showed bacteria mainly in the 
antrum. Nevertheless, bacteria could also be found near the forestomach-stomach transition 
zone. Remarkably, K. heterogenica was also found near the forestomach-stomach transition 
zone in some animals in the present study. 
When infected with gastric Helicobacter species, Mongolian gerbils develop lesions 
similar to those seen in humans, such as chronic active gastritis, intestinal metaplasia, gastric 
ulcer and even gastric cancer (Watanabe et al., 1998; Ikeno et al., 1999). Court et al. (2002) 
have found that H. pylori-infected Mongolian gerbils show an inflammatory response in their 
antral mucosa at four weeks after infection. In contrast, little or no inflammatory changes 
were observed in the corpus mucosa. In the present study, similar changes were observed in 
Mongolian gerbils infected for 3 weeks with H. suis alone.  
Three out of seventeen animals naturally infected with K. heterogenica suffered from 
mild lymphocytic infiltrates in association with K. heterogenica, indicating that infection with 
these yeast cells may independently cause mild pathologic changes in the gastric mucosa of 
Mongolian gerbils. In total, twelve separate colonies were tested in the present study. All of 
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them were shown to be K. heterogenica. However, it can not be excluded that other yeast 
species were also present in the gerbil stomachs in lower numbers. Possibly, other yeast 
species can also have an effect on inflammation. For instance, Kurtzman et al. (2005) have 
found a chronic inflammation with lymphocytes in a minority of mice infected with Candida 
pintolopesii, a closely related yeast species. Moreover, Schofield et al. (2005) have described 
an immune response elicited by gastric candidiasis in germ-free immunocompetent C57BL/6 
and BALB/c mice. In contrast to the naturally infected animals in the present study, none of 
the animals infected experimentally with K. heterogenica showed a gastric lymphocytic 
infiltrate, except one Kazachstania-infected animal of group 2 in the 
Helicobacter/Kazachstania co-infection study. All experimentally infected animals in the 
Kazachstania infection study were euthanized within twenty two days after the first 
inoculation. So possibly, the naturally infected animals were colonized for a longer time, 
although this can not be stated with certainty.    
To our knowledge, this is the first report on co-infection of Helicobacter and yeasts 
colonizing the stomach. Several interactions between H. pylori and other micro-organisms 
have already been described. Ansorg and Schmid (1998) described the possibility of H. pylori 
to adhere to different Candida species. Moreover, Rokka et al. (2006) found that culture 
supernatants of different lactobacilli inhibit the in vitro growth of H. pylori. The third 
experiment in this paper has shown that gerbil stomachs can be colonized simultaneously with 
H. suis and K. heterogenica. Colonization with K. heterogenica did not seem to influence the 
degree of colonization with H. suis. However, a significant increase in inflammation was 
observed in animals infected with both micro-organisms, already three weeks after 
experimental H. suis infection. The underlying mechanism remains to be investigated. 
Nevertheless, these results show that the uncontrolled presence of K. heterogenica can lead to 
an overestimation of the inflammation and thus pathology caused by Helicobacter organisms 
in Mongolian gerbils. Therefore, Mongolian gerbils having a gastric infection with K. 
heterogenica or related yeasts should be considered unsuitable for experimental research on 
gastric helicobacters.  
The stomach mucosa by mere secretion of acid constitutes an antimicrobial barrier, 
and thus a very harsh environment for microbes. The fact that two totally different classes of 
micro-organisms colonize the same stomach regions suggests that these sites constitute 
special niches where these organisms find environmental factors suiting some very specific 
needs. Both antrum pyloricum and limiting ridge constitute transition zones between an acid-
secreting mucosa and a non-acid-secreting mucosa. De Bock et al. (2006b) showed that H. 
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felis induced loss of parietal cells from the limiting ridge onwards and progressing in time. 
Simultaneously, bacteria moved their residence in parallel with their preferred niche. Further 
in vivo and in vitro studies are needed not only to investigate the unique features of K. 
heterogenica but also to further elucidate its possible interactions with gastric helicobacters. 
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Abstract 
 
Background: “Helicobacter (H.) heilmannii” type 1 is the most prevalent gastric non-H. 
pylori Helicobacter species in humans suffering from gastric disease. It has been shown to be 
identical to H. suis, a bacterium which is mainly associated with pigs. To obtain better 
insights into the long-term pathogenesis of infections with this micro-organism, experimental 
infections were carried out in different rodent models.  
Methodology/Principal findings: Mongolian gerbils and mice of two strains (BALB/c and 
C57BL/6) were infected with H. suis and sacrificed at 3 weeks, 9 weeks and 8 months after 
infection. Gastric tissue samples were collected for PCR analysis, histological and 
ultrastructural examination. In gerbils, bacteria mainly colonized the antrum and a narrow 
zone in the fundus near the forestomach/stomach transition zone. In both mice strains, 
bacteria colonized the entire glandular stomach. Colonization with H. suis was associated 
with necrosis of parietal cells in all three animal strains. From 9 weeks after infection 
onwards, an increased proliferation rate of mucosal epithelial cells was detected in the 
stomach regions colonized with H. suis. Most gerbils showed a marked lymphocytic 
infiltration in the antrum and in the forestomach/stomach transition zone, becoming more 
pronounced in the course of time. At 8 months post infection, severe destruction of the normal 
antral architecture at the inflamed sites and development of mucosa-associated lymphoid 
tissue (MALT) lymphoma-like lesions were observed in some gerbils. In mice, the 
inflammatory response was less pronounced than in gerbils, consisting mainly of 
mononuclear cell infiltration and being most severe in the fundus.  
Conclusions/Significance: H. suis causes death of parietal cells, epithelial cell 
hyperproliferation and severe inflammation in mice and Mongolian gerbil models of human 
gastric disease. Moreover, MALT lymphoma-like lesions were induced in H. suis-infected 
Mongolian gerbils. Therefore, the possible involvement of this micro-organism in human 
gastric disease should not be neglected. 
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Introduction 
 
Although infection with Helicobacter (H.) pylori is considered to be the major cause 
of gastritis, peptic ulcer disease (Kusters et al., 2006; Marshall and Warren, 1984), gastric 
adenocarcinoma (Parsonnet et al., 1991) and mucosa-associated lymphoid tissue (MALT) 
lymphoma (Parsonnet et al., 1994) in humans, these gastric diseases have also been associated 
with other helicobacters, nowadays referred to as gastric non-H. pylori Helicobacter (NHPH) 
species or “H. heilmannii” (Morgner et al., 1995; Stolte et al., 1997; Debongnie et al., 1998; 
Mrgner et al., 2000). The latter, however, has never been a validated species name, since “H. 
heilmannii” represents a group of closely related, but distinct bacterial species, mainly present 
in different animal species and including H. felis, H. bizzozeronii, H. salomonis, ”Candidatus 
H. heilmannii” and H. suis (Haesebrouck et al., 2009). A common feature of these bacteria is 
their very fastidious nature, which seriously hampers the progress of gastric NHPH-related 
research. H. suis has only recently been cultured in vitro (Baele et al., 2008) and is in fact 
identical to “H. heilmannii” type 1 (O’Rourke et al., 2004b). It is the most prevalent gastric 
NHPH species in humans (Van den Bulck et al., 2005; De Groote et al., 2005). Moreover, its 
prevalence is probably underestimated since histological examination of a gastric biopsy, 
which is commonly performed in humans suffering from gastric disease,  is considered not to 
be the best diagnostic test for infections with H. suis and other NHPH species (Debongnie et 
al., 1995). 
Numerous studies have boosted the knowledge regarding the pathogenesis of H. pylori 
infections in humans. In contrast, only very few data are available dealing with the 
pathogenesis of H. suis infections in humans (Haesebrouck et al., 2009). In the past, several 
infection studies have been performed in mice with “H. heilmannii” or “tightly coiled spiral 
bacteria”, however often without a clear identification of these bacteria to the species level. 
Moreover, mucus or homogenized gastric tissue of infected mice, pigs or non-human primates 
was always used as inoculum (Moura et al., 1993; Peterson et al., 2001; Park et al., 2003; 
O’Rourke et al., 2004a; Cinque et al., 2006; Nakamura et al., 2007; Nishikawa et al., 2007; 
Park et al., 2008). This implies that other micro-organisms were also inoculated along with 
the helicobacters, which might influence the results, as has been shown for gastric yeasts 
interfering with a gastric H. suis infection in Mongolian gerbils (Flahou et al., 2010).  
To obtain better insights into the pathogenesis of human gastric diseases associated 
with H. suis, experimental infections with pure cultures of the bacterium are essential. In H. 
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pylori research, different rodent models have been shown to be very useful to obtain 
significant insights into the pathogenesis of this infection (O’Rourke and Lee, 2003; Rogers 
and Fox, 2004). Therefore, in the present study, C57BL/6 mice, BALB/c mice and Mongolian 
gerbils were used to explore the interactions between H. suis and the gastric mucosa. Mainly 
in Mongolian gerbils, long-term infection with H. suis was associated with severe gastric 
pathology, including necrosis of gastric epithelial cells and the development of gastric MALT 
lymphoma-like lesions. 
 
Materials and Methods 
 
Ethics statement  
The in vivo experimental protocol was approved by the Ethical Committee of the 
Faculty of Veterinary Medicine, Ghent University, Belgium (EC 2007/022; May 21, 2007). 
 
Animal and bacterial strains 
Twenty-seven specific-pathogen-free (SPF) female six-week-old mice of each of two 
strains (BALB/c and C57BL/6) were purchased from Harlan NL (Horst, The Netherlands). 
Twenty-seven female SPF outbred gerbils (Crl:MON) of six weeks old were obtained from 
Charles River Laboratories (Brussels, Belgium). Preliminary screening showed these animals 
to be free of Kazachstania heterogenica (Flahou et al., 2010). All animals were fed and 
housed as described previously (De Bock et al., 2006). 
H. suis strain HS5 was isolated from the gastric mucosa of a sow as described 
previously [10]. Bacteria were grown under microaerobic conditions (85% N2, 10% CO2, 5% 
O2; 37°C; 72 h) on biphasic Brucella (Oxoid, Basingstoke, UK) culture plates supplemented 
with 20% fetal calf serum (HyClone, Logan, UT, USA) and Vitox supplement (Oxoid) 
(Flahou et al., 2010). The bacteria were harvested and the final concentration was adjusted to 
2 x 108 viable bacteria/ml, as determined by counting in an improved Neubauer counting 
chamber.  
 
Experimental procedure 
Both for the mice strains and gerbils, 18 animals were inoculated three times at 48 
hours intervals with 0.4 ml of the bacterial suspension. Nine animals of each strain (BALB/c, 
C57BL/6 and Mongolian gerbil) were inoculated with Brucella broth (Oxoid) with a pH of 5 
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and served as negative controls. Inoculation was performed intragastrically under isoflurane 
anaesthesia, using a ball-tipped gavage needle. At 3 weeks, 9 weeks and 8 months after the 
first inoculation, six H. suis infected and three control animals of each group were euthanized 
by cervical dislocation under isoflurane anaesthesia. The stomach of each animal was resected 
and samples were taken for PCR analysis, histopathological and ultrastructural examination.  
 
PCR analysis.  
From each animal, one sample of approximately 4 mm2 was taken both in fundus and 
antrum. The DNeasy Tissue Kit (Qiagen, Hilden, Germany) was used for DNA extraction 
according to the manufacturer’s protocol. All samples were screened for the presence of H. 
suis DNA using an H. suis specific PCR (De Groote et al., 2000). 
 
Histological and ultrastructural examination 
Two longitudinal strips of gastric tissue were cut from the oesophagus to the 
duodenum along the greater curvature. One strip was fixed in 4% phosphate buffered 
formaldehyde, processed by standard methods, and embedded in paraffin for light 
microscopy. Nine consecutive sections of 5 µm were cut. After deparaffinization and 
hydration, heat-induced antigen retrieval was performed in citrate buffer (pH 6.0) using a 
microwave oven. Slides were incubated with 3% H2O2 in methanol (5 min) and 30% goat 
serum (30 min) to block endogenous peroxidase activity and non-specific reactions, 
respectively.  
On the first section, the H. suis colonization density was scored, as shown in Table 1, 
according to the Updated Sydney System (Dixon et al., 1996) after immunohistochemical 
staining using a polyclonal genus-specific rabbit anti-H. pylori antibody (1/320; 
DakoCytomation, Glostrup, Denmark) (De Groote et al., 2000). The second section was 
stained with haematoxylin and eosin (H&E) to score the intensity of the overall gastritis 
(infiltration with mononuclear and polymorphonuclear cells), also using a visual analog scale 
similar to the Updated Sydney System (Dixon et al., 1996) but with some modifications, as 
shown in Table 2. Both diffuse infiltration and the presence of lymphoid aggregates and 
lymphoid follicles were taken into consideration. Moreover, these H&E stained sections were 
used for counting the numbers of neutrophils. For differentiation between T and B 
lymphocytes, staining of CD3 and CD20 antigens, respectively, was performed on sections 
three and four, using a polyclonal rabbit anti-CD3 antibody (1/100; DakoCytomation) and a 
polyclonal rabbit anti-CD20 antibody (1/100; Thermo Scientific, Fremont, USA), 
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respectively. Incubation with primary antibodies directed against Helicobacter, CD3 and 
CD20 was followed by incubation with a biotinylated goat anti-rabbit IgG antibody (1/500; 
DakoCytomation). After rinsing, the sections were incubated with a streptavidin-biotin-HRP 
complex (DakoCytomation) and the colour was developed with diaminobenzidine 
tetrahydrochloride (DAB) and H2O2. A primary antibody directed against the F4/80 surface 
marker (1/50; Santa Cruz Biotechnology, Inc., Santa Cruz, USA) was used for highlighting 
mature macrophages. Detection was done using a rat ABC staining system (Santa Cruz 
Biotechnology, Inc.) Apoptotic cells were identified by immunohistochemical staining on 
section six using a rabbit polyclonal antibody directed against active caspase-3 and an anti-
rabbit HRP-AEC cell and tissue staining kit (R&D Systems, Minneapolis, USA). Replicating 
cells were identified on section seven using a mouse monoclonal anti-Ki67 antibody (1/25; 
Novocastra Laboratories Ltd, Newcastle upon Tyne, UK) and a biotinylated goat anti-mouse 
IgG antibody (1/200; DakoCytomation). Subsequent visualization was done as described for 
Helicobacter, CD3 and CD20 staining. Parietal cells were identified by immunohistochemical 
staining for the hydrogen potassium ATPase using a mouse monoclonal antibody (1/200; 
Abcam Ltd, Cambridge, UK) and a biotinylated goat anti-mouse IgG antibody (1/200; 
DakoCytomation). Subsequent visualization was done as described for Helicobacter, CD3 
and CD20 staining. Finally, a monoclonal mouse anti-cytokeratin antibody (1/50; 
DakoCytomation) was used to highlight lymphoepithelial lesions (LEL’s). These sections 
were further processed using an EnVisionTM+ system for use with mouse primary antibodies 
(DakoCytomation). 
During each immunohistochemical staining protocol, appropriate washing steps were 
included. After counterstaining of nuclei with haematoxylin, slides were dehydrated and 
mounted. 
To determine the numbers of cells belonging to defined immune cell populations (T 
cells, B cells, macrophages and neutrophils) in situ, positive cells were counted in five 
randomly chosen High Power Fields (magnification: x400), both in fundus and antrum. For 
each animal, an average of the positive cell count was determined for both stomach regions. 
For inflammatory aggregates and lymphoid follicles, the average area percentage of T and B 
cell populations was determined by using Optimas 6.51 image analysis software (Media 
Cybernetics, Inc., Bethesda, USA). Finally, for each individual animal, these data were 
translated into the respective percentages of both lymphocytic populations in aggregates and 
follicles. 
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The rates of apoptosis and epithelial cell proliferation were also determined by 
counting the number of active caspase-3 positive and Ki67 positive epithelial cells, 
respectively, in five randomly chosen High Power Fields at the level of the gastric pits, both 
in antrum and fundus. For each animal, an average of the positive cell count was determined 
for both stomach regions. 
The second longitudinal strip of tissue was processed for Transmission Electron 
Microscopy (TEM) as described previously (De Bock et al., 2006). Semithin sections (2µm) 
were stained with toluidine blue to select the most appropriate regions for ultrathin sectioning. 
Ultrathin sections were stained with uranyl acetate and lead citrate solutions before examining 
under a Jeol EX II transmission electron microscope at 80 kV.  
 
Statistical analysis 
Colonization and inflammation scores of infected groups of different animal strains 
were compared pairwise using the Wilcoxon rank sum test, using time as a stratification factor 
and a Bonferroni adjusted significance level of 0.05/3=0.0167. For analysis of defined 
immune cell populations, data from the three time points post infection were analyzed 
separately as appropriate, by analysis of variance with a Bonferroni post hoc test or the 
Wilcoxon rank sum test with Bonferroni adjustment of significance levels for multiple 
comparisons.  The numbers of Ki67 positive and active caspase-3 positive cells were analyzed 
by analysis of variance with a Bonferroni post hoc test assuming normally distributed error 
terms.  
 
Results 
 
Throughout the experiment, the animals were checked on a daily basis. Even by the 
end of the experiment, no animals showed overt clinical signs of discomfort or pain. 
 
Bacterial colonization  
Throughout the experiment, all control animals were negative for H. suis in PCR and 
immunohistochemical staining. All infected animals were PCR-positive in both antrum and 
fundus. The colonization levels of the infected animals are shown in Table 1. In general, 
colonization scores were higher in C57BL/6 mice compared to BALB/c mice (P = 0.0016 for 
fundus; P = 0.0035 for antrum). For both mice strains and for all timepoints, bacteria were 
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seen throughout the entire glandular stomach, both in antrum and fundus. For the gerbils, 
however, colonization in the antrum was moderate to marked at all timepoints (Table 1; 
Figure 1A), whereas colonization in the fundus remained limited to a very narrow zone at the 
limiting ridge (Figure 1B). Moreover, in some gerbils, no bacteria could be visualized in the 
fundic region. Although not statistically significant, colonization scores in infected BALB/c 
mice tended to drop in the course of time (P = 0.18 for fundus; P = 0.08 for antrum), whereas 
a tendency to increase was observed in the antrum of Mongolian gerbils (P = 0.15).  
 
Table 1: Gastric H. suis colonization in experimentally infected mice and gerbils 
Time pi a Group Colonization score fundus b Colonization score antrum b 
  0 c 1 c 2 c 3 c 0 c 1 c 2 c 3 c 
3 weeks BALB/c 0 3 3 0 0 1 3 2 
 C57BL/6 0 0 6 0 0 0 3 3 
 Gerbil 1 5 0 0 0 2 2 2 
9 weeks BALB/c 0 4 2 0 1 2 3 0 
 C57BL/6 0 2 4 0 0 1 4 1 
 Gerbil 3 3 0 0 0 3 1 2 
8 months BALB/c 0 6 0 0 2 2 2 0 
 C57BL/6 0 1 5 0 0 0 3 3 
 Gerbil 2 4 0 0 0 0 1 5 
a pi: post infection 
b Displayed are the numbers of animals out of six animals in each infected group with a specific colonization 
score. 
c 0, no bacteria; 1, mild colonization; 2, moderate colonization; 3, marked colonization  
 
 
 
Figure 1: Immunohistochemical Helicobacter staining of a gerbil stomach, showing H. suis colonization. H. 
suis bacteria (brown) are seen (A) in the glands of the antrum and (B) at the forestomach/stomach transition 
zone, accompanied by a focal infiltrate of mononuclear cells. Original magnification: 200x.  
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Inflammation 
At all timepoints, all uninfected control animals showed normal histomorphology, 
with little inflammatory cell infiltration in the gastric mucosa. For both mice strains and for 
the gerbils, inflammation in infected animals was characterized by mononuclear and 
polymorphonuclear cell infiltration in the lamina propria mucosae or the tunica submucosa or 
both, depending on the individual animal. The individual overall inflammation scores of the 
H. suis-infected animals are shown in Table 2. For BALB/c mice at all three timepoints and 
C57BL/6 mice at 8 months post infection, inflammation was observed mainly in the fundus. 
In general, BALB/c mice showed higher inflammation scores in the fundic region, compared 
to C57BL/6 mice (P=0.004). In Mongolian gerbils, however, inflammation in the fundic 
region was always limited to a very narrow zone near the limiting ridge, i.e. the forestomach-
stomach transition zone (Figure 1B). Generally, a more severe inflammation was observed in 
the antrum of infected gerbils, compared to BALB/c and C57BL/6 mice (P<0.0001). 
 
Table 2. Overall gastric inflammation in experimentally infected mice and gerbils 
Time pi a Group Inflammation score fundus b Inflammation score antrum b 
  0 c 1 c 2 c 3 c 4 c 0 c 1 c 2 c 3 c 4 c 
3 weeks BALB/c 4 2 0 0 0 4 2 0 0 0 
 C57BL/6 5 1 0 0 0 5 1 0 0 0 
 Gerbil 5 1 0 0 0 1 1 2 2 0 
9 weeks BALB/c 0 4 2 0 0 6 0 0 0 0 
 C57BL/6 5 1 0 0 0 3 3 0 0 0 
 Gerbil 1 3 2 0 0 0 0 1 4 1 
8 months BALB/c 0 0 4 2 0 5 1 0 0 0 
 C57BL/6 1 1 4 0 0 5 1 0 0 0 
 Gerbil 0 4 2 0 0 0 0 2 1 3 
 
a pi: post infection 
b Displayed are the numbers of animals out of six animals in each infected group with a specific overall 
inflammation score. 
c 0, no infiltration with mononuclear and/or polymorphonuclear cells; 1, mild diffuse infiltration with 
mononuclear and/or polymorphonuclear cells or the presence of one small (50-200 cells) aggregate of 
inflammatory cells; 2, moderate diffuse infiltration with mononuclear and/or polymorphonuclear cells and/or the 
presence of 2-4 inflammatory aggregates; 3, marked diffuse infiltration with mononuclear and/or 
polymorphonuclear cells and/or the presence of at least five inflammatory aggregates; 4, diffuse infiltration of 
large regions with large aggregates of mononuclear and/or polymorphonuclear cells   
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Figure 2: Counting of defined immune cell populations and image analysis of lymphocytic aggregates and 
lymphoid follicles. (A-H) Shown are the average (±SD) numbers of cells/High Power Field (HPF) belonging to 
a defined immune cell population, including T cells (CD3-positive), B cells (CD20-positive), macrophages 
(F4/80-positive) and neutrophils. * depict statistically significant differences between corresponding H. suis-
infected and uninfected control animals. ** depict statistically significant differences between infected groups of 
different animal strains at the same time point post infection. (I-J) Shown are the average percentages of T (CD3-
positive) and B (CD20-positive) lymphocytes in lymphocytic aggregates and lymphoid follicles in H. suis-
infected animals. BALB/c and C57BL/6, mice strains; G, gerbil; 3w, 3 weeks post infection; 9w, 9 weeks post 
infection; 8m, 8 months post infection. 
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Counting of defined immune cell poulations is shown in Figure 2. At 9 weeks and 8 
months post infection, an increase of the number of T cells (CD3-positive) was observed in 
the fundus of infected animals of both mice strains (Figure 2A). This increase was always 
higher for BALB/c mice, compared to C57BL/6 mice. Similar results were seen in the 
antrum, however not always statistically significant (Figure 2B). At 3 and 9 weeks post 
infection, no statistically significant increase could be observed for diffuse infiltration of the 
fundic mucosa with B cells (CD20 positive) in infected animals as compared to control 
animals. However, at 8 months post infection, a higher number of B cells was detected only in 
the fundus of infected BALB/c mice (Figure 2C). In the antrum of both mice strains, no 
significant differences were found for B cell infiltration between uninfected and infected 
animals (Figure 2D). For BALB/c mice infected for 3 and 9 weeks, a significantly higher 
number of macrophages could be detected in the fundus when compared to the control 
animals (Figure 2E). For C57BL/6 mice, similar results could be observed, however not 
statistically significant. Additionally, for the antrum of both mice strains, this increase was 
never statistically significant (Figure 2F). In both mice strains, neutrophils were always vastly 
outnumbered by mononuclear cells. At 8 months post infection, infected C57BL/6 mice 
showed higher numbers of neutrophils, compared to control animals, both in fundus and 
antrum (Figure 2G and Figure 2H). An increase of the number of neutrophils could be seen in 
BALB/c mice at 9 weeks post infection, an observation which was absent at the last time 
point of euthanasia.  
The presence of inflammatory cell aggregates and lymphoid follicles is shown in 
Table 3. Both the number of H. suis-infected animals with inflammatory cell aggregates and 
the mean number of aggregates/animal were always equal (3 weeks post infection) or higher 
(9 weeks and 8 months post infection) for BALB/c mice compared to C57BL/6 mice. At 8 
months post infection, the fundic region of all H. suis-infected BALB/c contained large 
lymphoid aggregates (Figure 3). For both mice strains, lymphoid aggregates and follicles 
were mainly composed of T cells (Figure 2I). 
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Table 3. Aggregates of inflammatory cells and lymphoid follicles in mice and gerbils after experimental 
infection with H. suis  
Time pi a Group Number of animals
 b
 with 
inflammatory aggregates 
(>50 cells) c 
Mean number of 
aggregates/animal in this 
group c 
LF e EGC f 
3 weeks BALB/c 1 0.17 0 0 
 C57BL/6 1 0.17 0 0 
 Gerbil NA d NA d 4 1 
9 weeks BALB/c 5 1.33 1 0 
 C57BL/6 0 0 0 0 
 Gerbil NAd NA d 4 4 
8 months BALB/c 6 4.33 2 1 
 C57BL/6 4 1.33 1 0 
 Gerbil NA d NA d 6 6 
a pi: post infection 
b out of 6 animals in each infected group 
c both parameters were determined on the entire longitudinal H&E stained tissue sections 
d not applicable 
e
 presented are the numbers of animals (out of 6 animals in each infected group) with gastric lymphoid follicles 
(LF) 
f
 presented are the numbers of animals (out of 6 animals in each infected group) with expanding germinal centers 
(EGC) in gastric lymphoid follicles  
 
 
 
Figure 3: H&E staining of the fundus of a H. suis-infected BALB/c mouse. In this animal, infected for 8 
months, two large lymphoid aggregates can be seen in the lamina propria mucosae, accompanied by loss of 
normal mucosal architecture. Original magnification: 200x. 
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Figure 4: Gastric inflammation in H. suis-infected Mongolian gerbils. (A) CD3 staining of the antrum of a 
gerbil infected with H. suis for 8 months, showing T-lymphocytes (brown). Original magnification: 100x. (B) 
CD20 staining of the antrum of a gerbil infected with H. suis for 8 months, showing B lymphocytes (brown) in 
germinal centers of lymphoid follicles. Original magnification: 100x. (C) Ki67 staining of the antrum of a gerbil 
infected with H. suis for 9 weeks showing distinct proliferation (brown) in the germinal centers of the lymphoid 
follicles. Original magnification: 100x. (D) Ki67 staining of the antrum of a gerbil infected with H. suis for 8 
months showing large, hyperproliferative (brown) and irregular (arrow) germinal centers of the lymphoid 
follicles. Original magnification: 200x. (E) H&E staining of the antrum of a gerbil infected with H. suis for 8 
months showing lymphocytic infiltration of the lamina muscularis mucosae (large arrow) and a small 
lymphoepithelial lesion (small arrow). Original magnification: 400x. (F) H&E staining of the antrum of a gerbil 
infected with H. suis for 8 months showing infiltration of the tunica muscularis with mononuclear cells (arrow). 
Original magnification: 100x. (G) Cytokeratin staining of the antral epithelium (brown) of a gerbil infected with 
H. suis for 8 months showing numerous lymphoepithelial lesions (arrows). Original magnification: 400x.  
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For H. suis-infected Mongolian gerbils, the vast majority of inflammatory cells 
consisted of T and B lymphocytes. Moreover, diffuse infiltrates and large inflammatory 
aggregates were very often fused together, which made counting of T and B cell populations 
virtually impossible. Organization into lymphoid follicles was present in the majority of 
gerbils at 9 weeks and 8 months post infection (Table 3; Figure 4A and Figure 4B). Image 
analysis revealed that from 9 weeks of infection onwards, lymphocytic aggregates and 
follicles in these animals contained at least 60% B cells (CD20 positive and CD3 negative) 
(Figure 2I and Figure 2J). This fraction was smaller at 3 weeks after infection. In gerbils 
infected for at least 9 weeks, a distinct B-cell proliferation in the germinal centers of the 
lymphoid follicles was present (Figure 4C). In gerbils infected for 8 months, these germinal 
centers were often large, hyperproliferative and irregular (Figure 4D). Moreover, in gerbils 
infected for 9 weeks and 8 months, severe destruction of the normal antral mucosal 
architecture with disruption of the lamina muscularis mucosae (Figure 4E) was seen in 4 and 
in all animals, respectively. In mice, only at 8 months after infection, infiltration and 
destruction of the lamina muscularis mucosae was detected in 1/3 of the animals. In one 
gerbil, the tunica muscularis was also invaded by a large number of lymphocytes (Figure 4F). 
Lymphoepithelial lesions could be detected in the mucosa of 2 gerbils infected with H. suis 
for 8 months (Figure 4E and Figure 4G). At all three timepoints post infection, diffuse 
infiltration of the antral mucosa with neutrophils was always higher in H. suis-infected gerbils 
compared to control animals (Figure 2H), although this cell type represented only a small 
fraction of the total population of inflammatory cells. Finally, two primary antibodies (F4/80, 
Santa Cruz Biotechnology, Inc.; MAC387, Abcam) were used to detect mature macrophages 
in the gerbils, however without success.  
 
Gastric epithelial cell death 
No differences in the average number of apoptotic cells were seen between control and 
infected animals, for all three animal strains at all timepoints (Figure 5). Transmission 
electron microscopy revealed that spiral-shaped H. suis bacteria were often closely associated 
with gastric epithelial, mainly parietal cells (Figure 6A) in all three animal strains at all three 
time points post infection. Frequently, these bacteria were seen surrounded by cellular debris 
of primary necrotic parietal cells with loss of plasma membrane integrity and formation of 
necrotic blebs (Figure 6B).  
Immunohistochemical staining showed no clear loss of parietal cells in the fundus of 
infected animals of all three animal strains. However, compared to uninfected animals (Figure 
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7A), an obvious loss of parietal cells was often detected at the transition zone between fundus 
and antrum in H. suis-infected gerbils at all timepoints post infection (Figure 7B).  
 
 
Figure 5: Apoptosis of gastric epithelial cells. For each individual animal, the rate of epithelial cell apoptosis 
was determined by counting the number of activated caspase-3 positive epithelial cells in five randomly chosen 
microscopic fields (magnification: x400) at the level of the gastric pits, both in fundus and antrum. Shown are 
the mean numbers of activated caspase-3-positive epithelial cells in each group. No significant differences were 
observed between H. suis-infected animals compared to uninfected control animals. BALB/c and C57BL/6, mice 
strains; G, gerbil; 3w, 3 weeks post infection; 9w, 9 weeks post infection; 8m, 8 months post infection.  
 
 
 
 
Figure 6. Transmission electron microscopic (TEM) images of  BALB/c mice infected with H. suis. (A) In a 
BALB/c mouse infected for 9 weeks, spiral-shaped H. suis bacteria are seen in close association with parietal 
cell microvilli (arrow). Bar = 500 nm. (B) TEM image of a BALB/c mouse infected for 3 weeks with H. suis 
showing H. suis bacteria (arrowheads) in between necrotic debris of gastric parietal cells, which can be 
recognized by the typical abundance of mitochondria (M) and deep folding of the apical membrane. The large 
arrow indicates the presence of necrotic blebs and the small arrow shows loss of plasma membrane integrity. Bar 
= 2 µm. 
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Figure 7. Immunohistochemical staining of the hydrogen potassium ATPase present in gastric parietal 
cells. (A) Moderate numbers of parietal (brown) cells are still present in the proximal antrum of uninfected 
Mongolian gerbils. Original magnification: 100x. (B) An abrupt loss of parietal cells is seen in the transition 
zone between fundus and antrum in Mongolian gerbils infected with H. suis for 9 weeks. Original magnification: 
100x. 
 
 
Gastric epithelial cell proliferation  
Results of the gastric epithelial cell proliferation scoring are shown in Figure 8. Higher 
numbers of Ki67-positive, and thus proliferating epithelial cells were seen at 9 weeks and 8 
months after infection in both fundus and antrum of H. suis-infected BALB/c mice, compared 
to control animals. Similar results were observed for C57BL/6 mice. In gerbils, a higher 
proliferation rate was seen in the antrum of infected animals at 8 months after infection. In the 
fundus of H. suis-infected gerbils, no significant increase of epithelial cell proliferation was 
observed.  
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Figure 8: Proliferation of gastric epithelial cells. For each individual animal, the rate of epithelial cell 
proliferation was determined by counting the number of Ki67 positive epithelial cells in five randomly chosen 
microscopic fields (magnification: x400) at the level of the gastric pits, both in antrum and fundus. Shown are 
the mean numbers of Ki67-positive epithelial cells in each group. An * denotes significantly higher values for H. 
suis infected animals compared to uninfected control animals. BALB/c and C57BL/6, mice strains; G, gerbil; 
3w, 3 weeks post infection; 9w, 9 weeks post infection; 8m, 8 months post infection.  
 
 
Discussion 
In the present study, at 3 and 9 weeks post infection, increased numbers of mature 
macrophages were observed in the gastric mucosa of H. suis infected mice, mainly in the 
BALB/c strain. In early H. pylori infection, macrophages are known to play an essential role 
as innate responders to released H. pylori factors (Ferrero, 2005; Wilson and Crabtree, 2007). 
They have been suggested to activate the adaptive immune response by producing factors 
such as IL-12, stimulating a Th1 response, and IL-10, which is considered a Th2-polarizing 
cytokine (Meyer et al., 2000; Wilson and Crabtree, 2007).  
At 9 weeks and 8 months post infection, a more pronounced lymphocytic infiltration 
was observed in fundus and antrum of BALB/c mice, compared to C57BL/6 mice. This 
contrasts with the results of Cinque et al. (2006), who found a higher degree of inflammation 
in C57BL/6 mice inoculated with gastric mucus from “H. heilmannii type 1”-infected pigs, 
compared to BALB/c mice. Moreover, results similar to those of Cinque et al. (2006) have 
been reported for mice infected with H. felis (Mohammadi et al., 1996; Skagami et al., 1996; 
De Bock et al., 2005). This suggests that inflammation in these studies was mainly driven by 
a T-helper (Th) 1 response, since C57BL/6 mice have been described genetically as Th1 
responders (Heinzel et al., 1989; Ferrero et al., 2000). In contrast, BALB/c mice are 
considered predominant Th2 responders. The higher inflammation in BALB/c mice in the 
present study might therefore indicate that H. suis strain 5 elicits a more predominant Th2 
response (Heinzel et al., 1989; Ferrero et al., 2000; O’Rourke and Lee, 2003). Indeed, only in 
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BALB/c mice infected for 8 months, significantly higher levels of B cell accumulation were 
observed, which suggests a more Th2-polarized response (Mueller et al., 1997; Wilson and 
Crabtree, 2007). Although this finding was not reflected in the fraction of B cells in lymphoid 
aggregates and follicles and although no MALT lymphoma-like lesions were seen in these 
mice in the present study, this might eventually lead to a severe B-cell lymphocytic 
proliferation and even gastric MALT lymphoma, as shown for BALB/c mice infected for over 
18 months with H. felis (Enno et al., 1995).  
Humans suffering from a “H. heilmannii” gastritis have been suggested to develop 
gastric MALT lymphoma more frequently than those suffering from a H. pylori gastritis 
(Stolte et al., 2002). Interestingly, in the present study, in some gerbils euthanized at 8 months 
after infection, severe inflammation had evolved to a pathology resembling gastric MALT 
lymphoma. Similar MALT lymphoma-like lesions have been described in mice infected for at 
least 18 months with different “H. heilmannii”-like strains, isolated in vivo in mice 
(O’Rourke et al., 2004a). Some of these inocula were shown to contain H. suis in a separate 
paper from the same authors (O’Rourke et al., 2004b). Nakamura et al. (2007) also described 
the development of gastric MALT lymphoma in C57BL/6 mice infected for at least 6 months 
with an in vivo “isolate” that was erroneously designated “Candidatus H. heilmannii”, but that 
in fact belonged to the species H. suis (Baele et al., 2009). It is not clear why in the present 
study MALT lymphoma-like lesions were not detected in the mouse models. Differences in 
H. suis strains and duration of infection probably play an important role (O’Rourke et al., 
2004a). Other micro-organisms which may have been present in the inoculum used by 
O’Rourke et al. (2004a) and Nakamura et al. (2007) might also have influenced lesion 
development (Flahou et al., 2010). 
In Mongolian gerbils, inflammation was limited to the antrum and a narrow zone at 
the forestomach-stomach transition zone. These results are not surprising, since H. suis 
mainly colonizes these stomach regions in Mongolian gerbils, while it tends to colonize both 
antrum and fundus in mice. In “H. heilmannii” infected humans, colonization and 
inflammation are also mainly localized in the antrum (Stolte et al., 1997). Therefore, the 
Mongolian gerbil model more closely resembles the human situation. This together with our 
finding that Mongolian gerbils developed a more severe pathology after H. suis infection 
compared to mice, indicates that the Mongolian gerbil model may be more suitable for 
studying H. suis-host interactions.  
In all infected animal strains, a relative absence of neutrophils was observed. Similar 
findings have been described for mice infected with H. felis (Ferrero et al., 2000; De Bock et 
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al., 2005). However, in the present study, an increase in the number of neutrophils was 
observed in C57BL/6 mice infected for 8 months. In BALB/c mice, a similar increase was 
observed, however less pronounced and only at 9 weeks post infection. At 8 months post 
infection, the level of neutrophil infiltration in this mouse strain had dropped back to basal 
levels. Possibly, different and fluctuating levels of IL-17 expression, a cytokine which has 
been shown to be a key regulator of neutrophil infiltration, could play a role, as has been 
described in long-term H. pylori infection studies in mice of different strains (Algood et al., 
2007; Shiomi et al., 2008).  
In this study we report that H. suis induces necrosis of gastric parietal cells, which 
may have important implications for the development of various gastric pathologies, such as 
gastric erosion and/or ulcer formation (Dixon, 2001), gastric atrophy and even gastric cancer 
(Shirin and Moss, 1998). These lesions all have been observed in “H. heilmannii”-infected 
humans (Morgner et al., 1995; Stolte et al., 1997; Debongnie et al, 1998) and are often 
accompanied by a gastritis (Stolte et al., 1997). The chronic gastritis observed in the present 
study is possibly caused by direct effects of H. suis, but most likely also driven indirectly by 
necrosis of gastric epithelial cells. Cell necrosis results in the release of cellular contents, 
including molecules involved in the promotion of inflammation (Fink and Cookson, 2005). 
Interestingly, mainly parietal cells were affected by necrosis, which has also been described 
for other non-H. pylori helicobacters, such as H. felis (De Bock et al., 2006). In the present 
study, also a clear increase of gastric epithelial cell proliferation was seen in the H. suis 
infected animals. For H. pylori, data derived from in vitro experiments suggest that this 
hyperproliferation may be a secondary response to increased cell death in order to maintain 
cell mass in the mucosa (Shirin and Moss, 1998). In any case, hyperproliferation may result in 
a shift towards population of gastric epithelium with immature cells, resulting in impaired 
gastric acid secretion (Dixon, 2001). Both hyperproliferation of the gastric epithelium and 
reduced gastric acid secretion due to loss of parietal cells may eventually lead to the 
development of gastric cancer (Shirin and Moss, 1998; Kusters et al., 2006). 
In conclusion, our results clearly demonstrate the ability of a pure culture of H. suis to 
cause severe gastric pathology. In humans suffering from gastric disease, the possible 
involvement of this micro-organism should therefore not be neglected. 
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Abstract 
 
Helicobacter (H.) suis colonizes the stomach of more than 60% of slaughter pigs and 
is also of zoonotic importance. Recently, this bacterium was isolated in vitro, enabling the use 
of pure cultures for research purposes. In this study, mice were immunized intranasally or 
subcutaneously with whole bacterial cell lysate of H. suis or the closely related species H. 
bizzozeronii and H. cynogastricus, and subsequently challenged with H. suis. Control groups 
consisted of non-immunized and non-challenged mice (negative control group), as well as of 
sham-immunized mice that were inoculated with H. suis (positive control group). Urease tests 
on stomach tissue samples at 7 weeks after challenge infection were negative in all negative 
control mice, all intranasally immunized mice except one, and in all and 3 out of 5 animals of 
the H. cynogastricus and H. suis subcutaneously immunized groups, respectively. H. suis 
DNA was detected by PCR in the stomach of all positive control animals and all 
subcutaneously immunized/challenged animals. All negative control animals and some 
intranasally immunized/challenged mice were PCR-negative. In conclusion, immunization 
using antigens derived from the same or closely related bacterial species suppressed gastric 
colonization with H. suis, but complete protection was only achieved in a minority of animals 
following intranasal immunization. 
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Introduction 
 
Helicobacter (H.) pylori infection is the major cause of gastritis and peptic ulcer 
disease as well as gastric cancer in humans (Marshall and Warren, 1984; Veldhuyzen van 
Zanten and Sherman, 1994; Dunn et al., 1997). Therapy with proton pump inhibitors and two 
or three antibiotics, e.g. clarithromycin and amoxicillin, is recommended as a first line 
treatment (Malfertheiner et al., 2002). Such therapies, however, face increasing problems of 
antimicrobial resistance (Graham, 1998; Malfertheiner et al., 2007) and recurrence of 
infection (Kepekci and Kadayifci, 1999). To solve these problems, immunization may be a 
useful alternative. Different animal models have been developed in order to test such 
approach (Del Giudice et al., 2001). The immunoproteome of H. pylori in the mouse model 
appears similar to that in human infections, suggesting that the mouse model is a suitable tool 
for preclinical screening of vaccine candidates (Bumann et al., 2002).  
Helicobacter pylori, however, is not the only bacterial pathogen capable of colonizing 
the human gastric mucosa. Indeed, non-H. pylori helicobacters (NHPH) with a typical spiral-
shaped morphology have been found in a minority of gastric biopsies (Heilmann and 
Borchard, 1991; Stolte et al., 1994; Svec et al., 2000; Solnick, 2003). These bacteria were 
provisionally named “H. heilmannii”. However, it has been shown that these NHPH do not 
represent a single species, but a group of different bacterial species with similar spiral 
morphology (Trebesius et al., 2001; Haesebrouck et al., 2009). Based on 16S rRNA gene 
sequences, the “H. heilmannii” group was further divided into two types (Solnick et al., 
2003). “H. heilmannii” type 2 organisms are closely related, if not identical, to the canine and 
feline Helicobacter spp., namely H. felis (Lee et al., 1988), H. bizzozeronii (Hänninen et al., 
1996), H. salomonis (Jalava et al., 1997), ‘Candidatus H. heilmannii’ (O’Rourke et al., 2004) 
and two recently described new species, H. cynogastricus (Van den Bulck et al., 2006) and H. 
baculiformis (Baele et al., 2008a). The majority of “H. heilmannii” infections in humans 
however, are due to “H. heilmannii” type 1 (Trebesius et al., 2001; De Groote et al., 2005; 
Van den Bulck et al., 2005). It is now accepted that “H. heilmannii” type 1 is identical to the 
recently cultured and described Helicobacter suis (Baele et al., 2008b), formerly “Candidatus 
Helicobacter suis” (De Groote et al., 1999; O’Rourke et al., 2004), a spiral-shaped bacterium 
that colonizes the stomach of more than 60 % of slaughter pigs (Mendes et al., 1991; Grasso 
et al., 1996; Park et al., 2004; Hellemans et al., 2007b). The role of H. suis in gastric disease 
in pigs is still unclear. It has been suggested that this bacterium is associated with gastric 
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ulceration of the pars oesophagea (Queiroz et al., 1996) and chronic pyloric gastritis in pigs 
(Mendes et al., 1991; Hellemans et al., 2007a; Kumar et al., unpublished results). Up to this 
moment, mouse inoculation has been used to grow and maintain this bacterium viable for 
more than two years starting from infected pig stomach mucosa (Dick et al., 1989; Park et al., 
2003). Using the mouse model, studies have been carried out on the control of H. suis 
infection by antibiotic treatment (Hellemans et al., 2005) and by immunization using 
heterologous antigens from related species (Hellemans et al., 2006). 
A succesful in vitro culture method has recently been developed for H. suis (Baele et 
al., 2008b).The purpose of the present study was to determine the effect of prophylactic 
immunization against H. suis using antigens from in vitro cultured H. suis, compared to that 
obtained using antigens from related species, namely H. bizzozeronii and H. cynogastricus. 
 
Materials and methods 
 
Animals 
Three week-old male Helicobacter spp.-free SPF BALB/c mice were purchased from 
an authorized breeder (HARLAN, Horst, The Netherlands). The animals were housed in 
groups of five on autoclaved wood shavings in filter top cages. They were fed an autoclaved 
commercial diet (TEKLAD 2018S, HARLAN) and received autoclaved water ad libitum for a 
period of at least 2 weeks prior to the initiation of the study. At the time of the onset of the 
study, mice were housed individually according to a random treatment allocation plan. All 
experiments involving animals were approved by the Animal Care and Ethics Committee of 
the Faculty of Veterinary Medicine, Ghent University. 
 
Antigens for immunization 
H. cynogastricus (LMG 23188T) and H. bizzozeronii (R1051T) antigens were obtained 
using two different protocols. 
In the first protocol, H. cynogastricus and H. bizzozeronii were grown in l l or 250 ml 
vented and baffled shake flasks containing 200 ml and 50 ml, respectively, of porcine brain 
heart infusion (BHI) broth (Oxoid, Basingstoke, UK) with 10% pig serum and Vitox 
Supplement (Oxoid). H. cynogastricus and H. bizzozeronii were seeded at 8.8 x 106 and 1 x 
107 cells/ml, respectively.  The flasks were placed in a 37°C incubator and shaken at 120 rpm 
in a micro-aerobic environment for approximately 20 h to a cell density of ± 1 x 108 CFU per 
  
125
 Chapter 3   
ml.  For H. cynogastricus, approximately 1050 ml of culture containing 1.16 x 1011 cells was 
centrifuged at 2000 g for 30 min and the cell pellet was resuspended in 33.3 ml 0.9% sodium 
chloride. For H. bizzozeronii, approximately 969 ml of culture containing 1.62 x 1011 cells 
was centrifuged at 2000 g for 25 min and the cell pellet was resuspended in 50 ml 0.9% 
sodium chloride. Both suspensions were stored at -80°C until further processing. The frozen 
cell suspensions were thawed and subjected to 3 passages through a high pressure 
homogenizer (EmulsiFlex-C5; Avestin Inc., Ottawa, Ontario, Canada) at 17000 PSI. The 
homogenates were filtered through a 0.45 µm PES filter (pre-filter), followed by a 0.22 µm 
PES filter.  
In the second protocol, H. bizzozeronii and H. cynogastricus were grown on brain 
heart infusion (BHI) agar (Oxoid) containing 10 % horse blood, 5 mg amphotericin B/l 
(Fungizone; Bristol-Myers Squibb, New York, USA), Campylobacter Selective Supplement 
(Skirrow; Oxoid) and Vitox supplement (Oxoid). Plates were incubated at 37°C in 
microaerobic conditions. The antigens used for immunization were prepared by harvesting 3-
day-old bacterial cultures in sterile phosphate buffered saline (PBS). The bacterial suspension 
was sonicated 8 times for 30 seconds with a sonicator (Sonicator ultrasonic processor XL 
2015; MISONIX, Farmingdale, USA). After centrifugation (5000 g, 5 min, 4°C), the 
supernatant was filtered through a 0.22-µm pore filter (Schleicher and Schuell, Gent, 
Belgium) and stored at -70°C.  
H. suis strain HS1 (LMG 23995T ) was grown on Mueller Hinton agar (Oxoid) 
containing 10% horse blood, 5 mg amphothericin B/l, Skirrow Supplement (Oxoid) and 
vitamins (Vitox; Oxoid). In addition, the pH of the agar was adjusted to 5 by adding HCl to a 
final concentration of approximately 0.05%. Since H. suis does not form distinct colonies on 
dry agar plates, one ml of Mueller Hinton broth (Oxoid) with a pH of 5 was added on top of 
the agar to obtain biphasic culture conditions. After three days of incubation at 37°C in 
microaerobic conditions, the Mueller Hinton broth, containing the bacteria, was harvested. 
Bacteria were washed and concentrated by centrifugation (5000 g, 10 min, 4°C) and 
suspended in PBS. The bacterial suspension was further homogenized by sonication and 
processed as for H. bizzozeronii and H. cynogastricus. For all antigen preparations, the protein 
concentration was determined using the Lowry assay (Lowry et al., 1951).  
 
Preparation of H. suis challenge material 
Challenge of the mice was done using in vivo isolated H. suis from naturally infected 
pig stomachs. This isolation was performed by mouse inoculation as previously described 
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(Hellemans et al., 2006). Briefly, H. suis infected pig stomachs were collected from the 
slaughterhouse. Mucosal scrapings were inoculated into mice by stomach tubing. Four serial 
passages in mice were carried out. H. suis-specific PCR (De Groote et al., 2000) confirmed 
the presence of H. suis in the mice stomachs in each passage. Challenge material was 
prepared from stomach homogenates of mice from the fourth passage. This fourth mouse 
passage was performed in 10 BALB/c mice. From these animals, the urease-positive stomachs 
were pooled and homogenized. The homogenate was frozen at -70°C.  
 
Immunization/challenge study design 
The mice used for intranasal and subcutaneous immunization were divided into ten 
groups of five animals each with a set-up as presented in Table 1. Subcutaneous immunization 
was performed on day 0 followed by two boost immunizations on day 21 and day 42. For this 
purpose, 100 µg of the sonicated filtrate (in a volume of 54 µl) was mixed in an equal volume 
with a saponin-based adjuvant (50/50 vol/vol %) and injected subcutaneously at the lower 
back of the animals. Intranasal immunization was performed at day 21 followed by one boost 
immunization at day 42. This immunization was done by the application of a total volume of 
15 µl containing 100 µg of sonicate or high pressure homogenized filtrate mixed with 5 µg 
cholera toxin (List, Campbell, California, US) on the external nares of unanaesthetized mice. 
Group 1 was sham immunized intranasally by application of saline. 
On day 70 of the study, the mice were challenged with H. suis. Therefore, the frozen 
stock of H. suis infected mice stomach homogenate, prepared as described above, was placed 
at 37°C for 15 minutes, and each animal (except the animals of group 10) was inoculated 
intragastrically with 0.3 ml, using a ball-tipped gavage needle. This dose had proven to infect 
100% of the inoculated mice in a preliminary experiment.  
On day 119-120 of the study, all animals were euthanized by cervical dislocation 
following isoflurane anaesthesia (IsoFLo; Abbott, Illinois, USA). The non-glandular part of 
the stomach was discarded, and then the stomach was divided longitudinally into 2 halfs from 
the esophageal opening to the pylorus. Since H. suis does not grow in distinct colonies, 
quantitative culture of this bacterium is not possible. Therefore, one half of the stomach from 
each of the animals was used for a semi-quantitative urease assay. From the other half, 4 mm2 
mucosal tissue samples were frozen (-20°C) and used for PCR detection of H. suis DNA. One 
sample was taken both in antrum and fundus. 
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Serology - ELISA 
Just before necropsy, blood was collected by tail bleeding. After centrifugation (10 
min, 1000 g, 4°C), serum was frozen at -70°C until further use. Serological responses were 
assesed by ELISA. In short, 96 well flat bottom plates (Nunc MaxiSorp; Nalge Nunc Int., 
Rochester, NY, USA), were coated with 200 ng per well of H. suis, H. bizzozeronii or H. 
cynogastricus whole bacterial cell proteins diluted in carbonate coating buffer (24 hours at 
4°C). Each plate was blocked with 1% poly-vinyl alcohol in PBS, and the serially diluted 
serum samples were incubated in duplicates on each antigen coated plate. After incubation at 
37oC, all plates were washed and bound antibodies were detected with affinity purified goat 
anti-mouse IgG peroxidase conjugated (KPL, Gaithersburg, MD, USA) followed by ABTS 
Peroxidase Substrate System (KPL).  
Titers were determined as the reciprocal of the serum dilution that equaled 50% of the 
mean OD of the wells with positive control serum. For the generation of positive control 
serum, NIH-Swiss mice (20-30 grams) were injected subcutaneously, 3-times at two-week 
intervals, with 42 µg protein of whole bacterial cell antigens of H. suis, H. cynogastricus or 
H. bizzozeronii per dose in TiterMax Gold Adjuvant (Sigma-Aldrich, St. Louis, MO, USA). 
To collect serum, mice were bled 2 weeks after the last immunization. Sera were diluted 
1:400 before adding to the positive control wells. 
 
Urease assay for assessment of colonization of Helicobacter bacteria in the mouse 
stomach 
Urease activity in the stomach of mice, typical for gastric Helicobacter spp., was 
assessed using the method of Corthésy-Theulaz et al. (1995) with some modifications. One 
half of the stomach was immersed in 500 µl of rapid urease test (CUTest; Temmler Pharma, 
Marburg, Germany) and incubated at 37°C for 3 h. After centrifugation (5 min, 1000 g), the 
level of urease activity was measured by spectrophotometric analysis at 550 nm. The cut-off 
value was calculated and corresponded to the mean + 5 x SD of the optical density (OD) 
values obtained with gastric samples of non-immunized, non-challenged mice. 
 
PCR for detection of Helicobacter suis in mouse gastric tissue samples 
DNA from mucosal tissue samples was extracted using the DNeasy Tissue kit 
(Qiagen, Hilden, Germany) according to the instructions of the manufacturer. PCR for the 
specific detection of H. suis was performed as described previously (De Groote et al., 2000). 
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Statistical analysis 
The semi-quantitative urease assay results were compared by a fixed effects model. In 
a first analysis, antigen was introduced in the fixed effects model to test for the overall effect 
of antigen. In a second analysis, route of administration of the vaccine was introduced in the 
model, with adjustment for antigen, to test for the difference between intranasal and 
subcutaneous administration. Finally, mode of preparation was introduced in the model, with 
adjustment for antigen, to test for the difference between sonication and high pressure 
preparation. 
The number of PCR-positive animals per group and the anti-H. suis IgG antibody 
titers were compared by the Kruskall-Wallis test. In a first analysis, the difference between 
the antigens was tested. In a second analysis, route of administration was tested by the 
Wilcoxon/Mann-Whitney test stratified for antigen. Finally, mode of preparation was tested 
by the Wilcoxon/Mann-Whitney test stratified for antigen. 
Tests were performed at the 5% global significance level, and the significance level 
for multiple comparisons was adjusted by Bonferroni’s technique. 
 
Results 
 
Animals 
During the study, 4 animals died from a cause unrelated to the treatment: two animals 
from group 3, one animal from group 4, and one animal from group 8.  
 
Serology-ELISA 
The resulting anti-H. suis IgG titers are presented in Table 1. These data show that in 
all groups, a higher serum IgG titer was observed when compared to both the negative and 
positive control group (P<0.05). This indicates that animals responded to immunization and 
that homologous as well as heterologous antigens can cause a serological response towards H. 
suis antigens. Similar results were seen for the ELISA tests using H. bizzozeronii and H. 
cynogastricus antigens (data not shown). The elevated titers in all three ELISA tests show that 
cross-reactivity between species has to be taken into account. Only for the subcutaneous 
immunization route, H. suis immunization yielded significantly higher serum anti-H. suis IgG 
titers than immunization with H. cynogastricus and H. bizzozeronii (P = 0.01).   
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When comparing the two immunization routes in animals that were immunized with 
the H. suis antigens, significantly higher (P = 0.0079) titers in the H. suis ELISA were found 
for the subcutaneously immunized animals compared to the intranasally immunized animals. 
No significant difference between preparation techniques was found for the anti-H. suis IgG 
antibody titers. 
 
Urease activity of gastric tissue sections 
The results of the semi-quantitative urease assays are presented in Table 1. The cut-off 
value calculated from the non-immunized/non-challenged group was 0.218. 
Prophylactic intranasal immunization with H. bizzozeronii, H. cynogastricus or H. suis 
antigen preparations resulted in an urease activity that was similar to the non-immunized/non-
challenged animals, but significantly lower (P<0.05) as compared to the non-
immunized/challenged group. Indeed all intranasally immunized animals (except animal 2 in 
group 6) had an urease OD value below the cut-off value, so differences between intranasally 
immunized groups were considered not significant. H. suis and H. cynogastricus 
subcutaneously immunized animals showed a significantly lower (P<0.05) urease activity 
when compared with the non-immunized/challenged group, with 3 out of 5 and all animals, 
respectively, yielding urease OD values below the cut-off value.  
There was a significant effect (P = 0.0131) of the route of immunization on the urease 
activity. The mean urease activity for intranasal immunization was 0.107, compared to 
subcutaneous immunization with a value equal to 0.429. There was no significant difference 
between the mode of preparation of the vaccine (P = 0.567). 
 
PCR analysis of gastric tissue sections 
All non-challenged animals were negative in PCR whereas all sham-
immunized/challenged animals scored positive in all stomach samples (Table 1). 
In the immunized/challenged groups, a clear distinction could be made between the 
two administration routes (intranasal versus subcutaneous), taking into account the number of 
PCR-positive animals (P = 0.0486). In all subcutaneously immunized groups all stomach 
samples – antrum as well as fundus – were positive in PCR. This contrasts clearly with the 
results from the non-immunized/non-challenged group and is identical to the results from the 
non-immunized/challenged group. For most of the intranasally immunized groups, however, 
several immunized animals were negative in PCR (for H. cynogastricus, 3/8; for H. suis, 2/5; 
for H. bizzozeronii, 1/8).  
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There was a significant difference in PCR-positivity between the antigens used for 
immunization (P = 0.0008). In the H. cynogastricus and H. suis intranasally immunized 
groups, several animals were PCR-negative and only one animal in each group was positive in 
both stomach samples. For H. bizzozeronii intranasal immunization, most animals were PCR-
positive in both stomach samples (group 4) or no animals were PCR-negative (group 5). 
There was no significant difference in the number of PCR-positive animals between 
the two vaccine preparation methods (P = 0.4317). For instance, for the H. cynogastricus 
intranasally immunized group, both homogenization procedures gave comparable results 
(40% negative animals for high pressure homogenization versus 33.33% for sonication). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 1.  Intranasal and subcutaneous immunization/challenge experiment: serum anti-H. suis IgG antibody titers, semiquantitative urease activity in gastric tissue and PCR 
results for the specific detection of H. suis in murine stomach tissue.  
 
a
 Titers were determined as the reciprocal of the serum dilution that equaled 50% of the mean O.D. of the wells with positive control serum, diluted 1:400.  
b
 For urease OD and PCR, the statistical comparisons between vaccine administration route, antigens used for immunization and antigen preparation are discussed in the text. 
c
 Number of positive animals/Total no of animals per group.  
d
 The IgG antibody titers marked with a d are significantly higher compared to the titers of the sham-immunized/infected and non-immunized/non-infected control groups 
(group 1 and 10, respectively. 
e
 Urease OD values differing significantly from the urease OD value of the non-immunized infected control group (group 1). 
f
 For immunization with H. suis antigens: subcutaneous immunization yields significantly higher serum anti-H. suis IgG titers than intranasal immunization. 
g
 For subcutaneous immunization: immunization with H. suis antigens yields significantly higher serum anti-H. suis IgG titers than immunization with H. cynogastricus and       
H. bizzozeronii antigens. 
Group Infection Vaccine 
administration 
route 
Antigens used for 
immunization 
Antigen 
preparation 
Antibody titera 
Median (Min-Max) 
Urease activity: 
mean OD ± SDb 
 
PCR-positive 
miceb,c 
 
mice PCR-positive 
in both antrum 
and fundusb,c 
 
1 H. suis Intranasal saline - <100 (all) 1.630 ± 0.655 5/5 5/5 
2 H. suis Intranasal H. cynogastricus high pressure 227 (197-251)d 0.098 ± 0.026 e 3/5 1/5 
3 H. suis Intranasal H. cynogastricus sonication 172 (145-187) d 0.092 ± 0.006 e 2/3 1/3 
4 H. suis Intranasal H. bizzozeronii high pressure 411 (293-1074) d 0.079 ± 0.003 e 3/4 3/4 
5 H. suis Intranasal H. bizzozeronii sonication 662 (189-1310) d 0.094 ± 0.009 e 5/5 1/5 
6 H. suis Intranasal H. suis sonication 1053 (178-2395) d,f 0.136 ± 0.053 e 3/5 1/5 
7 H. suis Subcutaneous H. cynogastricus sonication 306 (<100-1247) d,g 0.122 ± 0.048 e 5/5 5/5 
8 H. suis Subcutaneous H. bizzozeronii sonication 312 (<100-418) d,g 0.826 ± 0.754 4/4 4/4 
9 H. suis Subcutaneous H. suis sonication 5595 (3891-14195) d,g,f 0.340 ± 0.224 e 5/5 5/5 
10 - - - - <100 (all) 0.118 ± 0.020 e 0/5 0/5 
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Discussion 
To our knowledge, this is the first report on immunization against H. suis (“H. 
heilmannii” type 1) using a homologous antigen preparation. Since this bacterium was 
recently cultured and characterized (Baele et al., 2008b), it is now possible to prepare antigens 
derived from pure H. suis cultures.  
Many antibacterial vaccines currently used in swine induce only partial protection 
(Haesebrouck et al., 2004). This protection may be influenced by several factors, including 
the route of immunization, the antigen composition/preparation, the vaccine formulation, the 
dose of antigen and the adjuvant used. The present results show that the route of 
immunization may indeed influence the protective effect of the vaccines used in this study. 
In the present study, immunization of mice with sonicated and pressurized whole 
bacterial cell antigens of H. cynogastricus and H. bizzozeronii was found to be partially 
protective against heterologous H. suis challenge. In an earlier study using the same challenge 
model, we showed partial protection against H. suis infection using whole bacterial cell 
antigens from H. felis and H. pylori (Hellemans et al., 2006). Cross-protection by 
heterologous vaccines is often attributed to the urease enzyme, given the high degree of 
amino-acid conservation between urease enzymes from closely related Helicobacter species 
(Ferrero and Labigne, 1993; Ferrero et al., 1994). Although information on the exact species 
used was not provided, one study showed that “H. heilmannii” infection may be prevented by 
immunization with “H. heilmannii” UreB and H. pylori UreAB. This confirms that protective 
immunity against Helicobacter infections may be elicited by homologous as well as 
heterologous Helicobacter urease (Dieterich et al., 1999). The protective effect of H. 
cynogastricus and, to a lesser degree, H. bizzozeronii immunization found in this study, is 
probably due to antigens conserved between different Helicobacter species with urease and 
heat shock proteins as possible candidates (Ferrero et al., 1995; Yamaguchi et al., 2000). 
Based on the sequences of the ureA, ureB and hsp60 gene sequences, H. bizzozeronii seems 
more closely related to H. suis than H. cynogastricus (Baele et al., 2008b). Therefore, one 
would expect to obtain better results with a H. bizzozeronii immunization. However, H. 
cynogastricus gave better protection than H. bizzozeronii. Not yet elucidated immuno-
dominant epitopes of specific proteins may play crucial roles.  
With respect to immunization route, in Helicobacter immunization studies, mucosal 
application has been the most frequently used method for administration of vaccines. Garhart 
et al. (2002) have found that intragastric immunization was less effective than intranasal 
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immunization, with the latter enabling most mice to clear an H. pylori infection. Several 
authors have demonstrated that parenteral immunization with appropriate schedules and 
formulations also constitutes a valuable approach to reduce Helicobacter colonization levels 
(Guy et al., 1998; Guy et al., 1999; Sanchez et al., 2001). In the present prophylactic 
immunization study, we demonstrated that a protective response against H. suis infection can 
be induced by administering the vaccine by the intranasal route with homologous (H. suis) as 
well as with heterologous (H. cynogastricus and H. bizzozeronii) antigens, in some cases 
leading to complete protection (negative in PCR and rapid urease test). Subcutaneous 
immunization resulted in a lower level of protection.  
In our study, subcutaneous immunization with H. suis antigens yielded higher serum 
anti-H. suis IgG antibody titers than homologous intranasal immunization but resulted in a 
lower level of protection. This is not entirely unexpected, since high levels of antigen-specific 
circulating antibodies do not protect mice against H. pylori challenge (Ermak et al., 1998). 
Moreover, protection to either H. felis or H. pylori colonization can occur in the absence of 
antibodies, as has been shown in B cell-deficient mice, lacking both local and serum 
antibodies (Blanchard et al., 1999).  
This study aimed at showing the use of antigens of H. bizzozeronii, H. cynogastricus 
and H. suis as protective agents against H. suis infection. It was not the intention at this point 
to study the development of post-immunization gastritis, although this seems an important 
issue, especially when using sonicates or cell extracts for prophylactic immunization in a 
mouse model (Michetti et al., 1994). However, the role of this post-immunization gastritis in 
protection is still unclear, since this phenomenon is absent in Mongolian gerbils protected by 
oral immunization against H. pylori infection (Jeremy et al., 2006). Sutton et al. (2001) have 
shown that post-immunization gastritis is more pronounced in the H. felis immunization and 
challenge mouse model, as compared to the H. pylori immunization and challenge mouse 
model, but even in the H. felis model, it is a transient event which does not produce long-term 
exacerbation of pathology. The presence of post-immunization gastritis might also be due to 
persistence of the H. felis challenge strain in partially protected mice, since the administration 
of  antibiotics to mice with post-immunization gastritis resulted in a significant decrease in 
inflammation (Ermak et al., 1997). 
These results hold promise for the development of a vaccine using crude antigen 
preparations against H. suis infection in the natural host, i.e. pigs. It may also be worth 
considering the development of a vaccine for use in humans, especially those people with an 
increased risk of infection, such as veterinarians, pig farmers and abattoir workers. However, 
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it remains to be elucidated whether vaccine-induced protection will be sufficient to tip the 
balance of the persistent H. suis infection towards partial protection or even towards a 
complete elimination.  
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Summary 
The recently isolated Helicobacter (H.) suis is the most prevalent non-H. pylori Helicobacter 
(NHPH) species colonizing the stomach of humans suffering from gastric disease. Until now, 
virtually nothing is known about possible H. suis virulence factors involved in human gastric 
pathology. In the present study, we aimed to unravel the mechanism used by H. suis to induce 
gastric epithelial cell damage. H. suis lysate induced death of AGS cells (human gastric 
adenocarcinoma cell line). Inhibition of γ-glutamyl transpeptidase (GGT) activity present in 
H. suis lysate and incubation of AGS cells with purified recombinant H. suis GGT showed 
that this enzyme was largely responsible for the observed cell death. Supplementation with 
glutathione strongly enhanced the observed effect, demonstrating that H. suis GGT-mediated 
degradation of glutathione and the resulting formation of glutathione degradation products 
play a direct and active role in the induction of cell death. This was preceded by an increase of 
extracellular H2O2 concentrations, generated in a cell-independent manner and causing lipid 
peroxidation. In conclusion,  H. suis GGT-mediated generation of pro-oxidant glutathione 
degradation products brings on cell damage and actively causes cell death.  
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Introduction 
Helicobacter (H.) pylori is considered to be the primary cause of gastritis, peptic ulcer 
disease as well as gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) 
lymphoma in humans (Marshall and Warren, 1984; Parsonnet et al., 1991; Parsonnet et al., 
1994; Kusters et al., 2006). In 0.2-6% of gastric biopsies, however, large spiral-shaped non-H. 
pylori helicobacters (NHPH) are found (Haesebrouck et al., 2009). Humans infected with the 
latter have been reported to suffer from gastritis (Stolte et al., 1997), sometimes accompanied 
by gastric ulcer, gastric MALT lymphoma and gastric cancer (Morgner et al., 1995; Stolte et 
al.,1997; Debongnie et al., 1998; Morgner et al., 2000). These bacteria have long been 
referred to as “H. heilmannii”. In reality, they represent a group of different bacterial species 
with similar spiral morphology, which are also highly prevalent in different animal species 
(Haesebrouck et al., 2009). The most prevalent NHPH in humans is H. suis (Van den Bulck et 
al., 2005; De Groote et al., 2005), hosted largely by pigs and only recently isolated in vitro 
(Baele et al., 2008).  
Until now, virtually nothing is known about possible H. suis virulence factors involved 
in human gastric pathology (Haesebrouck et al., 2009). Previously, we have shown that a H. 
suis infection induces loss of gastric epithelial, mainly parietal cells in mice and Mongolian 
gerbil models of human gastric disease (Flahou et al., 2010a).  Gastric cell death is considered 
an important mechanism involved in gastric ulcer formation (Dixon, 2001), gastric atrophy 
and gastric cancer (Shirin and Moss, 1998). Therefore, in the present study, we investigated 
the ability of H. suis to directly cause gastric epithelial cell death in vitro. Additionally, we 
explored which mechanisms of H. suis are involved in this process. In the closely related H. 
pylori, several factors have been shown to induce gastric epithelial cell death, including VacA 
(Cover et al.,  2003), and a γ-glutamyl transpeptidase (GGT) (Shibayama et al., 2003; Kim et 
al., 2007a; Gong et al., 2010). For the latter, the exact mechanism involved in the induction of 
gastric epithelial cell apoptosis remains to be elucidated. Besides its role in gastric epithelial 
cell apoptosis, H. pylori GGT has also been shown to play a pivotal role in the upregulation of 
COX-2 and EGF-related peptide expression and the inhibition of T-cell proliferation (Busiello 
et al., 2004; Schmees et al., 2007). Membrane-associated GGT activity is often present in 
eukaryotic cells, where the enzyme plays an important role in the metabolism of glutathione 
(Orlowski and Meister, 1970), a free thiol maintaining an optimal intracellular redox 
environment (Circu and Aw, 2010).  
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In this study, we demonstrate that H. suis actively causes apoptosis and necrosis of 
gastric epithelial cells. We identified H. suis ggt, encoding an active GGT, as an important 
factor involved in death of these cells. The enzyme mediates the disintegration of glutathione 
into its degradation products. This actively causes an extracellular and cell-independent 
increase of the oxidative stress burden, leading to lipid peroxidation and finally resulting in 
gastric epithelial cell death. 
 
Results 
 
Inhibition of GGT activity in H. suis whole bacterial cell lysates strongly reduces H. suis-
induced death of AGS cells  
Viability of H. suis bacteria is drastically reduced, already after 1 hour of incubation in 
various cell culture media, including Ham’s F12 which is used for cultivation of AGS cells. 
Therefore, in order to investigate the effect of H. suis on the viability of gastric epithelial 
cells, AGS cells (human gastric adenocarcinoma cell line) were incubated for 20 h with H. 
suis lysate. Flow cytometric and fluorescence microscopic analysis revealed an increase of the 
percentage of apoptotic cells, positive for active caspase-3 (not shown). After 44 hours of 
incubation, similar but more pronounced effects were detected, as well as an increase of the 
percentage of cells showing loss of plasma membrane integrity, detected by propidium iodide 
(PI) staining. (Figure 1; Figure 2A).  
 
Figure 1. Activated caspase-3 and Hoechst staining of control and H. suis lysate treated AGS cells. 
Fluorescence microscopic images of activated caspase-3 (green) and nuclear Hoechst staining (blue) of AGS 
cells. (A) AGS cells treated with HBSS for 44 hours. Only one activated caspase-3 positive cell is observed, 
reflecting the basal level of apoptosis in normal AGS cell cultures. (B) AGS cells treated with H. suis lysate for 
44 hours. An increased number (6) of cells positive for activated caspase-3 can be observed. Note that activated 
caspase-3 positive cells also reveal nuclear condensation and fragmentation, which can typically be observed in 
apoptotic cells. 
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Figure 2. Flow cytometric analysis of cell death of AGS cells.  
For each panel, the results of one representative experiment are depicted. HBSS-treated cells served as negative 
controls. (A) Incubation of AGS cells with H. suis whole bacterial cell lysate (HS lysate) induces both an 
increase in the number of propidium iodide-positive and activated caspase-3-positive cells. (B) Inhibition of 
GGT activity present in H. suis lysate with the known GGT inhibitor acivicin yielded a lower number of PI-
positive cells. Also a decrease of the number of activated caspase-3-positive cells could be observed, although 
not statistically significant. (C) Incubation of AGS cells with recombinant H. suis GGT (rHSGGT) induced an 
increase in the percentage of dead cells, only after 44 hours of incubation. (D) This rHSGGT-induced cell death 
could be abolished by acivicin-mediated inhibition of GGT activity. (E) Incubation of AGS cells for 20 h with 5 
mM GSH and 2 µg/mL rHSGGT did not result in a higher percentage of PI (propidium iodide)-positive cells 
compared to AGS cells incubated with rHSGGT alone. (F) In contrast, the cell death-inducing capacity of 
rHSGGT after 44 hours of incubation was enhanced by the addition of 5 mM GSH. Mainly caspase-3 (c3)-
independent cell death was induced. * depict relevant statistically significant differences (P<0.05).  
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After 44 hour of incubation, the increase of the percentage of PI-positive cells was 
higher compared to the increase of cells positive for activated caspase-3, indicating that both 
apoptosis and necrosis, or another type of caspase-3-independent cell death, were involved. 
Heat and trypsin treatment of H. suis lysate almost completely abolished the cell death-
inducing capacity (data not shown), allocating one or more proteins as the inducer(s) of cell 
death.  
Gamma-glutamyl transpeptidase activity was detected in the supernatant fluid of a 24-
hour-old biphasic culture of H. suis strain 5 (1.8-2.0 U/L). Moreover, GGT activity was 
detected in whole bacterial cell lysate of this same H. suis strain (Figure 3A: 20-30 mU/mg 
total protein). Lysates of all H. suis strains available at present, possess GGT activity in the 
same order of magnitude (results not shown). This urged us to investigate the possible role of 
this enzyme in the induction of gastric epithelial cell death. Incubation of H. suis lysate with 
acivicin, a known GGT inhibitor (Schmees et al., 2007), completely abolished GGT activity 
(Figure 3A) and reduced the H. suis-induced caspase-3-independent cell death (Figure 2B). 
Apoptosis also showed lower values, although statistically not significant. These data suggest 
that H. suis GGT is involved in the induction of gastric epithelial cell death. 
  
 
Figure 3. GGT activity detected both in H. suis (HS) lysate (A) and recombinant H. suis GGT (rHSGGT) 
(B). This enzymatic activity, expressed as mU/mg total H. suis protein or rHSGGT, respectively, was abolished 
completely after acivicin-treatment (50 µM).  
 
Recombinant H. suis GGT causes cell death of AGS cells 
To confirm whether H. suis GGT is involved in the induction of gastric epithelial cell 
death, we expressed a recombinant 6xHis-tagged H. suis GGT in E. coli. After nickel affinity 
chromatography, the enzyme was purified to homogeneity by gel filtration chromatography. 
This recombinant H. suis GGT (rHSGGT) was highly active in the GGT activity assay, as 
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shown in Figure 3B. SDS-PAGE analysis showed that this enzyme was purified mainly as a 
protein with a molecular weight of ~60 kDa, although two discrete protein bands with a 
molecular weight of ~40 and ~20 kDa, respectively, could also be seen (Figure 4). This 
suggests that H. suis GGT is synthesized as a precursor enzyme with subsequent processing 
into a large and a small subunit, which has been described for other bacterial GGT’s, such as 
the H. pylori and E. coli GGT (Suzuki and Kumagai, 2002; Boanca et al., 2006). To test 
whether rHSGGT retains a long activity in AGS medium, a supernatant aliquot of AGS cells 
incubated for 20 h with rHSGGT was tested in the GGT activity assay. Results revealed a 2.5-
fold increase in activity of the rHSGGT fraction, further confirming that the inactive 
precursor enzyme is processed into an active 2 subunits-containing enzyme. 
 
 
Figure 4. SDS-PAGE analysis of recombinant H. suis GGT. Proteins were visualized with Brilliant Blue G - 
Colloidal staining. Column M: Protein marker with size labelling in kilodalton (kDa) at the left. Column 1 shows 
the eluate after Ni-affinity chromatography, with a clear band of approximately 60 kDa, representing the 
unprocessed recombinant H. suis GGT (pro-enzyme). Column 2 shows recombinant H. suis GGT after gel 
filtration chromatography, revealing the presence of three protein bands, reflecting the processing of the pro-
enzyme (~60 kDa) into a large (~40 kDa) and small (~20 kDa) subunit. 
 
Incubation of AGS cells for 20 h with recombinant H. suis GGT showed no 
statistically significant increase of the number of propidium iodide-positive cells, compared to 
control cells (Figure 2C). After 44 hours of incubation, higher percentages of PI-positive cells 
were seen for final rHSGGT concentrations of 2 and 8 µg/mL, compared to control cells 
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(Figure 2C). An increase of the number of activated caspase 3-positive cells could also be 
detected, although statistically not significant (results not shown). This was confirmed by 
light and transmission electron microscopic examination of treated cell cultures. In 44 h 
HBSS-treated control cultures, the vast majority of cells showed no signs of cell death 
(Figures 5A and B), but approximately 4% of the cells showed blebbing of the plasma 
membrane and the presence of apoptotic bodies, of which some contained condensed 
chromatin (Figures 5C and D). These are all morphological features of apoptosis (Krysko et 
al., 2008; Kroemer et al., 2009). In cultures treated with 2 or 8 µg/ mL rHSGGT, cells 
appeared containing large, clear cytoplasmic vacuoles (Figures 5E and F), which is 
compatible with oncosis or primary necrosis (Krysko et al., 2008; Kroemer et al., 2009). 
Moreover, these cells did not show morphological signs of apoptosis. 
Pretreatment of rHSGGT with 50 µM acivicin rendered GGT activity completely 
undetectable (Figure 3B). Incubation of AGS cells for 44 h with 8 µg/mL of this inhibited 
rHSGGT, showed a complete loss of the cell death-inducing capacity of this enzyme (Figure 
2D). 
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Figure 5. Light and transmission electron microscopic images of treated AGS cells. 
(A) and (B) Bright field microscopic (magnification: 630x) and transmission electron microscopic (TEM) image 
(with bar: 1 µm), respectively, of a control AGS culture treated for 44 h with HBSS, showing normal cells. (C) 
and (D) Phase contrast image of 3 cells (magnification: 1000x) and TEM image (with bar: 2 µm) of 1 cell, 
respectively, showing a corona radiata of apoptotic bodies. Approximately 4% of cells in 44 h HBSS-treated 
control wells showed signs of apoptosis. (E) and (F) Phase contrast image of 1 cell (magnification: 1000x) and 
TEM image (with bar: 1 µm) of 1 cell, respectively, in an AGS culture treated for 44 hours with 8 µg/mL 
rHSGGT. In the rHSGGT-treated cultures, numerous cells appeared containing large, clear cytoplasmic 
vacuoles, compatible with oncosis or primary necrosis. Moreover, these cells did not show morphological signs 
of apoptosis. 
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Recombinant H. suis GGT causes cell death of AGS cells through extracellular 
glutathione degradation 
Normal basal values of total glutathione in cell culture supernatants of an overnight 
culture of AGS cells varied between 30 and 140 µM. These concentrations did not alter 
significantly when AGS cells were incubated with 2 µM rHSGGT for up to 44 hours (not 
shown).  
To detect degradation of extracellular reduced glutathione (GSH) in the AGS model, 
concentrations of supplemented GSH were monitored in the supernatant of AGS cell cultures 
in the presence or absence of 2 µg/mL rHSGGT (Figure 6A). Without the addition of 
rHSGGT, only 9 % of 5 mM supplemented GSH was degraded after 44 hours of incubation, 
whereas 95% of supplemented GSH was degraded in the presence of rHSGGT. Pre-
incubation of rHSGGT with 50 µM acivicin strongly reduced the capacity of the enzyme to 
degrade GSH. After 20 h of incubation, 5 mM GSH was reduced to approximately 1500 µM 
GSH, whereas 1 mM GSH in AGS culture supernatant was reduced to only 55 µM (not 
shown), which equals normal basal GSH values present in AGS cell culture supernatants. For 
this reason, AGS cells were treated with 2 µg/mL rHSGGT and 5 mM GSH (as opposed to 1 
mM) to determine the possible role of a sustained, 44-hour-lasting rHSGGT-mediated GSH 
degradation  in the induction of cell death.  
 
 
Figure 6. Recombinant H. suis GGT catalyzes the degradation of reduced glutathione (GSH).  
(A) Monitoring of the degradation of supplemented 5 mM GSH in AGS cell culture supernatant without 
rHSGGT, with 2 µg/mL rHSGGT and with 2 µg/mL acivicin-inhibited rHSGGT, showing rHSGGT-mediated 
degradation of GSH in the AGS model used. (B) When AGS cells were treated for 44 hours with rHSGGT, no 
change of intracellular glutathione concentrations was observed. 
 
Incubation of HBSS-treated AGS cells with 5 mM GSH had no effect on the 
percentage of PI-positive cells (Figures 2E and F). Moreover, this GSH supplementation 
induced a mild decrease in the number of cells positive for active caspase-3, revealing an anti-
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apoptotic effect of reduced glutathione (Figure 2F). Incubation of AGS cells for 20 h with 5 
mM GSH and 2 µg/mL rHSGGT did not result in a higher percentage of PI-positive cells 
compared to AGS cells incubated with rHSGGT alone (Figure 2E). Longer incubation for 44 
hours with 5mM GSH and 2 or 8 µg/mL rHSGGT, however, resulted in a clear increase of the 
number of PI-positive cells (Figure 2F). Moreover, only a slight increase in the number of 
apoptotic cells was observed when 5 mM GSH was combined with 8 µg/mL rHSGGT (Figure 
2F). These results demonstrate that H. suis GGT-mediated degradation of glutathione directly 
caused mainly caspase-3-independent, and thus non-apoptotic death of AGS cells. 
 
H. suis GGT-mediated glutathione degradation plays an active role in the increase of the 
extracellular hydrogen peroxide concentration 
Because the cleavage of glutathione by plasma membrane GGT of eukaryotic cells has 
been associated with the extracellular production of hydrogen peroxide (Dominici et al., 
1999), we sought to determine whether H. suis GGT-mediated glutathione degradation was 
correlated with an increase of extracellular hydrogen peroxide production. Incubation of AGS 
cells for 44 hours with 2 µg/mL rHSGGT was accompanied by a mild increase of the 
extracellular H2O2 concentration, as determined with the Amplex Red Hydrogen Peroxide 
Assay Kit (Invitrogen) (Figure 7A). However, when cells were incubated with 2 µg/mL 
rHSGGT and 5 mM GSH, even much higher concentrations of extracellular H2O2 were 
observed (Figure 7B). Shorter incubation for 20 hours showed similar results, however less 
pronounced. As shown in figure 7A, incubation of AGS cells with 5 mM GSH alone, did not 
yield an increase in extracellular H2O2 concentrations, showing that the observed increase of 
the extracellular H2O2 concentration was due to recombinant H. suis GGT-mediated 
degradation of reduced glutathione. The exact same experiments were performed in the same 
media, however without AGS cells. Comparable results were obtained (Figure 7C), with equal 
or higher H2O2 concentrations in rHSGGT + GSH-containing wells without AGS cells 
compared to identical wells containing AGS cells. Moreover, acivicin-induced inhibition of 
the enzymatic activity of rHSGGT completely abolished the observed effect. These data show 
that the observed increase of the H2O2 concentration is an event taking place extracellularly. 
Finally, an increase of the extracellular H2O2 concentration was also observed after  
incubation of AGS cells for 1 and 20 hours with 200 µg/mL H. suis lysate, when compared to 
HBSS-treated control wells (Figure 7D).  
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Figure 7. Determination of H2O2 concentrations in AGS cell culture supernatants. (A) Incubation of AGS 
cells for 44 hours with 2 µg/mL rHSGGT resulted in higher H2O2 concentrations compared to values in 
supernatant of control cell cultures, supplemented with HBSS instead of rHSGGT. (B) When a combination of  
rHSGGT and 5mM GSH was used, this increase was even much higher, both after 20 and 44 hours of 
incubation. (C) Similar results were obtained in AGS culture medium with the absence of AGS cells. 
Additionally, pretreatment of rHSGGT with acivicin completely abrogated the observed effect. (D) Incubation of 
AGS cells for 1 or 20 hours with 200 µg/mL H. suis lysate induced an increase of the extracellular H2O2 
concentrations, compared to HBSS-treated cells. Shown are the mean values of 3 independent experiments or 
one representative experiment. * depict relevant statistically significant differences (P<0.05).  
 
Glutathione degradation-dependent extracellular hydrogen peroxide generation causes 
lipid peroxidation prior to death of cells  
Because H. suis GGT-mediated degradation of glutathione resulted in an increase of 
the extracellular oxidative stress burden, we investigated if these extracellular changes had an 
impact on the intracellular redox balance, since H2O2 is known to be able to permeate the 
eukaryotic plasma membrane (Bienert et al., 2006; Bienert et al., 2007), with subsequent 
actions inside the cell, possibly leading to necrotic cell death (Kim et al., 2007b).  
When AGS cells were treated for 44 hours with rHSGGT, no change of intracellular 
glutathione concentrations was observed (Figure 6B). However, after 44 hours of incubation, 
an increase of membrane lipid peroxidation was detected in AGS cells treated with 2 µg/mL 
rHSGGT and 5 mM GSH, compared to HBSS-treated cells and cells treated with rHSGGT 
alone (Figure 8). In cells treated with GSH alone, no increased lipid peroxidation was 
observed, compared to HBSS-treated control cells, whereas treatment of cells with rHSGGT 
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alone caused a slight increase of lipid peroxidation, although statistically not significant 
(Figure 8). These data indicate that this effect is largely caused by rHSGGT-mediated 
degradation of reduced glutathione. Interestingly, comparable effects were observed after 20 
hours of incubation, a point in time at which no increased cell death could yet be observed.   
 
 
Figure 8. Determination of lipid peroxidation in AGS cells. 
Cells were stained with BODIPY 581/591 C11. Upon peroxidation, fluorescence of this dye shifts from red to 
green. Example of the analysis of the red (FL-2) and green (FL-1) fluorescence intensities of a cell population 
treated for 44 hours with HBSS (A) and a combination of 2 µg/mL rHSGGT and 5 mM GSH (B). Note the 
marked decrease of the red fluorescence accompanied by an increased green fluorescence after treatment with 
rHSGGT and GSH, indicating peroxidation of cellular lipids. (C) Already after 20 hours of incubation with a 
combination of rHSGGT and GSH, an increase of the percentage of cells showing a fluorescence shift was 
observed. This lipid peroxidation was even more pronounced after 44 hours of incubation. Shown are the mean 
results of 3 independent experiments. Incubation for 30 min with 500 µM H2O2 was included as a positive 
control. * depict relevant statistically significant differences. 
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Mitochondrial respiration is considered one of the main sources of intracellular ROS 
(Orrenius, 2007; Poyton et al., 2009; Pourova et al., 2010). Therefore, the possibility that this 
mitochondria-derived ROS could serve as a source of lipid peroxidation was investigated. 
Already after 24 hours of incubation of AGS cells with a combination of rHSGGT and GSH, 
higher levels of mitochondrial depolarization were observed, as shown by the decrease in the 
red/green fluorescence intensity ratio of the cationic dye JC-1 (Figure 9). This loss of 
mitochondrial membrane potential rather indicates a decrease of mitochondral ROS 
generation (Starkov and Fiskum, 2003; Brookes et al., 2004).  
 
 
Figure 9. Measurement of mitochondrial membrane potential (∆Ψm) in treated AGS cultures. 
Cells were stained with JC-1, a ∆Ψm-sensitive probe. A decrease in the red/green fluorescence intensity ratio of 
this probe reflects mitochondrial depolarization. After 24 hours of incubation of AGS cells with rHSGGT and 
GSH, a decrease of the mitochondrial membrane potential could be observed. Shown are the mean values of 3 
experiments. * depict relevant statistically significant differences. 
  
Discussion 
Until now, very little is known about H. suis virulence genes (Haesebrouck et al., 
2009). In the present study, we showed that H. suis is actively involved in the induction of 
gastric epithelial cell death in vitro. These data support previous findings of H. suis-induced 
necrosis of gastric epithelial, mainly parietal cells in mice and Mongolian gerbils (Flahou et 
al., 2010a). This cell death may have important implications for the development of various 
gastric pathologies, such as gastric erosion and/or ulcer formation (Dixon, 2001), gastric 
atrophy and even gastric cancer (Shirin and Moss, 1998). These lesions all have been 
observed in humans infected with non-H. pylori helicobacters (Morgner et al., 1995; Stolte et 
al., 1997; Debongnie et al., 1998) and are very often accompanied by gastritis (Stolte et al., 
1997). Similarly, H. suis elicits a strong inflammatory response in experimentally infected 
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mice and Mongolian gerbils (Flahou et al., 2010a), possibly caused by direct effects of H. 
suis, but most likely also driven indirectly by necrosis of gastric epithelial cells. Cell necrosis 
results in the release of cellular contents, including molecules involved in the promotion of 
inflammation (Fink and Cookson, 2005; Vanlangenakker et al., 2008).  
Whole-genome screening of H. suis strain 5 has revealed the presence of a gene 
homologous to the H. pylori ggt, but also the absence of other virulence factors (Vermoote et 
al., 2011) involved in H. pylori-induced cell death, such as VacA (Cover et al., 2003). 
Inhibition of GGT activity present in H. suis lysate and the use of recombinant H. suis GGT 
revealed an important role for this enzyme in the induction of gastric epithelial cell death in 
the present study. Similarly, the H. pylori GGT has also been identified as a cell death-
inducing enzyme (Shibayama et al., 2003).  
SDS-PAGE analysis and the relative increase of GGT activity in supernatants of AGS 
cells incubated for 20 h with recombinant H. suis GGT showed that this enzyme is secreted as 
a pro-form with subsequent processing into a large and a small subunit. This has also been 
described for other bacterial GGT’s, such as the H. pylori and E. coli GGT (Suzuki and 
Kumagai, 2002; Boanca et al., 2006). Enzymatic γ-glutamyl transpeptidase activity typically 
catalyzes the release and transpeptidation of a γ-glutamyl group. This enzyme, also present on 
the membrane of mammalian cells, plays a role in the degradation and thus metabolism of 
extracellular glutathione (Orlowski and Meister, 1970). The tripeptide glutathione is an 
important antioxidant which degrades reactive oxygen species (ROS), including O2–derived 
free radicals, as well as O2–derived nonradical species such as hydrogen peroxide (H2O2) 
(Circu and Aw, 2010). In the present study, we describe the H. suis GGT-mediated 
degradation of reduced glutathione. Supplementation of the extracellular medium with GSH 
enhanced H. suis GGT-induced cell death, suggesting that metabolites of glutathione 
degradation are directly involved in this process.  
In the present study, approximately 2 U/L GGT activity was detected in the 
supernatant of a 24-hour-old H. suis culture, containing a majority of live and motile bacteria. 
Recombinant H.suis GGT was added to AGS cells to reach similar GGT activity levels in 
AGS cell culture supernatant. It is reasonable to assume that similar levels of GGT activity 
are present in the region of H. suis colonization in the human or porcine stomach. Conflicting 
reports have been made about the localization of GGT in the highly related H. pylori. Some 
authors suggest a periplasmic localization (Chevalier et al., 1999; Shibayama et al., 2007). In 
this case, GGT could have free access to the surrounding glutathione (Chevalier et al., 1999; 
Shibayama et al., 2007), both with or without autolysis of the bacteria, which has been shown 
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to be an event taking place frequently in H. pylori (Marcus and Scott, 2001; Fujita et al., 
2005). Other authors suggest, with strong argumentation, that H. pylori GGT is in fact a 
secreted protein (Bumann et al., 2002; Busiello et al., 2004; Schmees et al., 2007). In any 
case, the conclusion is that H. pylori GGT, and by extension most likely also GGT’s from 
other gastric helicobacters, have free access to glutathione, both as a secreted and a 
periplasmic enzyme.  
In the present study, normal basal concentrations of extracellular glutathione were in 
the micromolar range, which is in accordance with the results of previous studies (Yang et al., 
1997). Interestingly, no differences in extracellular concentrations of total glutathione 
(combined fractions of reduced and oxidized glutathione) were observed between control and 
H. suis GGT-treated cells (results not shown), suggesting that de novo synthesis of glutathione 
and subsequent transport out of the cells take place. Indeed, it is well known that glutathione 
is synthesized intracellularly and subsequently translocated towards the extracellular space 
(Griffith and Meister, 1979). By this means, epithelial cells could provide H. suis GGT with a 
continuous supply of its main substrate.  
Supplementation of AGS cell cultures with 5 mM GSH, strengthened the observed H. 
suis GGT-mediated increase of extracellular H2O2 concentrations and subsequent cell death. 
In order to produce similar effects in vivo, H. suis GGT must have access to relatively high 
concentrations of extracellular glutathione, which is indeed most likely provided by several 
sources. When cells die by means of necrosis, intracellular contents are released into the 
surroundings (Vanlangenakker et al. 2008), including large amounts of intracellular 
glutathione. In the stomach, intracellular glutathione concentrations are high (up to 10 mM), 
compared to most other tissues (Body et al., 1979; Meister and Anderson, 1983; Mårtensson 
et al., 1990). Moreover, foods like asparagus, cooked ham and orange juice contain high 
concentrations of glutathione (Valencia et al., 2001; Kuśmierek and Bald, 2008), resulting in 
daily uptakes up to more than 100 mg in adult humans (Flagg et al., 1994). Even bile reflux 
could serve as an important source of extracellular glutathione, since bile contains high levels 
(up to 6 mM) of GSH (Meister and Anderson, 1983). Several studies suggest that GSH can 
freely diffuse through the gastric mucus (Mårtensson et al., 1990; Ovrebø et al., 1997), in this 
way also reaching the fraction of H. suis bacteria residing in the mucus layer. All these 
mechanisms may also be important for H. pylori infections, since this bacterium also 
expresses a functional GGT. Interestingly, Farinati et al. (1996) have described an increase of 
both the reduced and oxidized glutathione content of gastric mucosa of H. pylori-infected 
humans suffering from chronic nonatrophic gastritis, possibly providing a greater source for 
  
155
 Chapter 4   
H. pylori GGT-mediated degradation of glutathione. Similar results have been described for 
total (sum of reduced and oxidized) glutathione contents in the stomach of H. pylori-infected 
Mongolian gerbils (Suzuki et al., 1999). However, these findings are in contrast with the 
results from another study, describing lower levels of reduced glutathione in H. pylori-
infected human patients compared to H. pylori-negative individuals (Jung et al., 2001). 
Deprivation of glutathione is one of the suggested mechanisms of H. pylori GGT-
mediated cell death (Shibayama et al., 2007). However, in our attempt to reduce the H. suis 
GGT-induced cell death by supplementing cell culture supernatants with reduced glutathione, 
we observed the opposite effect, a higher number of dead cells. An increase of the 
extracellular H2O2 concentration was observed in AGS cell supernatants of H. suis GGT-
treated cells. The relevance of this finding was confirmed by the observation that H. suis 
lysate also generated higher extracellular H2O2 concentrations, compared to HBSS treatment 
of cells, despite the presence in H. suis of enzymes involved in the neutralization of various 
ROS, including catalase and superoxide dismutase (Vermoote et al., 2011). The H. suis GGT-
generated increase of the extracellular H2O2 concentration was even much higher when cells 
were co-incubated with H. suis GGT and reduced glutathione. Interestingly, this vast increase 
was also observed in the absence of AGS cells, showing that the hydrogen peroxide was 
mainly generated in a cell-independent manner, which contrasts with recently published 
results describing the H. pylori GGT-mediated production of H2O2 by AGS cells (Gong et al., 
2010).  
In the present study, we did not examine the exact mechanism by which H2O2 was 
generated. Several studies have described that plasma membrane-bound GGT of mammalian 
cells initiates prooxidant reactions through the catabolism of GSH (Dominici et al., 1999; 
Maellaro et al., 2000). Transpeptidation of the γ-glutamyl group generates the more reactive 
thiol cysteinyl-glycine, leading to the production of H2O2 through the reduction of Fe3+ and 
subsequent production of thiyl radicals and the superoxide anion (O2•—) (Dominici et al., 
1999):  
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Moreover, H2O2 can generate, through Haber-Weiss and Fenton reactions, the highly reactive 
hydroxyl radical (Vanlangenakker et al., 2008). So probably, the increased H2O2 
concentrations also reflect the presence of these other reactive oxygen species or thiyl 
radicals, responsible for the observed increase of cell death. Anyhow, the observed H2O2 
concentrations in the present study were relatively low compared to cell death-inducing 
amounts described in other studies (Hampton and Orrenius, 1997; Zhuang et al., 2008). In 
these studies, however, these higher H2O2 concentrations induced cell death already after 2-6 
hours, so longer incubation with lower H2O2 concentrations, as in the present study, could 
explain the induced epithelial cell death. Interestingly, our findings in part contrast with 
earlier findings reporting the H. pylori GGT-induced apoptosis of AGS cells (Shibayama et 
al., 2003). In vitro, the type of H2O2-induced cell death has, however, been associated with 
variations in the concentration of this reactive oxygen species, with the higher concentrations 
inducing necrosis rather than apoptosis (Hampton and Orrenius, 1997; Krysko et al., 2008). 
Additionally, both apoptosis and necrosis have been observed in the same cell culture, 
dependent on a sustained c-Jun N-terminal kinase (JNK) activation due to an enhanced 
production of ROS (Kamata et al., 2005). In any case, it is well established that increased 
concentrations of ROS often result in necrotic cell death (Fiers et al., 1999; Duprez et al., 
2009; Kroemer et al., 2009). 
Twenty hours of incubation of AGS cells with the combination of rHSGGT and GSH 
did not result in a higher number of dead cells compared to AGS cells treated with rHSGGT 
alone. At this point in time, however, increased concentrations of extracellular H2O2 as well as 
peroxidation of cellular lipids could be observed. Lipid peroxidation in the plasma membrane 
often leads to loss of membrane integrity (Vanlangenakker et al., 2008), which is observed in 
the present study at later points in time compared to the detection of lipid peroxidation. 
Additionally, in mitochondria, reactive aldehydes derived from lipid peroxidation can affect 
oxidative phosphorylation and mitochondrial membrane potential (Vanlangenakker et al., 
2008), which was also observed in the present study.  
In conclusion, for the first time a H. suis virulence factor was identified, supporting 
earlier findings that also non-H. pylori helicobacters can cause human gastric disease. We 
have shown that H. suis directly causes gastric epithelial cell death in vitro, confirming the 
results of previous in vivo studies (Flahou et al., 2010a). Additionally, we have identified H. 
suis GGT as an important cause of H. suis-induced human gastric epithelial cell death in vitro. 
The observed necrosis is enhanced upon H. suis GGT-mediated degradation of reduced 
glutathione, resulting in an increase of extracellular concentrations of H2O2, generated by 
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glutathione degradation products in a cell-independent manner and resulting in cellular lipid 
peroxidation. This oxidative cell damage finally results in cell death.  
 
Experimental procedures 
 
Bacterial strain for DNA extraction and preparation of whole bacterial cell lysate 
H. suis strain HS5, isolated from the gastric mucosa of a sow (Baele et al., 2008), was 
grown under biphasic culture conditions as described previously (Flahou et al., 2010b).  
Bacterial genomic DNA was isolated as described by Wilson (1994) and used for expression 
of recombinant H. suis GGT (rHSGGT).  For the whole bacterial cell lysate of H. suis, 
bacteria were harvested by centrifugation, washed 2 times with HBSS and resuspended in 
HBSS. The bacterial suspension was sonicated 8 times for 30 seconds and centrifuged (15000 
g, 5 min, 4°C) to remove cellular debris. The supernatant was filtered through a 0.22-µm pore 
filter (Schleicher and Schuell, Gent, Belgium) and stored at -80°C. The resulting protein 
concentration was determined with the RC DC Protein Assay (Bio-Rad, Hercules, CA, USA). 
 
Preparation of recombinant H. suis GGT 
Screening of the whole-genome sequence of H. suis strain 5 revealed the presence of a 
1668 bp gene encoding a γ-glutamyl transpeptidase (GenBank accession number on 
http://www.ncbi.nlm.nih.gov/Entrez/: GU972556) which was approximately 73% identical to 
the GGT of H. pylori strain 26695 (GenBank accession number on 
http://www.ncbi.nlm.nih.gov/Entrez/: NP_207909.1) based on the predicted amino acid 
sequence. The enzyme was expressed in the E. coli Expression System with Gateway® 
Technology (Invitrogen, Carlsbad, CA, USA) as follows. The coding region of the H. suis 
GGT, without the predicted 18 aa signal sequence, was amplified by PCR (forward primer: 
5’-CACCATGGCCACTTTGCCTCCTATTAAAGGC-3’; reverse primer: 5’-
TTAAAATTCCTTGCGTGGATCTTGAGC-3’) using Pwo polymerase with proofreading 
activity (Roche Applied Science, Mannheim, Germany) according to the guidelines for this 
enzyme. The resulting PCR product was cloned into the pENTRTM/SD/D-TOPO® vector and 
transferred into the pDESTTM17 destination vector. The resulting expression clone was 
transformed into the chemically competent E. coli strain BL21-AITM. A fresh culture was 
allowed to grow until the OD600  reached 0.4, after which 0.2% L-arabinose was added to 
induce the expression of recombinant H. suis GGT (rHSGGT). After incubation at 37°C for 3 
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hours with shaking, bacteria were harvested by centrifugation (4500g for 20 min). N-terminal 
6xHis-tagged rHSGGT was purified on a Ni-sepharose column (His GraviTrap; GE 
Healthcare Bio-Sciences AB, Uppsala, Sweden) according to the manufacturer’s instructions. 
Bound protein was eluted with 3 mL of elution buffer (20 mM sodium phosphate, 500 mM 
NaCl, 500 mM imidazole, pH 7.4) and collected in 17 mL HBSS, to prevent precipitation due 
to high imidazole concentrations. This eluate was concentrated to a final volume of 1.5 mL by 
ultrafiltration (VIVASPIN 20, 5000 MWCO; Sartorius stedim biotech, Goettingen, Germany), 
analyzed in the GGT activity assay and by SDS-PAGE with subsequent Brilliant Blue G - 
Colloidal (Sigma-Aldrich) staining. For further purification, the concentrated eluate was 
loaded on a SuperdexTM 75 gel filtration column (GE Healthcare Bio-Sciences AB), eluted 
with HBSS and collected as one mL fractions. The purity and GGT activity of five peak 
fractions were determined by SDS-PAGE and the GGT activity assay (see below), 
respectively. Since all five fractions were pure on SDS-PAGE and showed GGT activity, they 
were pooled and stored at -80°C until further use. Protein concentration was determined with 
the RC DC Protein Assay (Bio-Rad). 
 
 Cell culture 
All in vitro cell experiments were performed with AGS cells (human gastric 
adenocarcinoma cell line; ATCC: CRL-1739). The cells were cultured in Ham’s F12 
(Invitrogen) supplemented with 10% fetal calf serum (FCS; HyClone, Logan, UT, USA), 
penicillin and streptomycin (Invitrogen). 
 
Cell treatment 
AGS cells were seeded at 2 x 104 cells for each well of a 24-well flat-bottom cell-
culture plate (Greiner Bio One, Frickenhausen, Germany), allowed to adhere for 6 hours and 
serum-starved overnight. Prior to each incubation experiment, cells were washed 2 times with 
HBSS. During the experiments, cells were incubated in Ham’s F12 supplemented with 
penicillin and streptomycin and FCS at a final concentration of 5%. Cell medium was 
supplemented with H. suis whole bacterial cell lysate at a final total protein concentration of 
200 µg/mL for 44 hours at 37°C, unless stated otherwise. This corresponds to a calculated 
theoretical multiplicity of infection (MOI) of approximately 200. To determine whether the 
cell death-inducing agent was of protein nature, the bacterial lysate was pre-treated with heat 
(95°C, 1h) or trypsin (1 mg/mL; 2 h, 37°C; Invitrogen), which in turn was inactivated by the 
addition of 1 mg/mL soybean trypsin inhibitor (Sigma-Aldrich) and 5% FCS prior to 
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incubation with AGS cells. Alternatively, cell medium was supplemented with recombinant 
H. suis GGT at final protein concentrations of 2 and 8 µg/mL and incubation was performed 
for 20 and 44 hours at 37°C, unless stated otherwise. For inhibition of GGT activity in both 
whole bacterial cell lysates and rHSGGT, pre-incubation with 50 µM of acivicin (Enzo life 
Sciences, Farmingdale, NY, USA), a known GGT inhibitor, was performed for 1 hour at 37°C 
(Schmees et al., 2007).  After this incubation, unbound acivicin was removed from the lysate 
and rHSGGT by repeated ultrafiltration (Vivaspin 500, 5000 MWCO; Sartorius stedim 
biotech). In additional experiments, the effect on AGS cells of supplementation with reduced 
glutathione (GSH) in the presence of recombinant H. suis GGT was determined. Therefore, 
GSH (Sigma-Aldrich, St. Louis, MO, USA) was added to the cell medium at a final 
concentration of 5 mM. For each experiment, negative control cells were incubated with 
HBSS which was treated in the same way as H. suis lysate or recombinant H. suis GGT. 
 
Evaluation of cell death  
For the evaluation of cell death, the combined fractions of floating and adherent AGS 
cells were analyzed. After an initial centrifugation step (1700g, 5 min), cells were 
resuspended and divided into 2 identical subpopulations. One half was used for the detection 
of caspase-3 activation as a marker for apoptosis (Fink and Cookson, 2005; De Bock et al., 
2006; Galluzzi et al., 2009). Briefly, these cells were fixed with 4% paraformaldehyde for 10 
min, followed by permeabilization with 0.1% Triton X-100 in HBSS for 2 min. Cells were 
incubated with a primary rabbit antibody directed against activated caspase-3 (R&D Systems 
Europe Ltd) for 1 h at 37°C, followed by an Alexa Fluor 488-conjugated goat anti-rabbit 
antibody (Invitrogen). Cells treated for 20 h with 0.5 µM staurosporine (Sigma-Aldrich) 
served as a positive control. The second cell subpopulation was used for the assessment of 
loss of plasma membrane integrity as a marker for necrosis (Fink and Cookson, 2005; 
Galluzzi et al., 2009).  Briefly, after an initial washing step in HBSS, cell pellets were 
incubated for 20 min on ice with 1 µg/mL propidium iodide in HBSS. Triton X-100 (0.1%)-
treated cells served as a positive control. All analyses were performed on a BD FACSCanto II 
flow cytometer and processed using FACSDiva software (Becton Dickinson, Erembodegem, 
Belgium). To confirm active caspase-3 staining of H. suis lysate-treated apoptotic cells, some 
cell suspensions were aditionally analyzed by fluorescence microscopy after counterstaining 
cell nuclei with Hoechst (100 µM, 15 min, RT). Images were captured using a Cell*M 
imaging workstation connected to a IX81 fluorescence microscope (Olympus). Except for 
brightness/contrast adjustments applied to the entire images, images were not digitally 
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manipulated. Washing steps in HBSS were included at appropriate points in time during all 
experimental protocols. 
To further characterize H. suis GGT-induced cell death, rHSGGT-treated cells were 
examined by light and transmission electron microscopy. Cells were fixed in 4% 
formaldehyde in a buffer (pH 7.4) containing 0.121 M Na-cacodylate and 1% CaCl2. After 
post-fixation in 1% osmium tetroxide, cultures were dehydrated in a graded series of ethanol 
and embedded in LX resin. Semithin sections of 2 µM were stained with toluidine blue and 
examined by light microscopy. Ultrathin sections were stained with uranyl acetate and lead 
citrate solutions before examining under a Jeol EX II transmission electron microscope at 80 
kV.  
 
GGT activity assay 
Detection of GGT activity of H. suis whole bacterial cell lysate, H. suis culture 
supernatant or recombinant H. suis GGT was based on the method described by Orlowski and 
Meister (1963). Briefly, reaction buffer consisted of 2.9 mM L-glutamic acid 5-(3-carboxy-4-
nitroanilide) (Sigma-Aldrich) as a donor substrate and 100 mM glycyl-glycine (Sigma-
Aldrich) as an acceptor in 100 mM Tris buffer (pH 8.25). Bacterial supernatants, whole 
bacterial cell lysate of H. suis or the recombinant H. suis GGT were added and the reaction 
mixture was incubated at 37°C for 5-60 min. The release of p-nitroaniline was determined by 
measuring the absorbance at 405 nm. Activity was expressed as U/L or mU/mg protein and 
one unit was defined as the amount of enzyme that catalyzes the formation of 1 µmole of p-
nitroaniline per minute under specified conditions.  
 
Glutathione assay  
To test the effect of H. suis GGT on reduced glutathione (GSH), AGS culture 
supernatants were supplemented with GSH to a final concentration of 5 or 1 mM GSH. 
Recombinant H. suis GGT was added at a final concentration of 2 µg/mL and incubation was 
done at 37°C for 44 h. After 0, 20 and 44 hours, an aliquot was removed to determine the 
concentration of GSH with the Glutathione Assay Kit (Sigma-Aldrich), according to the 
manufacterer’s instructions. This assay is based on the continuous reduction of 5,5'-dithiobis-
(2-nitrobenzoic acid) (DTNB) to TNB, which is measured spectrophotometrically at 412 nm. 
This same Glutathione Assay Kit was used for monitoring basal concentrations of total 
glutathione in the supernatants of AGS cell cultures. Total glutathione comprises both reduced 
glutathione (GSH), which is by far the most abundant form (Meister and Anderson, 1983), 
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and oxidized glutathione disulfide (GSSG). Catabolism of both forms has been shown to be 
mediated by eukaryotic membrane-bound γ-glutamyl transpeptidase (Meister and Anderson, 
1983; Franco et al., 2007). 
To determine if H. suis GGT activity also influences intracellular levels of total 
glutathione, the combined fractions of floating and adherent AGS cells were used. After 
counting cells in a Bürker counting chamber, the cells were pelleted by centrifugation (1700g, 
7 min) and lyzed by three freeze/thaw cycles in a 5% 5-sulfosalicylic acid solution. 
Precipitated proteins were removed by centrifugation (10000g, 10 min) and the supernatant 
was used for glutathione determination using the Glutathione Assay Kit. The amount of total 
glutathione was expressed as pmol/cell. 
 
Hydrogen peroxide assay 
To detect extracellular H2O2 production in supernatants of AGS cell cultures treated or 
non-treated with H. suis whole bacterial cell lysate, rHSGGT or the combination of rHSGGT 
and 5 mM reduced glutathione, 25 µL of the cell supernatants were collected for processing 
with the Amplex Red Hydrogen Peroxide Assay Kit (Invitrogen). This assay is based on the 
horseradish peroxidase-catalyzed oxidation of Amplex Red (10-acetyl-3,7-
dihydroxyphenoxazine), a nonfluorescent reagent that becomes highly fluorescent after 
oxidation by H2O2 (Maellaro et al., 2000). 
 
Determination of lipid peroxidation 
The possible involvement of previously described treatments in lipid peroxidation was 
determined by using 4,4-difluoro-5-(4-phenyl-1,3-butadienyl)-4-bora-3a,4a-diaza-s-indacene-
3-undecanoic acid (BODIPY 581/591 C11; Invitrogen), a probe which is distributed 
heterogeneously throughout the cell with predominant staining in the perinuclear region 
(Drummen et al. 2002). On excitation at 488 nm, this dye yields red emission with a 595 nm 
maximum. Upon oxidation, its red fluorescence is lost, coinciding with a shift of the emission 
maximum from 595 nm to 520 nm. This results in an increase of green fluorescence 
(Drummen et al., 2002; MacDonald et al., 2007).  
After incubation of AGS cells for 15 or 39 h with rHSGGT or a combination of 
rHSGGT and GSH, cell culture plates were briefly centrifuged (1700g, 2 min) to collect both 
floating and adherent cell populations at the bottom of the wells.  The cell supernatant was 
carefully aspired and kept at 37°C until further use. Cells were detached by brief 
trypsinization and resuspended in Ham’s F12 supplemented with 10% fetal calf serum. After 
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centrifugation (1700g, 5 min), the cell pellet was resuspended in 200 µL HBSS containing 5 
µM of the BODIPY 581/591 C11 probe. After incubation for 30 min at 37°C, cells were 
centrifuged (1700g, 5 min), followed by 2 washing steps in HBSS. Subsequently, the pellet 
was resuspended in the original cell culture supernatant and incubated for another 5 h at 37°C, 
with occasional shaking to keep the cells in suspension. Finally, cells were washed twice in 
HBSS and resuspended in HBSS for analysis of the red and green fluorescence intensity in the 
FL-2 and FL-1 channel of a BD FACSCanto II flow cytometer. Only cells with unchanged 
FSC (forward scatter) and SSC (side scatter) values were analyzed. Some control cells were 
treated with 500 µM H2O2 (37°C; 30 min) prior to analysis and served as a positive control. 
 
Mitochondrial membrane potential (∆Ψm) measurement 
To investigate the possible role of mitochondria in the generation of ROS in the 
present study, a ∆Ψm-sensitive probe (5,5’,6,6’-tetrachloro-1,1’,3,3’-
tetraethylbenzimidazolylcarbocyanine iodide; JC-1; Invitrogen) was used, since mitochondrial 
ROS generation is dependent on ∆Ψm (Starkov and Fiskum, 2003; Brookes et al., 2004; 
Galluzzi et al., 2009). Briefly, AGS cells were treated with HBSS or 2 µg/mL rHSGGT in the 
presence or absence of 5 mM reduced glutathione. After 24 hours of incubation, the combined 
fractions of floating and adherent cells were pooled and stained with 10 µg/mL JC-1 in HBSS 
(37°C, 15 min). Cells were centrifuged (1700g, 5 min), washed twice with HBSS and 
resuspended in HBSS prior to analysis with a BD FACSCanto II flow cytometer. Upon 
mitochondrial depolarization, a decrease in the red/green fluorescence intensity ratio of this 
probe can be observed. Only cells with unchanged FSC (forward scatter) and SSC (side 
scatter) values, which were considered living cells, were analyzed.  
 
Statistical analysis 
All experiments were repeated independently at least in triplicate. All data were 
analyzed with a Student t test or the non-parametric Mann-Whitney rank sum test. P values 
less than 0.05 were considered significant.  
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In contrast to H. pylori, only very little is known about the exact role in human gastric 
pathology of non-H. pylori Helicobacter (NHPH) species in general and H. suis in particular. 
Nevertheless, the latter is the most prevalent NHPH species in humans suffering from gastric 
disease (Trebesius et al., 2001; Van den Bulck et al., 2005). No doubt, the very fastidious 
nature of the bacterium has hampered progress in H. suis research. In 2008, our research 
group was the first to successfully isolate H. suis in vitro, opening new doors to investigate 
the exact role of this bacterium in gastric pathology and to develop possible strategies to 
control this infection (Baele et al., 2008). 
 
In Helicobacter pylori research, rodent models are very often used to investigate 
bacteria-host interactions. Mainly in Mongolian gerbils, severe H. pylori-related gastric 
pathologies have been reproduced, including gastric ulcer and adenocarcinoma (Watanabe et 
al., 1998; Ikeno et al., 1999). Additionally, a more rapid development of inflammatory 
changes is observed in this animal species, when compared to mice (Court et al., 2002). Only 
very few studies describe an experimental infection of Mongolian gerbils with non-H. pylori 
Helicobacter species, and these are limited to H. felis and H. bizzozeronii (Court et al., 2002; 
De Bock et al., 2006a and 2006b). In chapter one and two, we describe the ability of H. suis to 
colonize the Mongolian gerbil stomach. However, preliminary screening of a gerbil 
population, prior to their use for studying H. suis infection, revealed the abundant presence of 
a yeast, mainly in the antrum. Internally Transcribed rRNA Spacer 2 Region-PCR fragment 
length and sequence analysis revealed it to be Kazachstania heterogenica, previously detected 
in rodent faeces (Kurtzman et al., 2005). In subsequent experimental infection studies, K. 
heterogenica alone did not elicit significant pathology. However, in H. suis-K. heterogenica 
coinfected animals, a markedly enhanced inflammation was observed, compared to H. suis 
monoinfected animals. This indicates a synergism between these two completely different 
micro-organisms. In humans, some reports have also described a synergism, detrimental to the 
host, between H. pylori and gastric yeasts, as shown by the increased prevalence of gastric 
ulcers in humans with co-existence of H. pylori and Candida species in their stomach 
(Karczewska et al., 2009). Similarly, fungal colonization of gastric ulcers has been shown to 
impair ulcer healing, accompanied by persistent clinical symptoms (Zwolińska-Wcislo et al., 
2001). In contrast, however, some studies describe the beneficial impact of supplemented 
Saccharomyces boulardii, another yeast species, on the classic triple-therapy prescribed for H. 
pylori eradication both in adults and children (Hurduc et al., 2009; Song et al., 2010).  
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Besides yeast, several bacterial species may also influence the course of a gastric 
Helicobacter infection. Depending on the bacterial species involved and the animal or human 
host, this may result either in less or more severe gastric lesions.  
Bifidobacterium bifidum has been described to reduce H. pylori growth and the 
pathologies caused by this micro-organism (Chenoll et al., 2010). Likewise, Lactobacillus (L.) 
plantarum displays in vitro anti-H. pylori activity (Rokka et al., 2006) and various 
Lactobacillus spp. have been shown to attenuate, through increased expression of SOCS 
(suppressor of cytokine signaling), the expression of inflammatory mediators such as TNF-α, 
IL-8, iNOS and cox-2 in H. pylori-treated AGS cells (Lee et al., 2010). Treatment of H. 
pylori-infected mice with  L. fermenti or L. acidophilus decreases the mucosal inflammation 
and reduces the H. pylori colonization density (Cui et al., 2010). Aiba and coworkers (1998) 
showed that L. salivarius exerts an anti-H. pylori effect in gnotobiotic mice, however only 
when H. pylori was vastly outnumbered by the Lactobacillus strain. The question remains if 
similar results would have been obtained when using a H. pylori strain showing much higher 
colonization densities, such as the SS1 strain (Lee et al., 1997). Various factors have been 
suggested to be responsible for the anti-H. pylori activity of certain Lactobacillus strains, 
including the production of bacteriocins (Barrett et al., 2007; Deraz et al., 2007; Lin et al., 
2009), the mere presence of the Lactobacillus cell wall (Rokka et al., 2006) and the 
production of high quantities of organic acids, of which lactic acid is generally the most 
abundant one. Indeed, high concentrations of lactic acid have been shown to exert an anti-H. 
pylori activity in vitro (Aiba et al., 1998; Lin et al., 2009).  
Not all Lactobacillus spp. are, however, able to produce equally high concentrations of 
lactic acid (Aiba et al., 1998; Yoon et al., 2006). Low concentrations of this organic acid may 
be beneficial for growth of Helicobacter. In a recent metabolic profiling study, it was shown 
that H. suis uses lactic acid for metabolic purposes, possibly enhancing colonization and the 
associated gastric pathology in pigs or humans (Flahou et al., unpublished results). Other 
Helicobacter species such as H. pylori can also use lactic acid as a carbon source (Schilling et 
al., 2002). 
Persistent colonization of the stomach mucosa with Clostridium butyricum has been 
achieved after experimental infection of germ-free mice (Takahashi et al., 2000). In the same 
study, animals were first inoculated per os with H. pylori and subsequently with C. butyricum. 
This rapidly induced a marked reduction of  H. pylori bacteria colonizing the gastric mucosa. 
Additionally, culture supernatant of C. butyricum and also butyric acid alone, were shown to 
inhibit the growth of H. pylori in vitro. The question remains if butyric acid-producing 
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bacteria are also capable of colonizing the gastric mucosa of humans, as compared to the 
germ-free mice used in the study by Takahashi and coworkers (2000). In pigs, colonization of 
the pars oesophagea with significant populations of mainly anaerobic bacteria, including 
Clostridium spp., has been decribed (McGillivery et al., 1992). This may lead to the 
production of butyric acid at this exact location and a subsequent blocking of the development 
of H. suis-induced lesions of the pars oesophagea, as butyrate has been described to protect 
cells against damage (Bingham et al., 1997; Scharlau et al., 2009). On the other hand, 
lactobacilli can also colonize the pars oesophagea (McGillivery et al., 1992). It has been 
suggested that high concentrations of lactic acid (and other organic acids), produced by the 
metabolism of Lactobacillus and other bacteria in the stomach, might play a role in the 
pathogenesis of gastric ulcer disease in these animals (Argenzio and Eisemann, 1995). 
Krakowka et al. (1998) have reproduced such lesions in gnotobiotic piglets fed a high-
carbohydrate liquid diet and infected experimentally with Lactobacillus or Bacillus spp..  
Infectious agents colonizing the host in tissues other than the stomach may also 
influence H. pylori infection and the host response. Mice colonized in the lower bowel with 
the enterohepatic Helicobacter species H. bilis develop less severe gastric lesions compared to 
non-H. bilis-colonized mice after experimental infection with H. pylori (Lemke et al., 2009). 
Similarly, concomitant infection with several parasites, including intestinal helminths and 
systemic microfilaria, has been described to attenuate H. pylori-induced gastritis (Whary and 
Fox, 2004; Whary et al., 2005; Martin et al., 2010). These effects have mostly been ascribed 
to anti-inflammatory Th2 or Treg-polarized responses elicited by these other infectious 
agents. 
In conclusion, when performing research on gastric Helicobacter infections, one must 
be aware that other agents colonizing or infecting the host may influence Helicobacter-
elicited gastric pathology and host responses. On the other hand, interactions between gastric 
helicobacters and certain other micro-organisms may be utilized in therapeutic strategies by 
taking advantage of the beneficial effect of certain micro-organisms on gastric Helicobacter-
elicited pathology. 
 
In chapter 2, we describe the host response in 2 different mouse strains and Mongolian 
gerbils infected for up to 8 months with H. suis. A stronger inflammatory response was 
elicited in BALB/c mice, compared to C57BL/6 mice. Based on the different preferential T 
helper response in these 2 mouse strains (O’Rourke and Lee, 2003), this suggests that a more 
Th2-polarized response is associated with experimental H. suis infection. This was confirmed 
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in a recent study by our research group, describing a mixed Th17/Th2 response in BALB/c 
mice infected experimentally with H. suis, with predominant Th17 polarization (Van Deun et 
al., submitted). This contrasts with the mixed Th17/Th1 response observed in H. pylori-
infected mice (Shi et al., 2010). While Shi and coworkers (2010) and other research groups 
describe an important role for IFN-γ, a signature Th1 cytokine, in H. pylori-induced 
inflammation, we have never observed an upregulation of IFN-γ after experimental H. suis 
infection, neither in BALB/c nor in C57BL/6 mice (Van Deun et al., submitted), the latter 
nonetheless being a predominant Th1 responder (Ferrero et al., 2000). This contrasts with the 
results of Cinque et al. (2006), who described a central role for IFN-γ-induced inflammation 
after experimental inoculation of mice with a pig gastric mucus homogenate, containing H. 
suis bacteria. Other micro-organisms present in this homogenate may, however, have skewed 
the host reponse.  
The development of low-grade B cell MALT lymphoma has been associated with a 
Th2 response, rather than with a Th1-predominant response (Greiner et al., 1997; Knörr et al., 
1999). In Th2 responding BALB/c mice, we indeed observed an increased infiltration of the 
gastric mucosa with B lymphocytes, although no B cell MALT lymphoma-like lesions were 
observed. This type of lesions was, however, present in Mongolian gerbils infected for 8 
months with H. suis. The study of Helicobacter-related gastric pathology in hundreds of 
thousands of humans has revealed that the chance of developing gastric MALT lymphoma is 
higher in humans infected with NHPH, compared to H. pylori (Stolte et al., 1997; Stolte et al., 
2002), underlining the suitability of the Mongolian gerbil model for investigating H. suis-
related gastric pathology in humans.  
The suitability of the Mongolian gerbil model for modelling the pathology elicited by 
H. suis in humans, is further evidenced by the striking differences between H. suis 
colonization and inflammation observed in this animal species, compared to both mouse 
models described in chapter 2. Indeed, in gerbils, H. suis colonization and the associated 
inflammation were observed predominantly in the antrum and in only a very narrow zone at 
the transition zone between forestomach and stomach, whereas H. suis colonizes the entire 
stomach in mice and elicits inflammation mainly in the fundus in this latter animal species. In 
humans infected with non-H. pylori helicobacters, including H. suis, a chronic active gastritis 
is observed predominantly in the antrum and this correlates well with the colonization pattern 
of the bacteria, which can not be detected in the fundus (corpus) of the majority of these 
patients (Heilmann and Borchard, 1991; Debongnie et al., 1995; Stolte et al., 1997). Possibly, 
these differences could be explained by the absence of the cag pathogenicity island in H. suis 
  
175
 General Discussion   
and other non-H. pylori helicobacters (Vermoote et al., 2011 and unpublished results). Indeed, 
experimental infection studies in gerbils with wild-type and mutant ∆cagA and ∆cagY H. 
pylori strains have revealed that all strains elicit a strong inflammation and increased 
epithelial cell proliferation in the antrum, whereas severe inflammation, huge lymphoid 
aggregates, parietal cell atrophy, increased proliferation and mucous gland metaplasia in the 
corpus are mainly observed in WT-infected animals (Rieder et al., 2005; Wiedemann et al., 
2009). The latter cagPAI-dependent lesions correlate with bacterial colonization levels.  
 
As discussed in the general introduction of this thesis, H. pylori induces gastric 
epithelial cell death through the intervention of various virulence factors. Cell death plays an 
important role in the development of several gastric pathologies, including gastric ulceration, 
gastric atrophy and gastric cancer (Shirin and Moss, 1998; Dixon, 2001). Our in vivo studies 
have shown that H. suis is also capable of causing gastric epithelial cell death. Different types 
of cell death can occur in eukaryotes, of which apoptosis seems to be the most important type 
associated with H. pylori infection. In our study, however, no increased apoptosis could be 
detected. Although a basal apoptotic ratio was detected in both uninfected and infected mice 
and Mongolian gerbils, an increase of the apoptotic ratio was possibly missed, since active 
caspase-3 positive cells were often visualized dissociated from the surrounding tissue. It is 
indeed well-known that tight and adherens junctions are destroyed during apoptosis, leading 
to cell extrusion, already early in apoptosis (Rosenblatt et al., 2001; Bojarski et al., 2004; 
Kessler and Müller, 2009). Thus, a substantial fraction of apoptotic gastric epithelial cells 
must be carried along by the mucus and the peristaltic movement, making their detection in 
situ impossible.  
The lack of an increased apoptotic ratio was confirmed by ultrastructural analysis, 
revealing that H. suis bacteria are seldom associated with apoptosis of gastric epithelial cells, 
whereas they are often surrounded by debris of necrotic parietal cells. Immunohistochemical 
staining confirmed the loss of parietal cells, mainly at the transition zone between fundus and 
antrum. Because this cell type is highly specialized and extremely difficult to maintain in 
vitro, we investigated the possible direct effect of H. suis on gastric epithelial cell death in 
AGS cells, derived from a human gastric adenocarcinoma. In chapter 4, we identified H. suis 
γ-glutamyl transpeptidase as an important virulence factor involved in the induction of gastric 
epithelial cell death. We showed that this enzyme catalyzes the degradation of extracellular 
glutathione. The resulting degradation products actively cause a cell-independent extracellular 
generation of H2O2, leading to lipid peroxidation ahead of final necrosis. Increased 
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concentrations of ROS indeed often lead to necrosis (Fiers et al., 1999; Duprez et al., 2009; 
Kroemer et al., 2009). In our study, increased extracellular ROS may have induced necrosis 
by inflicting direct and uncontrolled damage to the cellular structures, including the plasma 
membrane. Alternatively, a strictly controlled and regulated form of necrosis (Vandenabeele 
et al., 2010) may be responsible for the observed effect. For instance, the generation of 
extracellular ROS could lead to a sustained c-Jun N-terminal kinase (JNK) activation, leading 
to necrotic cell death (Kim et al., 2007; Vanden Berghe et al., 2007). 
Secretion of hydrochloric acid is the main function of gastric parietal cells. The 
hydrogen/potassium ATPase, present in the membrane of these cells, is sentenced to pumping 
acid against a huge gradient, which requires large amounts of ATP (Forte and Zhu, 2010). 
This important cellular fuel is generated mainly in mitochondria (Brookes et al., 2004), which 
are indeed abundant in parietal cells. Abundant mitochondrial respiration, however, is also an 
important source of intracellular ROS (Poyton et al., 2009). The substantial generation of 
intracellular ROS in parietal cells could thus make them more susceptible to damage inflicted 
by exogenous ROS, for instance through the activity of H. suis GGT. Excessive ROS are 
generally scavenged by several antioxidants, including reduced glutathione. Higher 
concentrations of intracellular glutathione are present in gastric mucosa, compared to other 
tissues (Body et al., 1979; Mårtensson et al., 1990). Together with high concentrations of 
glutathione in certain foods, this provides a large amount of substrate for the GGT of gastric 
helicobacters (Figure 1). As a consequence, GGT-mediated degradation of large amounts of 
extracellular glutathione and subsequent oxidative damaging of cells could thus very well be a 
mechanism unique to gastric helicobacters. Finally, the massive degradation of glutatione in 
the gastric lumen by H. suis GGT may lead to a depletion of extracellular glutathione in the 
lumen of the small intestine. This may have an impact on intestinal epithelial cells, which also 
depend on glutathione for maintaining their health (Mårtensson, 1990) (Figure 1). 
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Figure 1. Summary of the proposed roles of H. suis GGT in the bacterial metabolism and their possible effects 
on the gastric and small intestinal epithelium. ALA, alanine; ASP, aspartate; α-KG, α-ketoglutarate; Cys, 
cysteine; CysGly, cysteinyl glycine; Gln, glutamine; GLS, glutaminase; Glu, glutamate; Gly, glycine; GSH, 
reduced glutathione; HsGGT, H. suis γ-glutamyl transpeptidase; OAA, oxaloacetate; PYR, pyruvate; ROS, 
reactive oxygen species; TCA, tricarboxylic acid. 
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GGT-mediated hydrolysis (as opposed to its transpeptidase activity) of glutathione 
results in the transfer of the γ-glutamyl moiety to water with formation of glutamate (Meister 
and Anderson, 1983; Shibayama et al., 2007) (Figure 2). Similar to H. pylori, H. suis GGT 
also catalyzes the deamidation of glutamine to glutamate, with formation of ammonia as a by-
product (Flahou et al., unpublished results; Shibayama et al., 2007; Leduc et al., 2010) (Figure 
2).  
 
Figure 2. Actions of GGT on glutathione and glutamine. 
Shown are GGT-mediated transpeptidation and hydrolysis of glutathione and GGT-mediated deamidation of 
glutamine. 
 
In addition, unpublished results of a recent metabolic profiling study of in vitro grown H. suis 
show a strong depletion of several amino acids in culture medium during H. suis culture, 
including aspartate, asparagine and cysteine. For glutamine (Gln), however, the levels even 
dropped below the limit of detection and genome analysis of H. suis has revealed the presence 
of several genes involved in the translocation of glutamine across bacterial membranes, 
revealing an important role for glutamine metabolization by this bacterium (Nohno et al., 
1986; Vermoote et al., 2011). For H. pylori, glutathione or glutamine-derived glutamate (Glu) 
is transported to the bacterial cytoplasm by a sole Glu transporter (HP-GltS), also present in 
the H. suis genome (Vermoote et al., 2011). A fraction can directly be used for glutamine 
synthesis, involving glutamine synthetase, which is also present in the H. suis genome 
(Shibayama et al., 2007; Leduc et al., 2010; Vermoote et al., 2011). More importantly, the 
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presence of a gene encoding a glutamate dehydrogenase in the H. suis genome suggests that 
the bacterium can channel glutamate to the energy-providing tricarboxylic acid (TCA or 
Krebs) cycle, by conversion to α-ketoglutarate (Schilling et al., 2002) (Figure 1). Energy may 
also be provided through several other amino acids and lactate, which are also depleted in the 
medium during H. suis cultivation. Indeed, pyruvate can be generated from several amino 
acids through the activity of enzymes such as alanine dehydrogenase and from lactate through 
D-lactate dehydrogenase activity. Both enzymes are present in H. suis and the latter suggests 
possible cross-feeding by lactate-producing bacteria in the stomach. Most likely, H. suis can 
not utilize glucose through glycolysis, as several enzymes, including glucokinase, involved in 
this process appear to be missing. The H. suis genome also lacks most components of the 
Entner-Doudoroff pathway, which is an alternative pathway for converting glucose to 
pyruvate, a main supplier of energy through the TCA cycle (Schilling et al., 2002). In H. 
pylori, the ability of the organism to extract energy from hexoses such as glucose also seems 
impaired (Schilling et al., 2002), although the bacterium has been shown to utilize D-glucose 
(Mendz et al., 1993). In conclusion, all available data indicate that, as in H. pylori (Stark et 
al., 1997; Schilling et al., 2002) or even more so, glucose metabolism is not an important 
source of energy for H. suis, whereas metabolites as lactate and several amino acids, including 
glutamine, are fed into the central bacterial metabolism through conversion to pyruvate or α-
ketoglutarate. 
As mentioned above, H. suis GGT has, besides glutathione, another important 
substrate, L-glutamine, in this way directly competing with epithelial cells for this amino acid 
(Figure 1). Interestingly, dietary glutamine supplementation attenuates H. pylori-induced 
gastric pathology, both in mice and gerbils (Hagen et al., 2009; Amagase et al., 2010). In the 
latter animal species, glutamine supplementation inhibits intracellular accumulation of toxic 
ammonia, possibly due to metabolization of ammonia to urea through glutamine-stimulated 
arginase activity (Nakamura and Hagen, 2002; Amagase et al., 2010). Also in the intestine, 
glutamine plays an important cell-protective role. In malnourished rats, glutamine can restore 
the gut intracellular glutathione stores and villus heights (Belmonte et al., 2007). This is not 
surprising, as L-glutamate, derived from L-glutamine in mitochondria through glutaminase, is 
a precursor for glutathione synthesis (Blachier et al., 2009) (Figure 1). In addition, glutamine 
supplementation in rats has been shown to induce an upregulation of several gut mucosal 
enzymes involved in glutathione synthesis and antioxidant activity, including glutaminase, 
membrane-bound γ-glutamyl transpeptidase, γ-glutamylcysteine synthetase and glutathione 
peroxidase (Kaufmann et al., 2008; Kul et al., 2009). Finally, glutamine starvation of cells in 
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vitro induces a reduced expression of protective Hsp70, through a reduced half-life of Hsp70 
mRNA (Roth, 2008).   
Besides this protective effect, glutamine also plays an essential role in the metabolism 
of gastrointestinal epithelial cells. It has been suggested that glutamine dependence is higher 
for intestinal epithelial cells compared to gastric epithelial cells (Madej et al., 1999). 
Intracellularly, glutamine can be converted to glutamate, which is, in the presence of 
oxaloacetate, converted to aspartate and α-ketoglutarate, which can be channeled into the 
Krebs cycle (Blachier et al., 2009) (Figure 1). Partial oxidation of glutamine to aspartate 
results in the fast delivery of 9 moles of ATP (Aledo, 2004). In pigs, glutamine was shown to 
be the only amino acid, out of about 17 dietary amino acids tested, to have a negative net 
portal balance, indicating a net uptake by portal-drained viscera (Stoll et al., 1997). When pigs 
grow older, an increase of glutamate dehydrogenase and alanine aminotransferase is observed 
in the epithelium of the small intestine, indicating that glutamine metabolism becomes more 
important with increasing age (Madej et al., 1999). Both delivered from the intestinal lumen 
as well as arterial blood, it is considered a major fuel for rapidly proliferating cells, including 
enterocytes, lymphocytes and macrophages (Windmueller and Spaeth, 1980; Wu, 2009). 
Together with other amino acids, including glutamate and aspartate, it is considered a more 
important fuel for enterocytes, compared to glucose (Windmueller and Spaeth, 1980). 
Depletion of this enterocyte fuel by H. suis GGT may thus result in an impaired intestinal 
function, for instance leading to a decreased weight gain, as observed in H. suis-infected pigs 
(Kumar et al., 2010). Finally, it has also been shown that glutamine plays an important role in 
the energy supply and anti-inflammatory functions of various cell types of the immune 
system, for instance proliferation and IFN-γ secretion of T cells (Newsholme et al., 1999; 
Roth, 2008). 
All these data, summarized in figure 1, reveal an essential role for glutamine in 
maintaining gastrointestinal health. The fact that gastric helicobacters, including H. suis, are 
ruthless adversaries of epithelial cells when it comes down to incorporating glutamine 
suggests that glutamine deprivation by GGT activity may also play a significant role in 
Helicobacter-related gastric pathology.  
 
Keeping in mind the adverse effects of H. suis GGT, it may be a good approach to 
target the enzyme by vaccination with the available recombinant H. suis GGT. In this way, 
potential, if any, undesirable side-effects linked to whole-cell protein vaccination could be 
eliminated and detrimental H. suis GGT enzymatic activity on extracellular glutathione and 
  
181
 General Discussion   
glutamine can be targeted. For H. pylori, the use of GGT as vaccine antigen has indeed 
proven to be successful (Anderl et al., 2010). Since H. pylori GGT is a secreted protein, 
specific T cells induced by a GGT-based subunit vaccine probably lack the capability of 
targeting the pathogen. To overcome this, mucosal immunization was done with H. pylori 
GGT, in combination with several outer membrane proteins (Anderl et al., 2010). This 
immunization strategy induced a strong antibody response to the GGT, blocking its enzymatic 
activity. Besides inducing gastric epithelial cell death, the H. pylori GGT has also been shown 
to cause inhibition of T cell proliferation (Schmees et al., 2007). As a consequence, mucosal 
immunization with H. pylori GGT results in neutralization of its immunosuppressive effect 
and subsequent recovery of the full proliferative capacity of T cells upon vaccination with a 
second antigen (Anderl et al., 2010). Careful examination of the H. suis genome may reveal 
possible additional candidate antigens for use in subunits vaccines, containing recombinant H. 
suis GGT. 
Besides the use of subunit vaccines instead of whole bacterial cell lysate for H. suis 
vaccination, as described in chapter 3, other vaccine formulations can be considered. A recent 
study has revealed that subcutaneous vaccination with H. suis lysate and complete Freund’s 
adjuvant against subsequent H. suis challenge induces a similar (>150-fold) reduction of 
colonization compared to intranasal H. suis lysate+CT vaccination (Van Deun et al., 
unpublished results). In contrast, the prophylactic subcutaneous vaccination with H. suis 
lysate and a saponin-based adjuvant described in chapter 3, induced a less protective effect 
compared to intranasal H. suis lysate+CT vaccination, underlining the importance of chosing 
not only the right antigen and route of administration, but also the right adjuvant. 
 
In conclusion, the results described in this thesis clearly demonstrate that H. suis 
causes severe inflammation in rodent models of human gastric disease. The Mongolian gerbil 
model is particularly suitable for modelling H. suis-induced pathology. However, when 
performing in vivo studies, attention should be paid to the fact that other agents can influence 
Helicobacter-elicited gastric pathology.  
Besides lesions related to the influx of various inflammatory cells, H. suis infection 
was also shown to cause necrosis of gastric parietal cells. In vitro, H. suis induces both 
apoptosis and necrosis of human gastric epithelial cells. Other possible cell death-inducing 
factors remain to be elucidated, for instance through the generation of random mutants by 
transposon shuttle mutagenesis (Odenbreit et al., 1996 and 1999). As for the induction of 
gastric epithelial cell necrosis, the H. suis γ-glutamyl transpeptidase was shown to play an 
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essential role, through the degradation of glutathione and subsequent oxidative damaging of 
cell components. Future experimental infection studies with dietary glutamine or glutathione 
supplementation  and/or experimental infection with a mutant H. suis strain lacking GGT will 
further unravel the complex interplay between glutamine, glutathione, H. suis and its host.  
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Already in the early days of Helicobacter research, pathologists identified patients 
where they did not find the typical comma-shaped Helicobacter (H.) pylori organisms in their 
histological sections, but rather large non-H. pylori helicobacters with a typical spiral-shaped 
morphology. In literature, these bacteria are often referred to as “Helicobacter heilmannii”. 
Recent investigations, however, have revealed that this group of non-H. pylori helicobacters 
comprises different species which have been detected in the stomach of different animal 
species. Therefore, at present, the name “H. heilmannii“ should be reserved to the species as 
described by Smet and coworkers (published in International Journal of Systematic and 
Evolutionary Microbiology). The most common gastric non-H. pylori Helicobacter species in 
humans is Helicobacter suis, naturally occurring in the stomach of the majority of pigs 
worldwide. Hitherto, the virulence mechanisms of H. suis were largely unknown, in part due 
to the very fastidious nature of this bacterium. Whole-genome screening of H. suis revealed 
that it lacks some typical virulence factors of H. pylori, such as the cag pathogenicity island 
and the vacuolating cytotoxin.  
Our research group was the first to successfully isolate H. suis in vitro in 2008. Taking 
advantage of this essential step forward, the general aim of this thesis was to obtain better 
insights into the pathogenesis of human gastric diseases associated with a H. suis infection 
and to develop possible strategies to control this infection.  
 
In chapter one, we describe the first successful colonization of Mongolian gerbils with 
a pure culture of in vitro grown H. suis. This animal model is considered very suitable for 
investigation of Helicobacter-related gastric pathology. However, a preliminary screening of 
a gerbil population intended for use in Helicobacter suis infection studies revealed a natural 
yeast infection in the stomach of these animals in exactly the same regions as described for 
gastric helicobacters, including H. pylori and H. felis. Identification was done by Internally 
Transcribed rRNA Spacer 2 Region (ITS2) PCR fragment length analysis and revealed it to 
be Kazachstania heterogenica, previously isolated from rodent faeces. To investigate a 
possible pathologic role of K. heterogenica, Mongolian gerbils were infected experimentally 
with this yeast. In all inoculated animals, high colonization densities were observed, mainly in 
the antrum, and few pathologic changes were seen in the stomach of infected animals. Next, 
gerbils free of K. heterogenica and gastric helicobacters were infected with H. suis, or K. 
heterogenica, or both, to investigate possible interactions between both micro-organisms. 
Dual infection resulted in a significant increase of inflammation compared to animals infected 
with Helicobacter suis alone, indicating a synergism between both agents. These results 
 192 
 
 Summary 
highlight the importance of considering the possible interference of other micro-organisms in 
experimental gastric Helicobacter infection studies. 
 
The second study deals with the interactions between H. suis and the gastric mucosa of 
the host. Therefore, long-term experimental H. suis infections were studied in the Mongolian 
gerbil model, as well as in two mouse models (BALB/c and C57BL/6 mice). Female six-
week-old animals, free of K. heterogenica and gastric helicobacters, were inoculated with 
pure in vitro grown H. suis (strain 5) and sacrificed at 3 weeks, 9 weeks and 8 months after 
infection. Gastric tissue samples were collected for PCR analysis, histological and 
ultrastructural examination. In gerbils, bacteria mainly colonized the antrum and a narrow 
zone in the fundus near the forestomach/stomach transition zone. In both mice strains, 
bacteria colonized the entire glandular stomach. Transmission electron microscopy revealed 
an association between H. suis colonization and necrosis of parietal cells in all three animal 
strains. Immunohistochemical staining of the hydrogen/potassium ATPase present on the 
parietal cell membrane showed that parietal cell loss was most pronounced at the transition 
zone between fundus and antrum. From 9 weeks after infection onwards, an increased 
proliferation rate of mucosal epithelial cells was detected in the stomach regions colonized 
with H. suis, as shown by counting of Ki67-positive cells.  
At all timepoints, all uninfected control animals showed normal histomorphology and 
no inflammation. In general, H. suis-infected BALB/c mice showed a stronger diffuse 
inflammation and more abundant inflammatory cell aggregates and lymphoid follicles, 
compared to C57BL/6 mice. In both mice strains, inflammation was mostly limited to the 
fundus. At 8 months post infection, a higher number of B cells was detected only in the 
fundus of BALB/c mice. These data suggest that, in contrast to a H. pylori infection, H. suis 
infection is mainly associated with a Th2 response.  
Most infected gerbils showed a marked lymphocytic infiltration in the antrum and in 
the forestomach/stomach transition zone. Diffuse infiltration as well as the presence of large 
lymphoid aggregates became worse in the course of time. This was accompanied by 
destruction of the gastric glands and disruption of the lamina muscularis mucosae. From 9 
weeks after infection onwards, lymphocytic aggregates contained a majority of CD20-positive 
B cells, mostly organized in germinal center-presenting lymphoid follicles. In gerbils infected 
for 8 months, these germinal centers were often large, hyperproliferative and irregular. 
Additionally, severe destruction of the normal antral architecture at the inflamed sites and 
development of mucosa-associated lymphoid tissue (MALT) lymphoma-like lesions, such as 
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lymphoepithelial lesions and infiltration of the tunica muscularis, were observed in some 
gerbils. The location and the induced pathology, including gastric MALT lymphoma, 
resemble those observed in humans infected with non-H. pylori helicobacters. In conclusion, 
these findings suggest that the possible involvement of H. suis in human gastric disease 
should not be neglected. Compared to mice, H. suis-induced gastric pathology in Mongolian 
gerbils more closely resembles the human situation, indicating that this model may be more 
suitable for studying H. suis-host interactions.  
 
Prevention and eradication of gastric Helicobacter infection are two very important 
steps to drastically reduce the number of people suffering from gastric disease. Therefore, in 
the third study, in vitro grown H. suis was used to vaccinate mice, in a first attempt to 
evaluate the protective effect of the in vitro cultured organisms. BALB/c mice were 
immunized intranasally or subcutaneously with whole bacterial cell lysate of H. suis or the 
closely related species H. bizzozeronii and H. cynogastricus, adjuvanted with cholera toxin or 
a saponin-based adjuvant, respectively. Four weeks after the last immunization, mice were 
challenged with H. suis. Control groups consisted of non-immunized/non-challenged mice 
(negative control group), as well as of sham-immunized mice that were inoculated with H. 
suis (positive control group). Animals were sacrificed 7 weeks after challenge. In all 
immunized groups, higher serum anti-H. suis IgG titers were observed, compared to both the 
non-immunized/non-challenged and the sham-immunized/challenged control groups. The 
highest titers were observed after subcutaneous vaccination with H. suis antigens. Urease tests 
on stomach tissue samples at 7 weeks after challenge infection were negative in all negative 
control mice and all intranasally immunized mice except one. In all and 3 out of 5 animals of 
the H. cynogastricus and H. suis subcutaneously immunized groups, respectively, urease 
activity values were below the cut-off value. Using a sensitive H. suis-specific PCR, H. suis 
DNA was detected in both the fundus and the antrum of all positive control animals and all 
subcutaneously immunized/challenged animals. All negative control animals and some 
intranasally immunized/challenged mice were PCR-negative in both stomach regions. In 
addition, most H. suis-positive animals in the intranasally immunized groups were PCR-
positive in only one of both stomach regions. In conclusion, immunization using antigens 
derived from the same or closely related bacterial species suppress gastric colonization with 
H. suis, but complete protection was only achieved in a minority of animals following 
intranasal immunization. 
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The results of this vaccination study were promising. The ultimate goal, however, 
being full protection in all vaccinated animals, the above mentioned vaccinal approach is 
insufficient. Further progress requires a better understanding of pathogenesis and virulence 
mechanisms. Regarding the pathogenesis, cell death plays an important role in the 
development of several Helicobacter-associated gastric pathologies, including gastritis, 
gastric ulceration, gastric atrophy and gastric cancer. In the second study, necrosis of gastric 
epithelial cells was observed in H. suis infected mice and gerbils. Therefore, in a fourth study, 
we investigated the possible direct effect of H. suis on gastric epithelial cell death, using 
human-derived AGS cells. Fluorescence microscopic and flow cytometric analysis revealed 
that H. suis lysate induces both apoptosis and necrosis. Inhibition of γ-glutamyl transpeptidase 
(GGT) activity, present in H. suis lysate, and incubation of AGS cells with purified 
recombinant H. suis GGT showed that this enzyme was largely responsible for the observed 
caspase-3-independent cell death. Ultrastructural analysis confirmed that H. suis GGT-treated 
cells show morphological signs of primary necrosis. Supplementation of recombinant H. suis 
GGT-treated cells with glutathione, a strong antioxidant under physiological conditions, 
strongly enhanced the observed induction of cell death. In addition, we showed that H. suis 
GGT catalyzes the degradation of glutathione. These data demonstrate that H. suis GGT-
mediated degradation of glutathione and the resulting formation of glutathione degradation 
products play a direct and active role in the induction of gastric epithelial cell death. Prior to 
cell death, an increase of the extracellular H2O2 concentration, generated in a cell-independent 
manner by glutathione degradation products, was observed and resulted in lipid peroxidation. 
The possible involvement of mitochondrial respiration in the generation of oxidative damage 
was excluded by determining the mitochondrial membrane potential. To our knowledge, this 
is the first detailed description of a gastric pathogen exploiting an important antioxidant in 
this way to actively cause damage in the stomach. 
 
In conclusion, the results described in this thesis clearly demonstrate that a pure in 
vitro culture of H. suis causes severe gastric pathology in rodent models of human gastric 
disease. In vitro, H. suis γ-glutamyl transpeptidase activity was shown to play an important 
role in the induction of gastric epithelial cell death. A first attempt to evaluate the protective 
effect of antigen preparations of in vitro cultured H. suis showed that vaccination may be a 
valuable approach to contol H. suis infections and related gastric pathology in pigs and 
humans.
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Al vroeg in de jaren tachtig werd duidelijk dat de overgrote meerderheid van de 
maagklachten bij de mens veroorzaakt wordt door een bacterie, Helicobacter pylori. In een 
minderheid van de gevallen van mensen met maagklachten echter, kon niet deze bacterie 
gedetecteerd worden, maar wel grote niet-H. pylori helicobacters met een typische 
spiraalvorm. In de wetenschappelijke literatuur werden deze bacteriën vaak “Helicobacter 
heilmannii” genoemd. Recent onderzoek heeft echter aangetoond dat het in werkelijkheid gaat 
over een groep van verschillende niet-H. pylori Helicobacter soorten die vaak ook 
aangetroffen worden in de maag bij verschillende diersoorten. Bijgevolg wordt, om 
verwarring te vermijden, de benaming “H. heilmannii” best enkel gebruikt voor de soort die 
heel recent officieel is erkend en beschreven werd door Smet en collega’s (manuscript 
gepubliceerd in International Journal of Systematic and Evolutionary Microbiology). De 
vaakst voorkomende niet-H. pylori Helicobacter in de maag van mensen met maagklachten is 
H. suis, een bacterie die wereldwijd van nature vaak voorkomt in de maag van varkens. Tot 
op vandaag waren de virulentiemechanismen van H. suis zo goed als ongekend, onder andere 
door het feit dat deze bacterie bijzonder moeilijk te kweken is onder 
laboratoriumomstandigheden. Screening van de volledige genoomsequentie van H. suis heeft 
aan het licht gebracht dat de bacterie enkele typische virulentiefactoren mist die wel bij H. 
pylori voorkomen, zoals bijvoorbeeld het cag pathogeniciteitseiland en het toxine 
verantwoordelijk voor celvacuolisatie (VacA). 
H. suis werd in 2008 voor het eerst in vitro geïsoleerd, aan onze vakgroep. Deze 
essentiële sprong voorwaarts heeft ons in staat gesteld om onderzoek te verrichten naar de 
pathogenese van H. suis-gerelateerde maagziekten en mogelijke strategieën om deze infecties 
onder controle te krijgen bij de mens en bij het varken. 
 
In hoofdstuk 1 beschrijven we voor het eerst de succesvolle kolonisatie van de maag 
van Mongoolse gerbils met een zuivere in vitro cultuur van H. suis. Deze diersoort wordt 
beschouwd als een geschikt model om onderzoek te doen naar Helicobacter-gerelateerde 
maagpathologieën. Een steekproef in een gerbilpopulatie die gebruikt zou worden in 
experimentele Helicobacter suis infectieproeven, bracht echter aan het licht dat deze dieren 
van nature in de maag geïnfecteerd waren met een gist. Het kolonisatiepatroon van dit micro-
organisme leunde erg dicht aan bij hetgeen beschreven wordt voor gastrale helicobacters, 
zoals H. pylori en H. felis. Internally Transcribed rRNA Spacer 2 Region (ITS) PCR fragment 
analyse toonde aan dat het hier Kazachstania heterogenica betrof, een gist die voorheen reeds 
uit de faeces van knaagdieren geïsoleerd was. Om na te gaan of K. heterogenica een rol speelt 
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in het ontstaan van maagpathologieën, werden Mongoolse gerbils experimenteel geïnfecteerd 
met deze gist. In elk van de dieren geïnoculeerd met K. heterogenica werd een uitgesproken 
kolonisatie waargenomen, voornamelijk in het antrum. Bovendien werden geen 
noemenswaardige pathologische veranderingen gezien in de maag van geïnfecteerde dieren. 
Vervolgens werden K. heterogenica- en gastrale Helicobacter-vrije gerbils geïnfecteerd met 
H. suis, K. heterogenica of beide, om een mogelijke interactie tussen deze micro-organismen 
na te gaan. Infectie met H. suis en K. heterogenica resulteerde in een significante toename van 
de ontstekingsreactie, in vergelijking met dieren die enkel met H. suis geïnfecteerd waren, wat 
wijst op een synergie tussen beide infectieuze agentia. Deze resultaten tonen het belang aan 
van rekening te houden met een mogelijke interferentie van andere micro-organismen in 
experimentele in vivo studies met gastrale helicobacters. 
 
In een tweede langetermijnstudie werd de interactie tussen H. suis en de maagmucosa 
van de gastheer onderzocht. Hiervoor werden Mongoolse gerbils en twee muizenstammen 
(BALB/c en C57BL/6) experimenteel geïnfecteerd met H. suis. Vrouwelijke dieren van 6 
weken oud en vrij van K. heterogenica en van gastrale helicobacters werden geïnoculeerd met 
een zuivere in vitro cultuur van H. suis stam 5 en vervolgens geëuthanaseerd na een 
infectieduur van 3 weken, 9 weken of 8 maanden. Maagstalen werden verzameld voor PCR 
analyse, histologisch en ultrastructureel onderzoek. In gerbils werd H. suis kolonisatie vooral 
waargenomen in het antrum en een heel smalle zone in de fundus, nabij de overgang tussen de 
voormaag en de klierzone van de maag. In beide muizenstammen daarentegen werd een 
duidelijke kolonisatie gezien in het volledige kliergedeelte van de maag (fundus én antrum). 
Transmissie elektronen microscopisch onderzoek toonde een verband aan tussen H. suis 
kolonisatie en necrose van pariëtale cellen in elk van de drie dierstammen. 
Immunohistochemische kleuring van de protonpomp (waterstof/kalium ATPase), aanwezig op 
de buitenste membraan van pariëtale cellen, bracht aan het licht dat het verlies van deze cellen 
het meest uitgesproken was ter hoogte van de overgangszone tussen fundus en antrum. Vanaf 
9 weken na infectie werd een toename gezien van de proliferatie van mucosale epitheliale 
cellen in de regio’s met de meest uitgesproken H. suis kolonisatie. 
Op elk tijdstip werd in de ongeïnfecteerde controledieren een normaal uitziende 
maagmucosa waargenomen, zonder noemenswaardige influx van ontstekingscellen. Globaal 
gezien was de diffuse inflammatie, de aanwezigheid van ontstekingscelaggregaten en 
lymfoïde follikels meer uitgesproken in BALB/c muizen, in vergelijking met C57BL/6 
muizen. In beide muizenlijnen was de inflammatie voornamelijk zichtbaar in lamina propria 
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mucosae en tunica submucosa van de fundus regio. Acht maanden na experimentele infectie 
kon een toename van het aantal B lymfocyten waargenomen worden, maar enkel in BALB/c 
muizen. Deze resultaten doen vermoeden dat H. suis voornamelijk een Th2 respons genereert, 
in tegenstelling tot H. pylori. 
In de overgrote meerderheid van de experimenteel geïnfecteerde gerbils was een 
uitgesproken infiltratie met lymfocyten aanwezig in het antrum en ter hoogte van de 
overgangszone tussen voormaag en maag. Een toename van zowel diffuse infiltratie als 
aggregaten van lymfoïde cellen was merkbaar naarmate de dieren langer geïnfecteerd waren. 
Daarnaast kon ook destructie van de maagklieren en onderbreken van de continuïteit van de 
lamina muscularis mucosae waargenomen worden. Vanaf 9 weken na infectie namen CD20-
positieve B cellen de bovenhand in de lymfocytaire aggregaten. Dit ging gepaard met 
organisatie tot lymfoïde follikels met duidelijke germinale centra die vaak erg groot, 
hyperproliferatief en onregelmatig van vorm waren. Bovendien was de normale 
weefselstructuur  ter hoogte van de ontstekingsreactie in het antrum vaak niet meer aanwezig 
en konden ook letsels waaargenomen worden die een sterke gelijkenis vertoonden met 
lymfoom van het mucosa-geassocieerd lymfoïd weefsel (MALT). Voorbeelden daarvan zijn 
lymfo-epitheliale letsels en massale lymfocytaire infiltratie van de tunica muscularis. De 
locatie en de aard van de veroorzaakte pathologieën, met inbegrip van MALT lymfoom, 
vertonen een sterke gelijkenis met hetgeen gezien wordt bij mensen geïnfecteerd met een niet-
H. pylori Helicobacter species.  
We kunnen dus concluderen dat de rol van H. suis in het ontstaan van humane 
maagpathologieën niet over het hoofd gezien mag worden. Bovendien vertoont de pathologie 
veroorzaakt door H. suis in Mongoolse gerbils meer gelijkenissen met de situatie bij de mens, 
wat aangeeft dat dit diermodel geschikter is dan het muismodel om de interactie tussen H. suis 
en de gastheer te onderzoeken. 
 
In de strijd tegen chronische infectieuze gastritis, peptische ulcera en MALT lymfoom 
in de maag van de mens, zijn preventie en eradicatie van gastrale Helicobacter infecties twee 
erg belangrijke stappen. Daarom werd, in een derde studie, een in vitro cultuur van H. suis 
gebruikt om muizen te vaccineren, in een poging om voor de eerste maal het beschermende 
effect van een zuivere H. suis cultuur na te gaan. BALB/c muizen werden intranasaal of 
subcutaan gevaccineerd met een lysaat van H. suis of de nauw verwante soorten H. 
bizzozeronii of H. cynogastricus. Respectievelijk cholera toxine of een saponine-gebaseerd 
adjuvans werden aan het vaccin toegevoegd voor intranasale of subcutane vaccinatie. Vier 
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weken na de laatste immunisatie werden de muizen intragastraal geïnoculeerd met H. suis. 
Niet-geïmmuniseerde/niet-geïnoculeerde muizen werden als negatieve controles ingesloten en 
muizen geïnoculeerd met H. suis na voorafgaande intranasale applicatie van een 
zoutoplossing in plaats van vaccinatie met antigenen, werden als positieve controledieren 
ingesloten. Zeven weken na inoculatie met H. suis werden de dieren geëuthanaseerd. In alle 
geïmmuniseerde groepen werden hogere serum anti-H. suis IgG antilichaam titers 
waargenomen, in vergelijking met beide controlegroepen. De hoogste titers werden 
gedetecteerd in het serum van muizen die subcutaan gevaccineerd waren met H. suis 
antigenen. Bij geen enkel dier uit de negatieve controlegroep en bij slechts één intranasaal 
geïmmuniseerd dier, werd urease activiteit gedetecteerd in de maag. Ook in de maag van 
respectievelijk alle en drie van de vijf met H. cynogastricus of H. suis subcutaan 
gevaccineerde dieren, werd geen moemenswaardige urease activiteit vastgesteld. Met behulp 
van een H. suis-specifieke PCR kon zowel in de fundus als in het antrum van alle positieve 
controledieren en alle subcutaan gevaccineerde/H. suis-geïnoculeerde dieren DNA van de 
kiem aangetoond worden. Daarentegen waren alle negatieve controledieren en sommige van 
de intranasaal gevaccineerde/H. suis-geïnoculeerde dieren PCR-negatief in beide maagzones. 
Bovendien was de meerderheid van de H. suis-positieve dieren in intranasaal gevaccineerde 
groepen PCR-positief in slechts één van beide maagzones. Dit betekent dat immunisatie met 
antigen bereidingen van dezelfde of nauw verwante Helicobacter soorten de kolonisatie van 
de maag met H. suis onderdrukt. Complete bescherming kon slechts waargenomen worden bij 
een deel van de intranasaal gevaccineerde dieren. 
 
De resultaten van de zonet beschreven vaccinatiestudie zijn veelbelovend. Het ultieme 
doel is echter een volledige bescherming tegenover H. suis kolonisatie op te wekken. Vanuit 
dit standpunt bekeken, voldoet het vaccinatieprotocol beschreven in hoofdstuk 3 slechts 
gedeeltelijk. Om verdere vooruitgang op dit vlak te boeken, is een beter begrip van de 
pathogenese en virulentiemechanismen van H. suis infecties onontbeerlijk. Met betrekking tot 
de pathogenese is het duidelijk dat celdood een belangrijke rol speelt in het ontstaan van 
allerhande Helicobacter-gerelateerde maagpathologieën, zoals gastritis, maagulcers, atrofie 
van de maagmucosa en maagkanker. In de tweede studie van dit doctoraatsonderzoek hebben 
we necrose van epitheelcellen in de maag van H. suis-geïnfecteerde muizen en gerbils 
waargenomen. Daarom werd, in een vierde studie, een mogelijk directe rol van H. suis in het 
induceren van epitheliale celsterfte onderzocht, met behulp van de continue AGS cellijn, 
afkomstig uit de maag van een mens. Fluorescentiemicroscopisch en flowcytometrisch 
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onderzoek toonde aan dat H. suis lysaat zowel apoptose als necrose van AGS cellen 
veroorzaakt. Inhibitie van γ-glutamyl transpeptidase (GGT) activiteit, aanwezig in dit H. suis 
lysaat, en incubatie van AGS cellen met gepurifieerd recombinant H. suis GGT brachten aan 
het licht dat dit enzyme voornamelijk verantwoordelijk is voor de waargenomen caspase-3-
onafhankelijke celdood. Analyse van de ultrastructuur bevestigde vervolgens dat H. suis 
GGT-behandelde cellen morfologische tekenen van primaire necrose vertoonden. Toevoegen 
van glutathion, een sterk antioxidans onder fysiologische omstandigheden, aan H. suis GGT-
behandelde cellen bracht een versterking van de geïnduceerde celdood teweeg. Bovendien 
konden we aantonen dat H. suis GGT de afbraak van glutathion katalyseert en dat dit een 
directe en actieve rol speelt in het veroorzaken van primaire necrose van maagepitheelcellen. 
Vooraleer celdood optrad, kon een sterke toename van de extracellulaire H2O2 concentraties 
waargenomen worden. Deze stijging werd onafhankelijk van de gastheercel veroorzaakt door 
afbraakproducten van glutathion en resulteerde in peroxidatie van vetten aanwezig in 
verschillende structurele componenten van de gastheercel. Een mogelijke rol van 
mitochondriale respiratie in het ontstaan van oxidatieve celschade kon worden uitgesloten na 
het bepalen van de mitochondriale membraanpotentiaal. Voor zover bekend, is dit de eerste 
gedetailleerde beschrijving van een dergelijke uitbuiting van een belangrijk antioxidans door 
een micro-organisme om weefselschade te veroorzaken in de maag. 
 
Zoals blijkt, tonen de resultaten van deze doctoraatsthesis aan dat een zuivere in vitro 
cultuur van H. suis ernstige maagpathologieën kan veroorzaken in knaagdieren, die model 
kunnen staan voor de ontwikkeling van maagziekten bij de mens. In vitro werd aangetoond 
dat H. suis γ-glutamyl transpeptidase activiteit een belangrijke rol speelt in het ontstaan van 
epitheliale celdood in de maag. Een eerste poging om het beschermend effect van H. suis 
antigen bereidingen na te gaan, toonde aan dat vaccinatie potentieel een goede benadering is 
om H. suis infecties en op die manier ook de gerelateerde maagpathologieën bij mensen en 
varkens onder controle te krijgen. 
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Als pas afgestudeerd dierenarts word je door velen verondersteld in de praktijk te 
stappen. Dat de praktijk misschien toch niets voor mij was, begon me in het laatste jaar te 
dagen. Maar wat dan wel? Onderzoek, misschien…? Toen ik dus, nu meer dan 5 jaar geleden, 
kwam solliciteren bij Professor Ducatelle wist ik, eerlijk gezegd, niet goed waar ik aan begon. 
Maar toen volgde een uiteenzetting om u tegen te zeggen. Overdonderd door de 
onderdompeling in de wereld van de helicobacters, hoopte ik vurig dat ik uitgekozen zou 
worden om een antwoord te zoeken op de vele vragen. Daarom ben ik prof. Ducatelle nog 
altijd heel dankbaar voor de kans die hij mij gegeven heeft. Sinds die eerste dag, en tot nu, 
kan ik altijd terecht bij hem met vragen allerhande. Die werden ook altijd feilloos 
beantwoord. Maar ondertussen vuurde hij ook vaak nieuwe onderzoeksvragen af, die dan een 
antwoord zochten in mijn onderzoek. Het mag duidelijk zijn, de bevlogenheid en het 
enthousiasme van prof. Ducatelle werken buitengewoon aanstekelijk. Bedankt hiervoor. 
 
Na een goeie twee jaar vroeg Professor Haesebrouck me te verhuizen naar het nieuwe 
gebouw van de dienst bacteriologie. Dichter bij het laboratorium, ingeschakeld worden in de 
bacteriële diagnostiek…waarom ook niet! Al snel werd duidelijk dat hier, weliswaar op een 
heel andere manier, dezelfde bevlogenheid en interesse in het Helicobacter - en andere - 
onderzoek schuil ging. Bij prof. Haesebrouck kon ik ook altijd terecht met vragen of 
problemen. Sta me dus toe u hiervoor te bedanken, maar ook voor het grenzeloze vertrouwen 
dat u in me stelt. De vrijheid die me gegeven wordt, ligt me wel. Ik kijk ernaar uit nog 
meerdere jaren met u, prof. Ducatelle en onze almaar uitbreidende Helicobacter groep te 
mogen blijven samenwerken. 
 
Natuurlijk zou ik ook graag prof. Chiers bedanken. Vooral je kennis van en de tips 
voor het beoordelen van weefselcoupes hebben me flink op weg gezet. Ook de rust waarmee 
je problemen benadert, zullen me bijblijven. Bedankt, Koen. 
 
En ook al was prof. Frank Pasmans geen officiële promotor, ik kon er, ondanks zijn 
hectische agenda, ook altijd terecht voor nuttige discussies of goede raad. Bedankt Frank, ook 
voor de West-Vleteren die je nochtans volstrekt verdiend veroverd had. 
 
Mijn oprechte dank ook aan de leden van mijn begeleidings- en/of examencommissie: 
Prof. dr. Deprez, Prof. dr. Vandamme, Prof. dr. Daminet, Prof. dr. D’Herde en PD Dr. Rieder. 
Jullie suggesties, tips en opbouwende kritiek heb ik graag ter harte genomen. Thank you, Dr. 
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Rieder, for flying over from far Vienna to attend my PhD defense. I hope we can meet again 
in the future on some Helicobacter conference. Prof. D’Herde, ik zou u ook graag persoonlijk 
bedanken voor de bijzonder goede samenwerking. Die heeft me een heleboel informatie en 
erg mooie TEM foto’s opgeleverd.  
 
Zonder financiering natuurlijk geen onderzoek. Daarom wil ik ook graag de 
Universiteit Gent bedanken voor het toekennen van de GOA onderzoeksbeurs, die me in staat 
gesteld heeft mijn onderzoek te voeren. Ook onze farmaceutische vrienden uit Kalamazoo, 
Michigan zou ik willen bedanken voor hun geloof in het Helicobacter onderzoek. 
 
Vanuit de grond van mijn hart bedank ik ook IEDEREEN van onze vakgroep. Het 
moet gezegd, de werksfeer is meestal uitstekend bij ons! Voorlopig zijn jullie nog niet van me 
verlost, maar ik kan me voorstellen dat het erg moeilijk wordt in de toekomst een leukere 
werkplek te vinden… 
 
Met een dermate grote vakgroep is het moeilijk iedereen persoonlijk te bedanken, 
maar toch zou ik dit graag doen voor een aantal mensen. Eerst en vooral de mensen die het 
kronkelende Helicobacter pad voor me geëffend hebben. Bedankt Dominic (de pionier…), 
Prof. dr. A. Decostere, Kathleen, Margo, Ann, Manuelle, Dieter, Hilde, Liesbeth, Jurgen, 
Karolien en Nathalie. Manuelle en Ann, jullie waren leuk gezelschap de eerste jaren. En 
Manuelle, de gerbil-moeder, we gaan er binnenkort nog eens één pakken op Het Zuid! Dieter, 
ik heb je ongetwijfeld af en toe de gordijnen in gejaagd met mijn paranoïde gedrag. Maar 
weet dat ik je dankbaar ben om me op professionele wijze in te wijden in de wereld van het 
laboratorium. Hilde, mijn eerste congres in Polen was, dankzij jou, een echte meevaller. 
Gelukkig waren de zoutmijnen de moeite… 
Daarnaast heb ik in onze Helicobacter groep met een aantal mensen voor een kortere 
periode erg goed samengewerkt. Bedankt Audrey, Tom, Steven, Veerle, Ellen en Smitha. 
Audrey, je was een goede laborante en een plezier om mee samen te werken! Tom, succes 
met de varkens in je verdere carrière. 
De persoon die waarschijnlijk het meest heeft bijgedragen aan dit onderzoek, mag ik 
natuurlijk in geen geval vergeten. Sofie, bedankt voor je engelengeduld, je ongelooflijke 
werkritme en je vermogen om mijn inderhaast samengeraapte protocols vlekkeloos uit te 
voeren. Ik hoop dat we nog een hele tijd mogen samenwerken, want het klikt wel, vind je 
niet? Veel plezier met de uitbreiding van je gezin... 
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Kim, onlangs verliet je ons opnieuw om een andere droom na te jagen. Ik heb een 
eindeloze bewondering voor je gedrevenheid. Ook je (soms apart) gevoel voor humor weet ik 
wel te pruimen. Succes! 
Ondanks het vertrek van Kim, is onze Helicobacter groep de laatste tijd flink 
gegroeid. In de eerste plaats met Annemieke. Jij bent, naast een geweldige collega, mijn 
sociaal contact in het Waasland. Hopelijk mogen we nog lang bezoekjes brengen aan de 
Senba, Siniscoop en de oevers van Schelde en Durme, die er vredig en rustig bij liggen, tenzij 
Jonin het op een lopen zet. Gelukkig is Johan er, om alles in goede banen te leiden. Veel 
geluk met jullie mooie dochter. 
Miet, je bent op de goede weg om een mooi doctoraat te behalen. Succes met de 
muizen en je Italiaanse droom. Lien, je bent al goed ingeburgerd. Nog veel plezier met je 
kaasdoek, koteletten en gehakt. Ik ben zeker dat je ze wel weet te vinden, die helicobacters. 
Stéphanie, je bent onze laatste aanwinst. Hopelijk kun je het mysterie van de Helicobacter en 
de maagzweer bij het varken ontsluieren. Sophie, de groep boft met een werkpaard als jij. Hoe 
je de laatste proef tot een goed einde hebt gebracht, verdient een dikke pluim. Nathalie, na een 
tussenstop bij de Salmonella’s ben je terug bij je oude liefde (!?), Helicobacter suis. Ik ben 
ervan overtuigd dat we nog goed zullen samenwerken! And finally, last but not least, my 
Chinese friends. Jungang, the Master Cycler no longer has secrets for you! Good luck with 
your research. Guangzhi, I hope we have seen enough precipitated proteins for some years to 
come. I am sure you will find some exciting GGT results. Good luck also with the 
enlargement of your family!  
 
Geen doctoraat zonder computer. Bedankt, Koen P, om alle kleine en grotere 
problemen feilloos op te lossen. Ook je speciale gevoel voor humor en kijk op het leven 
maken je tot een aangenaam persoon. 
Voor het oplossen van administratieve problemen allerhande kon ik ook altijd terecht 
bij dezelfde Koen, Isabel De Bleeker, Jo en Gunter. Deze laatste ziet me vanuit zijn aquarium 
meestal al met enige argwaan op hem afstappen, als ik weer eens een last-minute broodje wil 
bestellen.  
De laatste jaren werd ik ook ingeschakeld in de bacteriële diagnostiek. Dankzij Filip, 
Arlette, Serge, Marleen en alle anderen van de ‘routine’ is dit altijd een aangename 
afwisseling geweest. 
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Ook de collega’s van de dienst Pluimvee lopen we geregeld tegen het lijf. En het zijn 
allemaal fijne mensen, die weten waar ze mee bezig zijn. Het is altijd leuk jullie in de gang of 
aan het koffie-apparaat te ontmoeten, Marc, An G, David en co. Bedankt ook aan Prof. dr. An 
Martel (An), Prof. dr. Katleen Hermans (Katleen), Lieve, Lieven en alle anderen voor de 
goede zorgen aan Kareltje, die dit mooie moment jammer genoeg niet meer heeft 
meegemaakt.  
Karel, toch wel onze bureau-mascotte, was er nooit gekomen zonder Venessa. Bedankt 
hiervoor, maar natuurlijk vooral ook voor de toffe babbels, etentjes en kritische kijk op het 
wetenschappelijk onderzoek. Je gedrevenheid en nieuwsgierigheid zullen je nog erg ver 
brengen, geloof me.  
 
Het verwerken van mijn (soms pietluttige) weefselstalen tot prachtige weefselcoupes 
was nooit mogelijk geweest zonder de hulp van Sarah, Christian en Delphine. Bedankt 
hiervoor! En zonder het technisch vernuft van Dominique Jacobus waren we er nooit in 
geslaagd onze mooie TEM foto’s te maken. 
Bedankt ook aan alle mensen van de pathologie, en Sara en Griet in het bijzonder, om 
me af en toe wat ‘histologische’ raad te geven. 
Mijn oprechte dank ook voor de hulp en suggesties van Prof. dr. Herman Favoreel, 
voor wie fluorescerende cellen geen geheimen kennen. Bedankt ook aan Prof. dr. Evelyne 
Meyer, Kristel en de andere mensen van de dienst Biochemie voor de goede samenwerking. 
Van diezelfde vakgroep wil ik ook Anja bedanken voor de occasionele hulp met de varkens. 
Zonder de mensen van het ‘eiwitlabo’ zou ik mijn eiwitten nooit opgezuiverd 
gekregen hebben. Bedankt, Prof. dr. Bart Devreese, Lina, Isabel en Ruben, voor de vele tips 
en professionele raad in de Ledeganckstraat. 
Dankzij de hulp van Sofie Verschueren werd het werk voor hoofdstuk 1 wat verlicht. 
Bedankt aan Dr. Thierry De Baere en Prof. dr. Luc Duachateau voor hun bijdrage aan 
mijn manuscripten. 
De interesse in ons onderzoek naar niet-H. pylori helicobacters van Prof. dr. Fazia 
Mana, Dr. Vincent Lamy, Dr. Jean-Claude Debongnie, Dr. Ann Driessen en alle andere leden 
van de Belgian Helicobacter pylori Study Group doet me bijzonder veel plezier. Hopelijk 
vallen er interessante resultaten te rapen uit onze toekomstige samenwerking! 
 
De boog kan ook niet altijd gespannen staan, natuurlijk. In het gevecht tegen de werk-
gerelateerde stress is de jaarlijkse skireis met onze toffe groep collega’s een buitengewoon 
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goede remedie. Dit jaar was ik er niet bij, dankzij dit doctoraat, maar volgend jaar hoop ik 
weer met jullie op die bergen te staan. 
Maar wat de dienst bacteriologie misschien nog het meest tot een fijne werkplek 
maakt, is de ‘roze bureau’, met zijn inhoud: Furélintje, Bretsjen Liiiman en Analex. En ja, er 
wordt al eens geroepen, gehuild, of zelfs gebr…, maar toch ben ik er zeker van dat ik nooit 
nog zo’n fijne bureaugenoten zal vinden. Elin, Bregje, Alexander, bedankt om het daar met 
mij uit te houden, en omgekeerd ook: graag gedaan. Ik hoop dat we daar toch nog een tijdje 
mogen samen blijven! 
 
Natuurlijk zou ik ook graag mijn familie en vrienden bedanken, die nu gezien hebben 
waar ik me de laatste tijd zoal mee bezig gehouden heb. Misschien hebben jullie niet 
rechtstreeks bijgedragen tot dit doctoraat, maar des te meer onrechtstreeks.  
Mama en papa, zonder de kansen die jullie me gegeven hebben, stond ik hier nooit. 
Het zal ook niet altijd gemakkelijk geweest zijn om rustig om te gaan met mijn slecht humeur 
en halve paniekaanvallen tijdens de examenperiodes. Gelukkig heb ik tegenwoordig mijn 
zenuwen al wat beter onder controle… 
Thijs en Hanne, nog veel succes met jullie alpaca’s. Misschien vinden we er ooit wel 
een nieuwe Helicobacter soort.  
Silke, ook jij durft, net als ik, wel eens te twijfelen. Maar ik ben er zeker van dat je 
onlangs de juiste keuze gemaakt hebt. Als ik ooit een maagverkleining zou nodig hebben, ik 
weet je te vinden…  
Oma (van Ichtegem, maar nu van Torhout). Bedankt om me op regelmatige basis te 
tolereren tijdens de examenperiodes destijds. Ik was inderdaad niet de gemakkelijkste… 
Oma (van Koksijde) en tante Trees. Bedankt om altijd vol interesse naar mijn 
studieverhalen te luisteren. Binnenkort afspraak in de Normandie??? 
Aan alle tantes, nonkels, neven en nichten: bedankt om een toffe familie te zijn. 
Ilse, Staf, Anke, Stijn, Jenne en ?, er zijn ergere families om in terecht te komen ☺. 
Steek de eerste lentebarbecue maar aan! 
Wim, Lies, Lexe, Paul, Ariane en Ilse, bedankt voor de fantastische vriendschap. We 
zien elkaar misschien wat minder nu ik in het verre Waasland resideer, maar we doen ons 
best… 
Ine, nu zal ik wat meer tijd hebben voor de dagelijkse wandeling. Smeer je 
stembanden maar al in. 
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Wimmek…, sorry, Tim, je wil dat ik er niet teveel woorden aan vuil maak. Bij deze: 
bedankt, je weet wel waarvoor. Op naar de toekomst. Wie weet beginnen we ooit onze eigen 
kaaaaaaswinkel? Bedankt ook om zo goed voor onze viervoeters te zorgen.  
Ben (Sven), Bob (Bifi), Jeroen (Vettel) en Gabrielle (Eekhoorn): jullie begrijpen me 
wel niet zo goed, maar weet dat jullie een uniek kwartet zijn. Op naar Sint-Niklaaaaaas! 
 
Aan iedereen die ik vergeten ben: sorry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
